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Thesis abstract  
There is currently a rise in demand for high throughput analytical tools that can readily 
purify, separate, and analyse nucleic acids. Recent discoveries on the pivotal functions 
of RNA in a wide range of biological systems have led to the potential application of 
RNA as therapeutic drugs to treat several serious diseases and as alternatives to 
chemical pesticides for insect management. This thesis focuses on the development 
and application of analytical approaches based on ion-pair-reverse-phase high-
performance liquid chromatography (IP RP HPLC) and electrospray ionisation mass 
spectrometry (ESI-MS) for the analysis of RNA and oligonucleotides.  
Buffer systems on ESI-MS were systematically tested by varying the concentrations 
of ion-pair reagents and organic modifiers to increase oligonucleotide ionisation 
efficiency. Optimal buffer systems were identified with respect to analyte type. 
Hydrophobic tags on oligonucleotides were tested to increase ESI-MS sensitivity. 
Different RNA extraction methods were compared and optimised based on extraction 
yields of dsRNA from engineered microbial cells. The performance, benefits, and 
drawbacks of various extraction methods were reported. LC-ESI-MS was also used in 
conjunction with in vivo and in vitro stable isotope labelling techniques for the 
quantitative analysis of dsRNA. The identification and absolute quantification of 
dsRNA in complex total RNA mixtures were performed.  
The impact of porosity in monolithic columns on HPLC performance for nucleic acid 
analysis under both retentive (IP RP) and non-retentive HPLC modes was investigated. 
The RP-1S (standard porosity) and RP-2H (high porosity) columns achieved higher 
separation efficiencies for nucleic acids with larger molecular weights, while the RP-
3U column (ultra-high porosity) showed optimum performance in analysing small 
oligonucleotides. High flow rates produced significant improvement in 
chromatographic resolutions regardless of column porosity. It was proposed from non-
retentive mode analysis that micro, meso, and macropores exist within the RP-1S and 
RP-2H columns while only large channels or pores of limited accessibility exist in the 
RP-3U column.  
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Chapter I : Introduction 
Ribonucleic acids (RNA) are one of the three major biological macromolecules 
involved in the central dogma of molecular biology, acting as an intermediary for 
genetic information between DNA and protein (Jacob and Monod, 1961). Research on 
RNA has been continuously growing with significant interest because of the essential 
roles it plays in many fundamental biological processes (Kruger et al., 1982; Guerrier-
Takada et al., 1983; Fire et al., 1998a). Only recently, our understanding of the roles 
of RNA has been broadened to include a number of interesting functions such as the 
catalysis of biochemical reactions, the regulation of cellular processes, and gene 
functions (Guerrier-Takada et al., 1983; Fire et al., 1998a). In addition, it has been 
found that defective RNA and RNA viruses are involved in human diseases, further 
highlighting the importance of RNA in numerous biological processes and spurring 
extensive clinical research efforts for RNA-based drugs to cure these diseases 
(Melnikova, 2007). These drugs, which include small interfering RNA (siRNA) and 
antisense oligonucleotides have shown unprecedented versatility as biotherapeutic 
tools (Burnett and Rossi, 2012). Due to the important role that RNA plays in a variety 
of biological systems and its emerging industrial importance as bio-therapeutics and 
as alternatives to chemical pesticides (Mao et al., 2007; Baum et al., 2007), demand 
for the development of high-throughput analytical platforms such as liquid 
chromatography and mass spectrometry to characterise and quantify RNA have 
increased greatly. 
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1.1 Deoxyribonucleic acids (DNA) 
Deoxyribonucleic acids comprise double strands of long polynucleotides, with 
individual strands called DNA strands. The two strands are held together via hydrogen 
binding between the base portions of nucleotides. The four nucleotide bases in DNA 
are adenine (A), cytosine (C), guanine (G), and thymine (T).  
    
1.2 Ribonucleic acids (RNA) 
Ribonucleic acids (RNA) are linear polynucleotide chains composed of four 
ribonucleotide bases namely, adenine (A), cytosine (C), guanine (G), and uracil (U), 
which are chemically attached via phosphodiester bonds (Figure I-1). A ribonucleotide 
is composed of a nitrogenous base, a phosphate group, and a ribose sugar. RNA are 
involved in the regulation of cellular functions in all living cells. Multiple types of RNA 
exist within cells, and the three major classes of cellular RNA involved in protein 
synthesis are protein-coding messenger RNA (mRNA), the non-protein-coding RNA 
such as transfer RNA (tRNA) and ribosomal RNA (rRNA). A class of small non-coding 
RNAs which includes siRNA and miRNA are responsible for regulating gene 
expression. All of these RNA types are described in the following sections. 
 
 
Figure I-1: Chemical structure of an RNA ribonucleotide (C: cytosine, A: adenine, 
U: uracil, G: guanine). 
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 Messenger RNA (mRNA) 
In the protein synthesis process, messenger RNA acts as an intermediary to convey 
genetic information from DNA to ribosomes (Jacob and Monod, 1961). The 
transcription of mRNA from DNA occurs through the copying of information encoded 
in a gene onto an RNA molecule called the precursor mRNA or pre-messenger RNA 
(pre-mRNA), which is subsequently processed into mature mRNA (Soller, 2006). 
These genetic codes are in the form of codons, each consisting of triplets of 
nucleotides. Codons begin with (AUG), which encodes for a specific amino acid. Each 
codon encodes for a different amino acid with the exception of three stop codons which 
terminate protein synthesis: UAA, UGA, and UAG, (Brenner et al., 1961; Brenner et 
al., 1965; Brenner et al., 1967).  
 
 
Figure I-2: The central dogma of molecular biology. Genetic information is 
transferred from the double strands of DNA onto a single strand of mRNA, where it is 
converted into a polypeptide amino sequence that folds to form a protein. 
 
 Ribosomal RNA (rRNA)  
Ribosomal RNA (rRNA) is components of ribosomes (approximately 60%) which are 
transported to the cytoplasm to aid in the translation of information from mRNA into 
protein. They are synthesised in the nucleolus, which also contains the essential 
genes to encode rRNA. Encoded rRNA is differentiated by sizes, which are described 
as either large or small and all ribosomes contain at least one of each. In the nucleolus, 
the rRNA complex with ribosomal proteins to form two subunits: large subunits (LSU) 
(the 50s) and small subunits (SSU) (30S) of the ribosome in bacteria. During 
translation, the rRNA in LSU acts as an enzyme (ribozyme) which catalyses the linking 
of amino acids together to form polypeptides (Alberts et al., 1989).  
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Figure I-3: Three-dimensional models of the small and large subunits of 
ribosomes.  Each ribosomal subunit is made of proteins and ribosomal RNA (rRNA). 
Reprinted from Human Heredity: Principles and Issues (p. 201) by M. R. Cummings 
(2014), USA. Copyright 2014 by Brooks/Cole, Cengage Learning. Reprinted with 
permission. 
 
 Transfer RNA (tRNA) 
Transfer RNA (tRNA) are a form of short-chain RNA, approximately 80 nucleotides in 
length, and serve as adaptors to link mRNA and amino acids (Sprinzl et al., 1976). 
During translation, tRNA recognises and binds to the specific codons of the mRNA 
and decodes them into specific amino acids at the ribosomal site (Sprinzl et al., 1976). 
In eukaryotic cells, tRNA is synthesised from a larger precursor tRNA by RNA 
polymerase III via splicing, folding, and chemical modifications, resulting in four, short 
double-helical segments resembling, a cloverleaf structure (Altman and Stark, 1974; 
Smith, 1975). The cloverleaf structure of the tRNA undertakes further folding, 
facilitating the formation of an L-shaped structure which is held together by hydrogen 
bonds between different regions of the molecule (Kim et al., 1974; Moras et al., 1980). 
This L-shaped tRNA structure has two regions of unpaired nucleotides located at each 
end. The first region contains three nucleotides (called the anticodon) complementary 
to a codon in an mRNA. The other is a short single-stranded region where the 3’-
terminal for the corresponding amino acid attachment specified by that codon attaches 
to the tRNA (See Figure I-4) (Alberts et al., 2002).  
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Figure I-4: A transfer RNA molecule (tRNA).  tRNA contains two regions, an 
anticodon region (a three nucleotides sequence) which binds to the complementary 
codons of the mRNA, and a region on another end which binds to amino acids that 
correspond to the anticodon. Reprinted from Human Genetics and Society (p. 110) by 
R. Yashon and M. Cummings (2012), USA. Copyright 2012 by Brooks/Cole, Cengage 
Learning. Reprinted with permission. 
 
 Small non-coding RNA 
Small non-coding RNA such as small interference RNA (siRNA) and microRNA 
(miRNA) are molecules that control gene expression in eukaryotic cells (Bernstein et 
al., 2001; Pasquinelli and Ruvkun, 2002). The siRNA molecule is a small double-
stranded RNA molecule of approximately 20 base pairs in length (Figure I-5), is 
generated from the cleavage of dsRNA by the RNase III enzyme, Dicer, and targets 
perfectly matching mRNA for cleavage via a siRNA-protein complex (Bernstein et al., 
2001). On the other hand, miRNA can target many different mRNA sequences due to 
the imperfect pairing, inhibiting translation, and is the result of a small hairpin precursor 
cleaved to the relevant size by Dicer (Pasquinelli and Ruvkun, 2002). The role that 
small non-coding RNA plays in inhibiting translation was first discovered through a 
short, double-stranded RNA in C. elegans. This molecule was complementary to the 
sense strand of mRNA, binging to its 3’ untranslated region and resulting in specific 
degradation (Lee et al., 1993). This gene-specific degradation by small non-coding 
RNA is known today as RNA interference (RNAi), which is detailed in section 1.3.5. 
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Figure I-5: Schematic illustration of siRNA. siRNA consists of two RNA nucleotides 
forming a duplex core (19-20 bp), with 2 nucleotide (nt) overhangs on both of the 3’ 
ends. The 3’ ends are hydroxyls (OH) and the 5’ ends contain monophsphorylated (P).  
Reprinted from “Biogenesis and function of endogenous and exogenous siRNAs,” by 
N. Snead and J. Rossi (n.d.), Wiley Interdisciplinary Reviews: RNA, 1(1), p. 117-131. 
Copyright 2003 by John Wiley and Sons. Reprinted with permission. 
 
 Double-stranded RNA 
Double-stranded RNA (dsRNA) are molecules with an unique form appearing with two 
complementary strands, instead of the single-stranded structure which is more 
common for this type of genetic material. Molecules of dsRNA act as signals for gene-
specific silencing in a phenomenon known as RNA interference (RNAi), leading to 
specific degradation of the targeted mRNA in eukaryotic cells or any organism that 
can respond to gene-specific dsRNA.  
The occurrence of  RNAi was first demonstrated after researchers attempted the 
injection of dsRNA into a worm (Caenorhabditis elegans) and observed the 
corresponding gene disappear (Fire et al., 1998). This phenomenon has also been 
demonstrated in many other eukaryotic cells by other researchers (Ngô et al., 1998; 
Kennerdell and Carthew, 1998; Voinnet et al., 1998; Waterhouse et al., 1998). This 
dsRNA-mediated interference has been generalised to another level of control over 
the gene regulation and expression. 
Double-stranded RNA can be synthesised either in a bacterial system or through in-
vitro transcription for the purpose of RNAi (Li et al., 2011; Palli, 2014). Timmons and 
Fire found that the use of short-length dsRNA can cause a restriction in penetrance 
and expressivity (Timmons and Fire, 1998); dsRNA engineered in an E. coli BL21 
(DE3) strain showed degradation in some parts caused by endonuclease RNase III 
digestion (Timmons et al., 2001). Using an RNase III-deficient E. coli strain called 
HT115 to engineer dsRNA, they produced high quantities of specific dsRNA, which 
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activated effective interference when they were fed to cells of C. elegans (Timmons et 
al., 2001). This finding shows that exploiting E. coli cells which lack RNase III or using 
an in-vitro transactional process allows for the cost-effective production of large 
quantities of dsRNA, thus enabling the delivery of siRNAs to target organisms 
(Timmons and Fire, 1998; Aalto et al., 2007; Maori et al., 2009).  
 
 
Figure I-6: Tertiary structure of a 16-mer dsRNA. The distinguishing feature 
between the structures of RNA and DNA is the presence of a hydroxyl group located 
at the 2’ position of the ribose sugar of RNA, which constrains the helix to the A-form 
geometry. A consequence of the A-form geometry is that that the major grooves will 
be narrow and deep while the minor grooves will be wide and shallow. Image from the 
RCSB PDB (www.rcsb.org) of PDB ID 3ND4 by B. H. Mooers and A. Singh (2011) in 
“The crystal structure of an oligo(U):pre-mRNA duplex from a trypanosome RNA 
editing substrate.” RNA, 17: 1870-1883. Reprinted with permission under RCSB PDB 
copyright policies. 
 
1.3 Nucleic acid therapeutics  
Recent discoveries of nucleic acid-based therapeutic drugs show great promise under 
clinical investigation for combating a wide variety of human major diseases including 
cardiovascular genetic disorders, AIDS infectious disease and various cancers 
(Burnett and Rossi, 2012).  
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The first oligonucleotide therapeutic drug to launch on the market was fomivirsen 
(Vitravene®, Isis Pharmaceuticals, CA, USA), an antisense therapy based drug that 
was approved in 1998 and was used to treat cytomegalovirus retinitis (Roehr, 1998). 
However, fomivirsen was discontinued in 2007 due to improvements in HIV 
medications. As of 2016, only two oligonucleotide drugs have reached the market 
besides fomivirsen, pegaptanib and mipomersen ( 
Table I-1) (Offord, 2016). Pegaptanib, which was approved in 2004 is an aptamer 
oligonucleotide that can block specific proteins and is used to treat age-related 
macular degeneration. It was quickly substituted by a more effective monoclonal 
antibody. Mipomersen is an antisense oligonucleotide designed for the treatment of a 
genetic form of high-cholesterol (Offord, 2016).  
The slow advancement of nucleic acid-based drugs has not prevented more than 70 
oligonucleotide therapeutics from reaching or even completing clinical testing for the 
treatment of cancers, viruses, and genetic disorders. RNA oligonucleotides hold both 
therapeutic and commercial promise as shown by a recent report estimating that the 
global antisense and RNAi therapeutics market will reach $ 4.58 billion by 2022 (Offord, 
2016). 
 
Table I-1 Commercialised oligonucleotide drug sequences of in 2016  
Drug name Sequence  
Pegaptanib 5’-[40kD]-[HN-(CH2)5O]-
pCfpGmpGmpArpArpUfpCfpAmpGmpUfpGmpAmpAm 
pUfpGmpCfpUfpUfpAmpUfpAmpCfpAmpUfpCfpCfpGm3’-p-dT 
Mipomersen      2’MOE       2’Deoxy      2’MOE  
5’-GCCTCAGTCTGCTTCGCACC 
               Phosphorothioate  
                      backbone 
 
 The application of RNAi in agriculture improvement  
In agriculture, insect pests incur significant costs and are a growing threat due to ever-
present insecticide resistance, leading to efforts to research alternative pest-control 
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strategies. The RNA interference (RNAi) approach has been successfully 
demonstrated as a powerful tool in coleopteran and lepidopteran pests control (Mao 
et al., 2007; Baum et al., 2007), and can be used to engineer pathogen-resistant plants 
by altering plant gene expressions (Duan et al., 2012).  
The RNAi defence mechanism can down-regulate any gene effectively driven by the 
induction of double-stranded RNA (dsRNA) (Fire et al., 1998), resulting in high- quality 
traits, such as combined resistance to biotic and abiotic stresses and improved of 
nutritional content in crops (Saurabh et al., 2014). The regulatory potential of RNAi is 
immense and has led to breakthroughs in agricultural improvement.   
 
 Classification of RNA based therapeutics  
RNA-based therapeutics have unprecedented versatility as demonstrated by their 
multiple classifications based on mechanisms of action. These mechanisms include 
antisense, an mRNA translation inhibitor; siRNA, an agent involved in RNA 
interference; ribozymes, which are catalytically active RNA molecules; and aptamers, 
which are RNA molecules that bind to proteins and other specific ligands. 
 
Table I-2: Specification of different type of RNA based therapeutics 
Type Structure Target Key action 
Antisense 
oligonucleotide 
Single-stranded 
DNA or RNA 
Messenger RNA 
(mRNA) or pre-
mRNA 
Block ribosomal 
translation 
Small interfering 
RNA (siRNA) 
Double-stranded 
RNA 
mRNA siRNA to trigger 
target degradation 
MicroRNA Double-stranded 
RNA 
mRNA miRNA to inhibit 
translation 
Ribozymes Single-stranded  
RNA or 
transcribed 
therapeutic genes 
Specific 
phosphodiester 
bonds 
Catalyse site-
specific self-
cleavage of RNA 
Aptamer Single-stranded 
DNA or RNA 
Small molecules, 
proteins, toxins, or 
whole cells 
Inactivates or 
modifies targets 
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 Antisense oligonucleotides  
An antisense oligonucleotide is composed of short, single-stranded DNA or RNA 
oligonucleotide fragments of approximately 12-25 nucleotides in length that have 
undergone specific chemical modifications designed to increase stability (Crooke, 
1999). The genetic sequences of antisense oligonucleotides are deliberately designed 
to be complementary to a target messenger RNA (mRNA). This complementarity 
allows antisense oligonucleotides to suppress targeted genes by inhibiting ribosomal 
translation of mRNA, disrupting a vital link in the protein synthesis process. In contrast, 
most conventional drug compounds are designed to interact with protein molecules by 
changing their structure and function, in order to restrain the causes of disease-
potentiating or disease signalling pathways (Overington et al., 2006). 
 
 Antisense mechanism  
The inhibition of RNA function following the binding of oligonucleotides to target RNA 
is a key feature of antisense oligonucleotides. Multiple antisense mechanisms exist 
for this purpose, and the best-characterised ones either result in the target RNA’s 
cleavage by endonuclease such as RNase H or exploit nuclease association through 
a more elaborate pathway called RNA interference (RNAi) (Dean and Bennett, 2003).  
 
1.3.4.1 RNase H Mechanism 
RNase H is a ubiquitously expressed cellular enzyme which catalyses the hydrolysis 
of RNA strands from either an RNA or DNA heteroduplex. The RNase H mechanism 
is the most utilised method in clinical trials for antisense drugs due to its well-
characterised pharmacology, toxicity, and pharmacokinetics (Dean and Bennett, 
2003). Antisense oligonucleotides contain a continuous segment of approximately 5-
7 DNA-like nucleotides that can inhibit gene expression via the RNase H-mechanism 
and support RNase H activity (Monia et al., 1993; Wu et al., 1999). 
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Figure I-7: The RNase H-dependent antisense pathway. Firstly, single-stranded 
oligonucleotides are transited through the plasma membrane, either through (poorly 
characterised) natural processes or by the utilisation cationic lipids as facilitators. After 
entering the cytoplasm, the oligonucleotides promptly accumulate in the cell nucleus. 
Once the oligonucleotides bind to their targeted mRNA within the cell nucleus, the 
oligonucleotide/RNA duplex would be "recognised" as a substrate by the enzyme 
RNase H. Finally, RNase H cleaves the RNA strand, thereby releasing the antisense 
oligonucleotide strand. Reprinted from “RNA interference against viruses: strike and 
counterstrike,” by J. Haasnoot, E. Westerhout, and B. Berkhout (2007), Nature 
Biotechnology, 25, p. 1435. Copyright 2007 by Springer Nature. Reprinted with 
permission. 
 
 siRNA therapeutics-RNA interference 
Small interfering RNA (siRNA) are 21-23 nucleotides-long, double-stranded RNA with 
an antisense active strand that is exactly complementary to a sequence anywhere in 
the target mRNA. The RNAi process is initiated by RNase III enzymes (such as ‘Dicer’) 
which cleave either synthetic dsRNA or small hairpin RNA (shRNA) in order to produce 
small interference RNA (siRNA) and micro RNA (miRNA); small RNA molecules 
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central to the RNAi process (Dean and Bennett, 2003). Both molecules have the ability 
to bind with specific mRNA to either increase or decrease their activities by preventing 
the translation of that mRNA into a protein. The binding process is facilitated by the 
incorporation of siRNA and miRNA into an RNA-induced silencing complex (RISC), 
producing an siRNA-RISC complex or miRNA-RISC complex and leading to the 
degradation of its homologous target mRNA by endonucleases (see Figure I-8).  
RNA-based therapeutics usually target mRNA, but may also target miRNA. An 
example of a miRNA-based drug is miravirsen (developed by Santaris Pharma A/S) 
which targets an endogenous miRNA in the liver necessary for Hepatitis C virus (HCV) 
infections (Lanford et al., 2010). In addition, an siRNA drug OPI-1007 has been 
developed by Quark Pharmaceuticals which targets caspase-2 to treat vision loss due 
to causes related to the optic nerve. Another example of an siRNA drug is SYL04002, 
which was developed by Sylentis to hinder the production of aqueous humor to ease 
intraocular hypertension (Guo et al., 2002). 
 
 
Figure I-8: The RNA interference antisense mechanism. The steps involved in the 
RNAi pathway: (A) Double-stranded RNA oligonucleotides enter through the plasma 
membrane via either (uncharacterised) natural processes or facilitators. The ATP-
dependent RNase III enzyme “Dicer” initiates the process by cleaving the long double-
stranded RNA (dsRNA). This results in a shorter double-stranded RNA, also known 
A B 
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as siRNA which contains 21-25 base pairs. Once it reaches the cytoplasm, siRNA are 
recognised and bound to the RISC, a protein complex. Next, the two RNA strands 
unwind (requiring ATP) and stimulate in the single-stranded antisense strand, serving 
to "guide" the RISC to bind to the target messenger RNA which has a complementary 
sequence. After the target mRNA are bound, they are cleaved by a ribonuclease, and 
the antisense strands are hydrolysed. (B) The microRNA pathway: the cleavage of the 
hairpin miRNA precursor (~70 nt) into a miRNA (~22 nt). miRNA is activated by Dicer. 
miRNA differs to siRNA, in which a single strand is incorporated into the miRNA-
protein complex. The partial sequence of miRNA is complementary to the target 
mRNA, resulting in translational repression. Reprinted from “Killing the messenger: 
short RNAs that silence gene expression,” by D. M. Dykxhoorn, C. D. Novina, and P. 
A. Sharp (2003), Nature Reviews Molecular Cell Biology, 4(6), p. 457-467. Copyright 
2003 by Springer Nature. Reprinted with permission. 
 
 Ribozymes 
Ribozymes are self-processing catalytic RNA molecules that catalyse specific self-
cleavage and ligation reactions (Burnett and Rossi, 2012). These reactions occur at 
specific phosphodiester bonds via base-pairing and interactions aligning the cleavage 
site within the ribozyme active site (Doudna and Cech, 2002).  
The substrate that stimulates site-specific cleavage and recognises the domain of 
ribozymes can be engineered in cis (the same nucleic acid strand) or trans (a non-
covalently linked nucleic acid) (Scherer and Rossi, 2003). Ribozymes enable gene 
expression through RNA site-specific cleavage; thus making ribozymes RNA 
therapeutics and diagnostic agents. In addition, ribozymes can be engineered as 
biosensors termed ‘riboswitches’, which are capable of switching on and off while 
being bound to small-molecule allosteric effectors (Wieland et al., 2010; Liang et al., 
2011).  
Ribozymes are similar to siRNA/shRNA therapeutics and can be delivered in RNA 
form to target cells or transcribed from therapeutic genes. Merck and Sirna currently 
holds a licensed for Angiozyme (RPI.4610), which is the first synthetic ribozyme to be 
tested clinically and which acts by targeting a specific mRNA related to angiogenesis 
and tumour growth in order to treat them (Kobayashi et al., 2005). Another target of 
ribozyme treatment is HIV; despite lack of success, there have been efforts to utilise 
CD4+T-cells or CD34+hematopoietic stem cells (HSCs) due to them being more 
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favourably infected by HIV-1 (Wong-Staal et al., 1998; Macpherson et al., 2005; 
Amado et al., 2004; Michienzi et al., 2003).  
 
 Aptamers 
Therapeutic aptamers are short, single-stranded oligonucleotides (of 20-60 
nucleotides) that are capable of binding to target molecular ligands. This capability 
terms from their specificity, which allows them to fold into a 3-dimensional structure, 
giving them high affinity and high specificity for the targeting of various molecules 
(Ellington and Szostak, 1990). Aptamers are engineered from multiple rounds of in 
vitro or in vivo selection through the process of SELEX (systematic evolution of ligands 
by exponential enrichment) with the desired characteristics. During SELEX, random 
nucleotides are selected from a large, initial oligonucleotide pool (IOP) for binding to 
a wide range of targeting molecules. The modulation of their functions is analogous to 
antibodies, which is why aptamers are often called nucleic acid antibodies (Keefe et 
al., 2010).  
Aptamers are considerably easier and cheaper to produce than antibodies and are 
neither immunogenic nor toxic. These advantages are significant and have led to 
aptamers becoming an ideal candidate for numerous applications such as diagnostic 
and therapeutic tools as well as biosensors (Cibiel et al., 2012; Yang et al., 2011).     
Several RNA-based aptamers have been developed and clinically tested. 
Pfizer/Eyetech have licensed an FDA-approved drug using a VEGF-specific modified 
RNA aptamer (sold as Macaugen) for the treatment of age-related macular 
degeneration (AMD) (Keefe et al., 2010; Thiel and Giangrande, 2009). Aptamers have 
also been modified to respond to other effector RNA, such as the REG1 dual-aptamer 
therapy developed by Regado Biosciences for acute coronary syndrome (ACS) 
(Cohen et al., 2010).  
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1.4 Oligonucleotide synthesis 
 Synthesis methods  
Clinical research on oligonucleotides requires ranging amounts of material (from a few 
grams up to several kilograms) depending on the application. While small-scale 
synthesis of oligonucleotides is relatively attainable, large-scale production of a 
sufficient quality remains a challenge due to the high costs of the required reagents 
and chemicals, environmental safety regulations, and the scarcity of raw materials 
(Sinha et al., 2006). To improve the situation, synthetic techniques are being 
researched to manage large-scale synthesis at high throughput levels (Murgha et al., 
2014). 
Phosphoramidite chemistry has become the most widely applied solid phase synthesis 
technique, allowing convenient synthesis of oligonucleotides using nucleoside 
phosphoramidites as building blocks (Wei, 2013). Its advantages include easy 
implementation, efficient separation of end products and sufficiently high yields 
(Amarnath and Broom, 1977; Beaucage and Caruthers, 1981).  
Despite these advantages, purification remains a necessary step due to the impurities 
generated by the synthesis process (Huber et al., 1993). To that end, the use of liquid 
chromatography methods such as anion exchange chromatography (with improved 
protocols) are convenient and effective separation and purification techniques which 
can enhance the yield and quality of oligonucleotide products (Wincott et al., 1995).  
This solid phase synthesis of oligonucleotides involves four stages. A controlled pore 
glass (CPG) support is used to immobilise and protect the initial base the sequence. 
The protecting group is removed to release a free 5’-terminal hydroxyl of ribose sugar 
on the oligonucleotides precursor during the first stage of detritylation, following which, 
the nucleoside readily reacts with additional phosphoramidite nucleosides formed in 
the coupling stage for chain extension. The small amount of uncoupled 5-hydroxyl 
group remaining on the oligonucleotides chains is coupled with subsequent bases in 
the sequence by acetylation during the capping stage. Finally, the unstable phosphite 
triester (P (III)) linkage is converted to the stable phosphate triester (P (V)) linkage 
using an oxidation agent (iodine) to treat the developed oligonucleotide chains. The 
phosphoramidite synthesis cycle is shown in Figure I-9.  
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The critical step in the overall synthesis cycle is coupling, which is the limiting reaction. 
Thus, it should be quick and close to the quantitative position, and any serious side-
reactions should be avoided. In order to efficiently couple, an appropriate coupling 
activator is needed so that the phosphoramidites are in a highly activated mode (Wei, 
2013). 
 
 
Figure I-9: The oligonucleotide chemical synthesis cycle via phosphoramidite 
chemistry. Reprinted from Synthesis of DNA Using a New Two-Step Cycle, in: 
Oligonucleotide Synthesis, (pp. 1–16), Methods in Molecular Biology by D. J. Dellinger, 
J. R. Betley, T. K. Wyrzykiewicz, and M. H. Caruthers (2005). Copyright 2005 by 
Springer Science and Bus Media B V. Reprinted with permission. 
 
1.5 Oligonucleotide modification 
 Types of modifications  
Oligonucleotides can be chemically modified in order to increase nuclease stability, 
modify structural preferences, increase binding affinity, determine knockdown 
specificity, improve cellular uptake, and/or overcome immune stimulation (Nolte et al., 
2013)  (Deleavey and Damha, 2012; Watts and Corey, 2012). In particular, improved 
nuclease stability is crucial to avoid degradation of the oligonucleotides upon entry to 
cells due to the presence of nuclease enzymes. Chemical modifications of 
oligonucleotides can be broadly classified into three categories: Internucleotide 
linkage modifications (backbone), sugar modifications, and nucleobase modifications. 
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These modifications can be located at varying positions, for example at the 3’-end or 
5’-end of the backbone, internally within the sugar-phosphate or at nucleobases of the 
oligonucleotide sequence (Corey, 2007). Common examples of oligonucleotide 
modifications are shown in Figure I-10. Finally, it is worth noting that modifications 
involving RNase H-dependent mRNA cleavage require the modified oligonucleotide to 
preserve a polyanionic character (Sheehan et al., 2003). 
 
 
Figure I-10: Structures of commonly used chemical modifications. Reprinted 
from “Silencing disease genes in the laboratory and the clinic,” by J. Watts and D. 
Corey (2012), The Journal of Pathology, 226(2), p. 365-379. Copyright 2012 by John 
Wiley and Sons. Reprinted with permission. 
 
Phosphorothioate (PS) linkages are a common type of internucleotide linkage 
modification, providing greatly improved nuclease resistance (Watts and Corey, 2012). 
They are mainly represented by first-generation antisense therapeutic 
oligonucleotides, such as Fomivirsen (Deleavey and Damha, 2012). The key feature 
of the PS linkage modification is the substitution of sulfur with a single non-bridging 
phosphate oxygen (Deleavey and Damha, 2012). PS modifications are a cost-effective 
and easily implemented method to increase the nuclease resistance of 
oligonucleotides using typical solid-phase oligonucleotide synthesis procedures 
(Sanghvi, 2011). 
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Sugar modifications are frequently combined with internucleotide linkage 
modifications to exert additional control over oligonucleotide properties. Together, they 
feature heavily in second and third generation oligonucleotides. The key physical 
property manipulated by sugar modifications is the “nucleotide sugar puckering 
preference”, which is of interest because of its relation to oligonucleotide binding 
affinities, among other parameters (Deleavey and Damha, 2012).  
Most sugar modifications involve changing the 2’ position of RNA and replacing the 
hydroxyl with various other groups. Commonly used sugar modifications include 2’-O-
MOE (2’-O-(2-methoxyethyl)), locked nucleic acid (LNA), 2’-O-Me, 2’F-ANA, and 2’F-
RNA, with 2’-O-MOE featured through the drug Mipomersen (Deleavey and Damha, 
2012). Mipomersen, a second-generation oligonucleotide, was recently approved by 
the FDA (Pollack, 2013). A “gapmer” is commonly utilised for second and third 
generation sugar modifications, and features sugar-modified nucleotides on the 
oligonucleotide ends, adjoining a central DNA core (Deleavey and Damha, 2012).  
Finally, nucleobase modifications are less common than internucleotide linkage and 
sugar modifications, but are still numerous and can be used to improve thermal 
stability, in addition to the other properties mentioned above. Nucleobase 
modifications are usually performed to increase duplex stability while preserving and 
improving base pairing recognition as well as hydrogen bonding (Deleavey and 
Damha, 2012). 
 
1.6 Analytical approaches for the analysis of RNA 
The need for advanced knowledge and understanding of intracellular RNA functions 
has prompted the development of numerous approaches which address the different 
stages of large biomolecular RNA analysis, from upstream cell synthesis and 
extraction to downstream analysis. 
Unfortunately, in comparison to other macromolecules such as DNA and proteins, the 
development of a highly efficient approach for nucleic acid analysis has been 
hampered by the challenging nature of RNA which refuses to yield to conventional 
analytical techniques. These difficulties are primarily due to the chemically labile 
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structure of RNA leading to difficulties in extracting, storing, and transferring it to 
downstream analysis. Moreover, the presence of a polyanionic phosphate backbone 
in the RNA structure leads to a high tendency to form stable cation adducts during 
downstream characterisation of RNA, hindering mass spectrometry analysis. In 
addition, due to the similarity of the nucleic acid product to potential impurities (such 
as n-1 or single base conversions) separation of the oligonucleotide therapeutic from 
related impurities is challenging. To effectively analyse RNA, a wide variety of 
analytical approaches which specifically address these issues have been developed 
and are discussed in the following sections. 
 
1.7 RNA purification technology   
 Solid-phase extraction 
Historically, nucleic acid solid phase extraction involved the use of chaotropic agents: 
either guanidinium thiocyanate (GuSCN) or guanidine hydrochloride (GuHCl) in 
conjunction with a solid membrane silica column. In general, following cell lysis in 
GuSCN, DNA/RNA is purified by directly loading it onto the solid phase column prior 
to centrifugation and ethanol wash (Boom et al., 1990). Under the induced hydrophilic 
conditions, nucleic acids are attracted to the silica membrane surface via specific 
binding. The other non-selected materials do not undergo such an attraction to the 
surface and can be removed with an additional ethanol wash.  
Solid phase extraction has some similarities to the classical liquid chromatography 
approach. Both methods involve dissolving the samples in solvents before passing the 
mixture through a solid phase containing column. The primary difference between SPE 
and chromatography is that SPE does not rely on partitioning phenomena, which is 
described as on and off separation procedure. The resulting materials from SPE are 
crude compared to the ones obtained from chromatography (Gjerde et al., 2009). A 
number of commercially available kits often use silica or glass spin columns for their 
quick selectivity of the nucleic acid of interest from prokaryotic and eukaryotic cells. 
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 Agarose gel electrophoresis  
Gel electrophoresis has become the standard method for the characterisation and 
separation of charged macromolecules, including nucleic acids (Ylmaz et al., 2012). 
During electrophoresis, a voltage gradient is applied across the gel; the negatively 
charged phosphate backbone of RNA/DNA has a strong affinity to the positive 
electrode in an electric field and migrates towards it. Frictional forces in the pores of 
the gel slow down this migration process at rates dependent on the hydrodynamic size 
and shape of RNA molecules, thus enabling separation based on size (Lehrach et al., 
1977).  
The charaterisation and quantification of RNA are usually determined using standards 
of known molecular weights and concentrations while performing traditional agarose 
gel analysis. However, RNA might migrate in a folded or semi-folded form, and the 
resultant smearing bands lead to the imprecise measurement of RNA (Lehrach et al., 
1977). In response, denaturing agarose gel electrophoresis conditions are often 
employed with the aim of improving these smearing issues (Lehrach et al., 1977). 
Unfortunately, many of these denaturing methods either require complicated 
procedures or utilise toxic, carcinogenic chemicals, such as the glyoxal/dimethyl 
sulfoxide and methyl mercury hydroxide (Bailey and Davidson, 1976, McMaster and 
Carmichael, 1977). To avoid the use of these hazardous chemicals, other denaturants 
have been proposed such as urea, guanidine thiocyanate, DMSO, formamide, and 
formaldehyde (Floyd et al., 1974, Pinder et al., 1974, Skopp and Lane, 1988, Goda 
and Minton, 1995). Although these methods were an improvement over previous ones, 
they were still imperfect due to the involvement of extensive washing before staining 
with ethidium bromide as well as interference with the electrophoretic mobility of RNA 
molecules (Tsang et al., 1993). In addition, following gel electrophoresis, RNA requires 
further extraction from the gel matrix, (a process that is done by cutting out the band 
and re-extracting the material), leading to a high potential for RNase contamination.   
Drawbacks of gel electrophoresis include the required use of hazardous denaturants, 
risks of RNase contamination, difficulty in automation and less than accurate 
quantification. These caveats limit the performance of gel electrophoresis for the 
analysis of nucleic acids.     
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1.8 High-performance liquid chromatography 
High-performance liquid chromatography (HPLC) is a widely used separation 
technique based on the specific interaction between analytes and a stationary phase 
(a column). During its process, the analyte is dissolved in a solvent and carried through 
a column in a liquid phase (known as the ‘mobile phase’). The separation rate of each 
compound depends on its affinity to the column. The difference in affinity between 
different compounds allows the separation of the constituents of a sample (Gjerde et 
al., 2009).  
The use of HPLC for nucleic acid analysis has been proposed as an alternative to 
conventional methods such as gel electrophoresis. The superior capabilities of HPLC 
become apparent when it is used for the identification, separation, and quantification 
of nucleic acids. Some of these advantages include sample automation, fraction 
collection, and data reporting functions, which promote higher sample analysis 
throughput and recovery rates (Huber, 1998). Thus far, a variety of HPLC approaches 
have been employed for the analysis and purification of RNA, with the ion-pair reverse-
phase high-performance liquid chromatography (IP RP HPLC) mode being the most 
widely utilised technique for this purpose (Huber and Krajete, 1999; Premstaller et al., 
2000; Dickman, 2011). 
 
 Ion-pair reverse-phase chromatography (IP RP HPLC)  
IP RP HPLC has been defined by numerous alternate names in literature, each 
depending on the suggested mechanism and application (Wittmer et al., 1975; Kraak 
and Bijster, 1977; Bidlingmeyer et al., 1979; Bidlingmeyer, 1980; Hoffman and Liao, 
1977; Knox and Jurand, 1976). The ion-pair model proposes the use of ion-pair 
reagents in the mobile phase due to their tendency to interact with solute ions to form 
neutral ions, which are retained on the hydrophobic column with an improved retention 
time (Wittmer et al., 1975; Knox and Jurand, 1976). An alternate dynamic ion 
exchange model suggests that the adsorption of ion-pair reagents first occurs on the 
surface of the hydrophobic column, which then provides the exchange sites for solute 
ions (Kraak and Bijster, 1977; Hoffman and Liao, 1977; Bidlingmeyer et al., 1979). A 
third model combines the previous two models, proposing that both ion-pairing and 
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dynamic ion exchange processes occur and that the degree of significance of each 
process depends on experimental conditions (Knox and Jurand, 1976; Wittmer et al., 
1975). Bidlingmeyer et al., (1979) indicated that an electrical double layer is formed 
once the ion-pair reagent binds via the dynamic adsorption onto the hydrophobic 
stationary phase (Bidlingmeyer et al., 1979; Bidlingmeyer, 1980).  
IP RP HPLC is the principal HPLC mode for nucleic acid separations, and was first 
demonstrated by Huber et al., (1995) through the unique separation properties of an 
alkylated polystyrene-divinylbenzene (PS-DVB) polymer bead stationary phase with a 
nonporous surface (Huber et al., 1992). Their technique facilitated rapid and high-
resolution separation of single-stranded (ss) and double-stranded (ds) DNA. In 
addition, a resolution of the fragments differing by only a single base pair in length was 
achieved in very short analysis times (Huber et al., 1995). The C18 PS-DVB column 
was later commercialised by Transgenomic (USA) as the “DNAsep column,” which 
contributed significantly to the development of nucleic acid chromatography. 
Subsequently, a few monolithic, polymer-based materials have been extensively 
reviewed to prove their potential as alternatives to particle-packed columns, and have 
shown results demonstrating their capacity for high-resolution separation of nucleic 
acids (Premstaller et al., 2000; Huber and Oberacher, 2002; Oberacher and Huber, 
2002; Nwokeoji et al., 2016).  
Results from recent studies using IP RP HPLC to analyse and purify RNA indicate its 
capability to perform in a wide range of RNA applications, from the purification of 
synthetic oligoribonucleotides to the analysis of more complex RNAs (Murray et al., 
1994; Hölzl et al., 2005; McCarthy et al., 2009; Farand and Gosselin, 2009; Ivleva et 
al., 2010; Nwokeoji et al., 2016).  
 
 Mechanism of ion-pair reverse-phase chromatography for nucleic acid 
analysis 
Nucleic acids are naturally hydrophilic and are negatively charged due to the presence 
of a phosphate backbone, which cannot interact with the hydrophobic stationary phase 
for chromatographic separation without pre-treatment. Thus, an ion-pair reagent 
(organic alkylammonium cation salt) is necessarily added into the eluent to form a 
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nonpolar hydrophobic ion-pair with the phosphate anion group of nucleic acids, 
increasing its hydrophobicity and allowing it to interact with the stationary phase. In 
general, triethylammonium acetate (TEAA) is the most commonly used amine cation 
salt for this purpose, as nonpolar ion-pairs (N+A-) are formed when a nucleic acid 
sample is introduced, allowing subsequent adsorption of the TEAA/ nucleic acid ion-
pair fragments onto the non-anionic and hydrophobic surface column. Acetonitrile 
(ACN) is another additive that is frequently added to the mobile phase in a gradual 
manner according to a specific gradient to reduce the polarity of the mobile phase: a 
prerequisite for successful separation. Once the nucleic acid ion-pair fragments 
desorb from the column, the fragments will elute in the order of increasing size as the 
concentration of acetonitrile is increased. For instance, the smaller fragments will be 
eluted first, followed by the larger fragments. Figure I-11 illustrates the mechanism of 
the IP RP HPLC separation process for nucleic acids.   
 
 
Figure I-11: Schematic illustration of the mechanism of the IP RP HPLC 
separation process for nucleic acids. TEA=Triethylammonium; A= acetate; P= 
phosphate; B= nitrogenous base. The ion-pairing reagent, triethylammonium acetate 
(TEAA) is prepared by mixing triethylamine with acetic acid to make a final solution 
with pH 7.0. The positively charged hydrophobic TEAA ions interact with the negatively 
charged polyanionic backbone of nucleic acid fragments to form neutral ion-pairs. 
Thus, TEA/ nucleic acid ion-pairing complexes become hydrophobic and can interact 
with the hydrophobic stationary phase. The separation process is size-based as the 
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acetonitrile percentage rises larger nucleic acids are able to desorb. Reprinted from 
RNA Puriﬁcation and Analysis (p. 55) by D. T. Gjerde, L. Hoang, and D. Hornby (2009), 
USA. Copyright 2009 by John Wiley and Sons. Reprinted with permission. 
 
 
 Separation of RNA using IP RP HPLC 
The chromatographic separation of RNA using IP RP HPLC is dependent on the 
choice of the mobile phase as well as the particular properties of the RNA being 
analysed. For instance, the separation of single-stranded nucleic acid is heavily 
influenced by differences in size, sequence hydrophobicity, and conformation. 
However, in some cases, different molecules may exhibit relatively similar separation 
behaviours, such as that of short oligodeoxynucleotides (from DNA) and 
oligoribonucleotides (from RNA). 
The presence of polar phosphodiester groups in nucleic acids have a greater effect on 
retention time due to their interaction with non-polar ion-pairing ions. For example, 
ssRNA which is smaller than dsRNA and has half the amount phosphodiester groups 
only interacts with half the amount of ion-pairing ions, leading to shorter retention times 
(Gjerde et al., 2009).  
The hydrophobic properties of the stationary phase are directly correlated to the 
number of methyl groups present in the alkyl chain of the ion-pair reagent. In TEAA, 
these short alkyl chains, only manage to retain the stationary phase in a partially 
hydrophobic state due to partial coverage. Under such conditions, the separation 
process depends on both size and base composition.  
The effect of base composition is a result of all four bases of RNA being different in 
their relative hydrophobicity: adenine (A) and uracil (U) are more hydrophobic 
compared to cytosine (C) and guanine (G). Thus, sequences rich in C- and G will elute 
prior to sequence rich in A and U. This effect has been found to be more pronounced 
if the C and G nucleotides are positioned at the end of the fragment (Huber et al., 1992; 
Huber et al., 1993). In the case of ssRNA separation, replacing the less hydrophobic 
TEAA with a more hydrophobic ion-pairing reagent such as tetrabutylammonium 
bromide (TBAB) or N-hexylammonium acetate (HAA) may reduce or eliminate this 
sequence dependency (Dickman et al., 2002; Dickman, 2005). This is because the 
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longer alkyl chains contained in TBAB and HAA are able completely to cover the 
stationary phase, causing the dynamic anion-exchange process to dominate in size-
dependent separation. 
 
 Reversed-phase stationary phases  
1.8.4.1 Silica-based stationary phases  
Initially, conventional silica-based C18 resins and polymeric reversed-phase stationary 
phases were widely adopted for nucleic acid separation (Swiderski et al., 1994). The 
porous stationary phases were shown to successfully separate small-sized molecules, 
but were ineffective for biopolymers, thus limiting their application. This limitation was 
explained by the small pores of the chromatographic support restricting access to large 
biomolecules (Unger et al., 1987). 
Subsequently, advanced silica packing media with a wide range of pore sizes from 
normal to large (300-4000 Å) were developed. The large pores provided macro-
biomolecules with sufficient access to the functional surface of stationary phase, 
removing a crucial limitation and proliferating the use of HPLC in the field of 
biotechnology (Jilge et al., 1989). Despite this advancement, researchers found that 
the large macropores in the stationary phase support considerably slowed down the 
mass transfer of small molecules, causing poor resolutions and low sample recovery 
rates (Rozing and Goetz, 1989). In addition, low molecular diffusion rates of 
biopolymers in porous stationary phase meant that only low flow rates and shallow 
gradients were feasible, resulting in time-consuming separations (Huber, 1998). 
Overall, the described disadvantages of conventional C18 silica-based columns make 
them unsuitable for nucleic acid research where high throughputs are needed.  
 
1.8.4.2 Polymeric stationary phases  
Polymeric reversed-phase resins are made of polystyrene divinylbenzene (PS-DVB) 
and are formed through crosslinking of several polymer chains. Porous and non-
porous variants exist, and both forms have been used for IP RP HPLC separations. 
The porous variant consists of small pores, which suffer from the same issues as 
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small-pore silica-based columns (Unger and Janzen, 1986). The non-porous variant 
was introduced as 2 µm, C18 non-porous polymeric media and was a breakthrough at 
the time, revolutionising nucleic acid separation with its significant advantages  (Huber 
et al., 1992; Oefner and Huber, 2002). 
 
1.8.4.3 Monolithic stationary phases 
Most recently, the use of monolith columns as part of separation processes has been 
the subject of much research. A wide variety of monolith polymeric materials has been 
employed for high-efficiency nucleic acid separation including the poly-
(styrene/divinylbenzene) PS-DVB monolith (Premstaller et al., 2000) and one made 
from poly (p-methylstyrene-co-bis (p-vinylbenzyl) dimethylsilane) MS/BVBDMS. 
These polymeric columns have a wide range of internal pore sizes, going from micro- 
(< 2 nm) to meso- (2-50 nm) and macro scales (> 50 nm) (Tanaka et al., 2001; Unger 
et al., 2008). 
Premstaller et al., (2000), in their seminal paper, used a PS-DVB monolithic particle 
to demonstrate its capacity for high-efficiency separation and its potential in both 
proteomic and genomic research. This promising particle shows significant 
improvement in terms of large biomolecule mass transfer rates, which is a result of its 
micropellicular monolith configuration. The monolithic bed consists of a single porous 
polymer rod with internal porosity (consisting of macropores and mesopores) which 
facilitates convective flow while lacking interstitial volume (Horvath et al., 1977).  
The morphology of monolith column consists of interconnected network structure links 
throughout the inner capillary wall (Eeltink et al., 2017). As a result of the high 
interconnectivity of its channels, diffusional distances in a monolithic column are 
significantly reduced, resulting in higher chromatographic efficiencies. The same 
interconnectivity which provides its mass transfer capabilities is also responsible for 
its structural robustness. The durability of monolith columns was demonstrated by 
Škeříková and Urban (2013) who reported over 10,000 chromatographic injections 
performed using a single monolith column.  
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Stationary phases built with polymer-based materials are favoured for nucleic acid 
separation, because of their excellent chemical and mechanical stabilities. They are 
resilient toward acidic, alkaline, and hydro-organic conditions, and are also able to 
withstand extreme temperature conditions. A high degree of polymeric crosslinking in 
a monolith column minimises the swelling of packed materials in an organic solvent, 
resulting in mechanical stability and allowing for operation under high pressures (Maa 
and Horvath, 1988). Its high permeability avoids the loss of column efficiency and 
resolution normally associated with high flow velocities. Overall, monolithic columns 
can achieve high efficiencies comparable to conventional non-porous media while also 
delivering higher yields (Huck and Bonn, 2005).  
Finally, the features of monolith materials mean that they can be readily used in 
miniature scale experiments: for example, in capillary and microfluidic liquid 
chromatography. Coincidentally, these techniques are also preferable for direct 
coupling to ESI-MS for the online analysis of structure and the identification of 
separated compounds, as only small amounts of sample are required.  
In summary, the unique characteristics of monolith materials make them ideally 
positioned to tackle the unique and often difficult requirements of nucleic acid 
separation, which has led to their increasing attractiveness as the column material of 
choice for many researchers.  
 
1.9 Mass spectrometry  
 Mass spectrometry of RNA analysis 
Mass spectrometers measure the mass to charge ratio (m/z) of ions, in the gas phase. 
One of the key components of mass spectrometers are ion sources, whose basic 
function is to convert the sample from a liquid phase to a gaseous phase and to 
channel the resulting gaseous ions into the mass spectrometer. In the case of nucleic 
acids, their ionisation and delivery into the gas phase can be achieved by several 
different MS ion sources such as matrix-assisted laser desorption ionisation (MALDI) 
or electrospray ionisation (ESI) via an online high-performance liquid chromatography 
system (HPLC).  
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Both ioniser and mass analyser technologies have undergone multiple innovative 
improvements over the years. Some of the developed ioniser technologies include 
electrospray ionisation (ESI), matrix-assisted laser desorption ionisation (MALDI), fast 
atom/ion bombardment (FAB), electron ionisation (EI) and chemical ionisation (CI) 
(Fenn et al., 1989; Karas and Hillenkamp, 1988; Karas, 1996). Meanwhile, the 
advancement of analysers has significantly contributed to the power of MS analysis. 
Analysers currently available include quadrupole, quadrupole ion trap, time-of-flight 
(ToF), time of flight reflectron, quad-ToF and Fourier transform ion cyclotron 
resonance (FT-ICR) mass spectrometers. In this PhD project, ESI-MS using Q-ToF 
and 3D ion trap instrument were used for the analysis of RNA and oligonucleotides.  
 
 Ion source  
1.9.2.1 Electrospray ionisation source  
Electrospray ionisation converts a solution sample into gas-phase ions using an 
electrospray at atmospheric pressures, a process which preserves the analytes’ 
integrity, resulting in intact, ionised molecular species with multiple charge states. This 
feature of the ESI is why it is described as a “soft” ionisation method in the sense that 
only a small degree of fragmentation occurs upon ionisation (Fenn et al., 1989). In 
addition, the multiple charge states of the ions cause lower mass ranges (m/z values) 
and allow them to be detected by all common mass analysers. Unsurprisingly, ESI has 
become a key tool for subsequent mass spectrometric analysis of important biological 
macromolecules such as proteins and nucleic acids, revealing structural 
characteristics and identifying basic molecular features. Its revolutionary impact on the 
analysis of important classes of large biomolecules led to the inventor of ESI-MS, Fenn, 
being awarded the Nobel Prize in Chemistry in 2002 for his breakthrough. 
The overall ESI process consists of three consecutive stages: droplet formation 
(dispersion), droplet fission, and desolvated ion production, which are shown 
graphically in (Figure I-12 B). In the first stage, the solution analyte flows through the 
metal capillary, which is retained at a high-voltage (2-6 kV). The polarity of the applied 
voltage results in the counter electrode producing either positive or negative ion. This 
strong electric field induces electrophoretic movement of ions, causing dispersion of 
29 | P a g e  
the sample solution and forming an aerosol of highly charged droplets from the 
electrospray. A heated, inert gas (e.g. nitrogen) flows around the capillary to enhance 
the nebulisation. Solvent evaporation (desolvation), which is the precursor to droplet 
fission, reduces droplet sizes and increases the surface tension of the droplets until 
they reach the Rayleigh limit, ultimately resulting in Coulomb fission (Rayleigh, 1882). 
The fission process creates smaller droplets (called “progeny” droplets), which are 
enriched with the ions surrounding the “parent” droplet. Repeated fission leads to 
smaller and smaller droplets, eventually creating charged nanodroplets, with the end 
result being multi-charged analyte molecules in a gas-phase (Figure I-12 B). 
 
 
 
Figure I-12: Diagrammatic representation of Electrospray ionisation. (A) An ESI-
ion source. (B) The Electrospray ionisation process. Reprinted from “Electrospray 
Ionization Mass Spectrometry: A Technique to Access the Information beyond the 
Molecular Weight of the Analyte,” by S. Banerjee and S. Mazumdar (2012), 
International Journal of Analytical Chemistry, 2012, p. 1-40. Copyright 2012 by 
Shibdas Banerjee and Shyamalava Mazumdar. Reprinted with permission under the 
Creative Commons Attribution License. 
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 Mass analysers 
1.9.3.1 Quadrupole analysers 
A quadrupole analyser operates based on the stability of the trajectories of ions in 
oscillating electric fields and separates them according to their mass-to-charge ratio 
(m/z). Two and three-dimensional ion traps operate on the same basic principle. 
Quadrupole analysers consist of four parallel cylindrical metal rods, with each 
opposing pair connected by an electrical constant such as a direct current (DC) 
voltages and radio frequency (RF).  
The stability of the trajectory of the ions that travel to the mass filter is dependent on 
the oscillation of the RF voltage applied. Only ions of a selected m/z range are stable 
enough to reach the detector via the supplied voltages, while ions with unstable 
trajectories will collide with the rods. The selectivity of ions according to their m/z 
allows continuous scanning across a range of m/z values through the variation of 
voltages.   
 
1.9.3.2 Time-of-flight mass analysers  
The time of flight (TOF) analyser contains a long metal tube and operates based on 
the acceleration of ions through a high electric field.  In a TOF analyser, the mass-to-
charge ratio is measured from the velocity of the ions and the time taken for an ion to 
travel down a flight tube until they reach the detector. This acceleration (Vs) of ions is 
such that provided they have equal kinetic energy (Ek) (which is converted from the 
potential energies Eel) and the same charge (q=ze), their velocities will depend on only 
mass (m) (equation 1)(Hoffmann and Stroobant, 2007).  
𝐸𝑘 =
𝑚𝑣2
2
= 𝑞𝑉𝑠 = 𝑧𝑒𝑉𝑠 = 𝐸𝑒𝑙 
Equation 1 
Once these ions pass through the field, they will be separated based on velocity, which 
itself is a function of mass-to-charge-ratio. The time (t) needed to cover the distance 
(L) is given by equation 2; Using equation 3 and a measurement of t2 mass-to-charge 
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ratio can be calculated, with the terms in parentheses being constant, and all other 
factors being equal. As a result, given the same charge, heavier ions will travel to the 
detector at lower speeds.  
𝑡 =
𝐿
𝑣
 
Equation 2 
 
𝑡2 =
𝑚
𝑧
 (
𝐿2
2𝑒𝑉𝑠
) 
Equation 3 
The TOF analyser suffers from limited mass resolutions due to the range of kinetic 
energies required for ions, resulting in a widening effect on the ion packet. In addition, 
other factors such as variability in flight times also contribute to the poor resolution, 
resulting in a distribution of ions with identical m/z ratios. 
A reflectron is a series of electrostatic mirrors of equal charge and is utilised to improve 
the resolution of TOF analysers (Mamyrin et al., 1973). In principle, the reflectron is 
applied at one end of the flight tube and the field effect decelerates ions flying towards 
the end of the tube. The ions are then reflected out of the mirror into the detector, 
which is offset from the source. Ions with higher kinetic energies will decelerate since 
they penetrate deeply into the field, rendering them unable to quickly reflect back to 
the detector (ions with lower kinetic energy will reflect quicker)(Larsen and McEwen, 
1998). The advantages of replacing the third quadrupole (Q2) with a TOF mass 
spectrometer are higher mass accuracy, sensitivity, and mass resolution (Morris et al., 
1996; Shevchenko et al., 1997). 
The Q-TOF is a configuration of the triple quadrupole (Q0, Q1, and Q2) interfaced with 
a TOF mass analyser instrument. The first quadrupole mass filter (Q0) serves mainly 
in transmission mode, focusing on transmitting the ions generated across the whole 
m/z range from the ESI to the next quadrupole (Q1). Application of both constant and 
RF voltages allows scanning of a range of m/z values along the axis of the poles. Thus, 
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only a narrow band of m/z values are selected (precursor ions) and transmitted to the 
third quadrupole (Q2). The ions that move to Q2 are collision cells and are bombarded 
into fragment ions through collision-induced dissociation (CID). The information 
gathered from the sequence of the precursor ions permits identification based on the 
resulting fragment ions and the analysis of fragmentation patterns.  
 
 
Figure I-13: Schematic diagram of a Q-TOF mass spectrometer. The mass 
spectrometer has a triple quadrupole (Q0, Q1, and Q2), and the last quadrupole 
section is replaced with a TOF analyser.  
 
 Three-dimensional ion trap analysers 
The three-dimensional (3D) ion trap consists of a circular electrode with two ellipsoid 
end caps which form a 3D quadrupolar field. An oscillating electric field operating at a 
radio frequency (RF) and a direct current (DC) voltage is subsequently applied to the 
ring electrodes, trapping incoming ions which fall under a specific m/z mass range 
within the 3D quadrupolar electrostatic field. Once the trap is filled with ions the mass 
analysis process begins (see Figure I-14).  
The stability of the ions (maintains by the RF signal) is perturbed by ramping the RF 
signal to destabilise them in trap one after the other. This causes the ions to eject from 
the trap based on their m/z ratio; a scan of the trapped masses is created as a 
spectrum on the basis of these values when they are detected.  
Moreover, specific precursor ions can be isolated in the trap by the exiting voltage with 
the inert gas supplied to the trap to induce fragmentation. Over time the ions’ 
trajectories in the trap expand, resulting in some ion losses. This is countered by 
Reflectron 
Detector 
Q2 Q1 Q0 
Ion  
source 
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having a damping gas (e.g. helium) in the trap to remove excess energy and reduce 
collisions (Paul, 1990; Hoffmann and Stroobant, 2007). 
 
 
Figure I-14: Schematic of a 3-dimensional ion trap mass analyser. After being 
formed in the capillary, the ions are directed through an ion trap device where an 
oscillating electric field operates at a radio frequency (RF) and a direct current (DC) 
voltage, trapping them for subsequent mass measurement. 
 
1.10 Interfacing IP RP chromatography with mass spectrometry  
Interfacing IP RP HPLC with ESI MS has proven to be an effective strategy, increasing 
the power of assessments such as the identification and characterisation of nucleic 
acids. The efficiency of this combination depends heavily on the choice of an 
appropriate mobile phase, yet it is known that both systems have individually optimised 
mobile phases, which do not perform well on the other system. Specifically, the 
optimised HPLC mobile phase suffers from weak ESI-MS signals, while the optimised 
ESI mobile phase (with high volatility, low conductivity, and surface tension designed 
to minimise adduct formation) is not suitable to be applied on the HPLC (Apffel et al., 
1997). For instance, TEAA or TBAB enable high-resolution nucleic acid separation but 
both are not considered fully volatile and result in significant ion suppression. In 
addition, reducing the concentration of the ion-pair reagent in the mobile phase is often 
attempted to enhance MS sensitivity but it significantly lowers chromatographic 
performance at the same time. In an attempt to solve this dichotomy,  Apffel et al., 
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(1997) introduced an advanced mobile phase containing 1,1,1,3,3,3- hexafluoro-2-
propanol (HFIP) as an additive to triethylamine (TEA), which was LC-MS compatible. 
Their findings have been successfully extended and applied in a wide variety of 
applications within nucleic acid research (Gilar, 2001; Fountain et al., 2003; Taoka et 
al., 2009; Emmerechts et al., 2007; Emmerechts et al., 2008).  
Alternatives to the TEA ion-pair reagent aimed at improving LC ESI MS compatibility 
with higher volatilities such as triethylammonium bicarbonate (TEAB) (Premstaller et 
al., 2000), butyldimethylammonium bicarbonate (BDMAB)/butyldimethylammonium 
acetate (Hölzl et al., 2005) and Cyclohexyldimethylammonium acetate 
(CycHDMAA)(Oberacher and Pitterl, 2009), have demonstrated positive results in LC 
separation interfaced with online mass spectrometry for nucleic acid analysis. 
Enhancement of the LC ESI MS analysis for nucleic acids remains a challenge and is 
an active area of research today. 
Another dimension of study in addition to mobile phase choice is the utilisation of 
monolithic capillary columns in conjunction with the aforementioned MS-compatible 
mobile phases for a  wide range of LC-MS analyses on nucleic acids (Oberacher and 
Huber, 2002). This approach has enabled the extraction of oligonucleotide sequence 
information from either synthetic siRNA or small RNA (tRNA and 5S rRNA) at low 
concentration quantities (down to picomole/L levels)(Hölzl et al., 2005). Recently, the 
analysis and sequencing of synthetic oligonucleotides using IP RP UHPLC interfaced 
with MS and a TEA/HFIP buffer in conjunction with  UPLC OST C18 columns was 
demonstrated (Ivleva et al., 2010).  
 
 Problems associated with RNA mass spectrometry  
Inherent to the structure of RNA is the presence of a polyanionic phosphate backbone 
which leads to a high tendency to form stable cation adducts, i.e. with Na+ and K+ as 
a countermeasure to stabilise their secondary and tertiary structures (Wacker, 1969; 
Misra and Draper, 1998). These metal ions often exist in analyte solutions, associating 
with RNA molecules and impeding the ability of ESI-MS to detect and characterise 
oligonucleotides (Huber and Krajete, 1999). This has become one of the most major 
issues in RNA mass spectrometry. 
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A wide variety of approaches (either off-line or on-line prior to RNA ESI-MS analysis) 
have been attempted to remove these metal ions, including cation ion exchange 
(Huber and Buchmeiser, 1998; Limbach et al., 1995) ,ethanol precipitation with 
ammonium salts (Limbach et al., 1995), addition of organic bases (triethylamine) 
(Greig and Griffey, 1995; Limbach et al., 1995) and denaturing gel electrophoresis 
(Berhane and Limbach, 2003). These approaches have also been combined with 
different methods in various combinations to overcome the problem associated with 
cation adduct formation. The pairing of the LC system with MS, with the LC acting as 
an on-line sample separation system, is a demonstrably successful method of 
desalting while reducing cation adducts, which directly improves oligonucleotide 
analysis (Oberacher et al., 2004). 
 
1.11 Aim of the study  
Recent advancements in the understanding of the functions of RNA in different 
biological systems have raised the potential of RNA to be applied as therapeutic drugs 
for serious diseases and innovative tools to replace chemical pesticides in insect 
management strategies. This has resulted in an increase in the demand for analytical 
tools which can efficiently purify, quantify, and characterise these analytes. For 
instance, an important aspect of drug quality control involves validating purity levels 
as well as identifying impurities to determine whether the drug will function effectively 
while simultaneously avoiding side-effects such as unwanted off-target gene silencing. 
The overall aim of this thesis is to develop a high throughput analytical platform based 
on ion-pair reversed-phase chromatography (IP RP HPLC) and electrospray ionisation 
mass spectrometry (ESI-MS) for the analysis of nucleic acids including RNA 
therapeutics and dsRNA. The successful development of an effective platform will be 
an important step towards clearing another roadblock in drug analysis. The first step 
in achieving these aims will focus on examining the effect of the mobile phase 
composition on the performance of ESI-MS of oligonucleotides, specifically comparing 
their different physiochemical properties. The analyses will aim to optimise signal 
intensities while reducing cation adduct formation, which often limits the sensitivity and 
accuracy of oligonucleotide analysis.    
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The second part of this study aims to fulfil the need for a method which produces large-
quantities of high-quality dsRNA for use in RNAi applications, as recent discoveries 
show that RNAi holds great potential as therapeutic drugs as well as in insect 
management strategies by serving as an alternative to chemical pesticides. To that 
end, it is proposed to develop a method capable of isolating, purifying, and quantifying 
of dsRNA extracted from microbial cells. Techniques such as metabolic and genetic 
engineering in vitro stable isotope labelling of RNA will be explored in conjunction with 
LC-ESI-MS analysis to characterise and quantify of dsRNA.  
Monolithic porous columns have demonstrated their capability for highly efficient 
separation of large-biomolecules. However, their behaviour in relation to nucleic acids 
has not been fully characterised. A part of this study will aim to compare the 
performance of monolithic columns of different pore sizes in combination with retentive 
and non-retentive HPLC modes for the analysis of nucleic acids.    
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Chapter II : Materials and methods 
2.1 Materials  
 Equipment  
Equipment  Company 
Automatic Pipettes (P10, P100, 
P100) 
Gilson, Eppendorf 
Weighing balance  Kern 
Heating Block Techne 
Heated ultrasonic bath  Fisher Scientific 
Centrifuge Eppendorf 
Nanodrop Spectrophotometer Fisher Scientific 
Ultrospec 1100 Pro 
Spectrophotometer  
Amersham Bioscience 
UV transilluminator UVP 
Cell disruptor  scientific industries 
Vortex mixer Fisher Scientific 
pH meter  Mettler Toledo 
Real Time PCR Applied Biosystems 
Horizontal gel apparatus  Bio-rad 
Power supplies Bio-rad 
Autoclave Prioclave 
Incubator Shaker SciQuip 
Transgenomic HPLC Transgenomic 
HPLC Ultimate 3000  Dionex 
HPLC Agilent 1100 Agilent 
HTC Ultra PTM Discovery System  Bruker Daltonics 
maXis UHR ToF MS Bruker Daltonics 
Corning® syringe filters (0.2 µm) Sigma 
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 Chemicals and reagents  
Chemicals, reagents, kits, and samples Company 
Acetic Acid VWR 
Acetonitrile Fluka 
Agarose Bioline 
Ammonium acetate Sigma 
Ammonium sulfate Sigma 
15N ammonium sulfate  CK gas products LTD 
Ampicillin sodium salt Sigma 
Chloroform  Thermo fisher 
Diisopropylamine (DIPA) Sigma 
Dimethylsulfoxide (DMSO) Sigma 
DNA primers MWG 
DNAzol reagent  Life technologies, GeneArt 
Enpresso B Defined Nitrogen-Free pack  BioSilta 
Ethanol  Fluka 
Ethylenediaminetetraacetic acid (EDTA) Sigma 
Ethidium Bromide Sigma 
Formamide (RNA grade) Sigma 
Guanosine-13C10, and 15N5  
5’-triphosphate sodium salt solution 
Sigma 
Hexylamine (HA) Sigma 
HiScribeTM T7 High Yield RNA Synthesis 
Kit 
Sigma 
HyperLadderTM 1kb New England Bioabs 
Isopropyl-β-D-thiogalactopyranoside 
(IPTG) 
Bioline 
Isopropanol Fluka 
Nuclease-free water Life Technologies 
2-mercaptoethanol Life Technologies 
Mix and Go transformation kit  Zymo research 
MS2 RNA Sigma 
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Oligonucleotides Sigma 
PCR mix master MWG Eurofins 
Phosphate buffered saline  Thermo Fisher  
PurelinkTM Genomic DNA Mini Kit Life Technologies (Invitrogen) 
Proteinase K Thermo Fisher  
pUC18 DNA Hae III digest ladder  Sigma 
RiboPure kit  Sigma 
RNA loading dye 2x Ambion 
RNase A New England Biolabs 
RNAzol reagent  Life Technologies (Ambion-Invitrogen) 
Sodium chloride (NaCl) Sigma 
Sodium dodecyl sulphate  Thermo Fisher  
Sodium hydroxide reagent grade, ≥98%, 
pellets (anhydrous) 
Sigma 
Tributylamine (TBA) Sigma 
Tetrabutylammonium acetate (TBAA) Sigma 
Tetracycline hydrochloride Sigma 
Tris Sigma 
Triethylamine VWR 
Triethylammonium acetate Sigma 
Trifluoroethanol (TFE) Sigma 
TRIzol max bacterial RNA isolation kit Sigma 
1,1,1,3,3,3,-Hexafluoro-2-propanol (HFIP) Sigma 
Urea solution, BioUltra ~8M in H2O Life Technologies (Ambion-Invitrogen) 
 
 Oligonucleotides 
Oligonucleotide Sequence 
BC2 5̍-CAAAAGTCCGTGAGA-3 ̍
BC2b C6 (amino-link C6) 5̍-C6CAAAAGTCCGTGAGA-3̍ 
BC2b C12 (spacer C12) 5̍-C12CAAAAGTCCGTGAGA-3̍ 
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 Oligonucleotide sample preparation  
Oligonucleotide samples (listed in section 2.1.3) were received dry and re-suspended 
in 200 µL of nuclease-free water. Each sample was dissolved into the mobile phase 
system to reach a final MS direct-infused oligonucleotide concentration of 2 μM. 
 
 DNA primers 
The designed forward and reverse primers were obtained from MWG Eurofins 
Details Sequence 
Forward-T7+Spacer TAATACGACTCACTATAGGGTGGCGCCCCTAGATG 
Forward-Spacer+linker GGTGGCGCCCCTAGATGGATATCGGACATCTTGCG
GT   
Reverse-T7+Spacer TAATACGACTCACTATAGGGCGACGCCCGCTGATA 
Reverse-Spacer+linker GGCGACGCCCGCTGATACGGGCAGGAACCTATCCT
AT 
 
 Double-stranded RNA gene sequence 
Details Sequence 
COIV PMA  
Length: 765 bp   
 
TAATACGACTCACTATAGGGAGCAAAAAACCCCGCGAGACC
CCCGAAGAGGCCCCGCGGGGTTAATGGCCCTGCGACTACT
CAACAGTGCTGTGCTCCGCCAGCTGGCCTCTCAGCTGCCCA
AGAGTGCCCAGGTGGGCAGCGTGGCCGCCGTCCACACACT
GGACAAGATCGGCAAGCGGGAGATCGTTGGCTACGGCTGG
AACGGCACCGCCTGCTACGCGGATCGCGTGGACTACCCTCT
GCCCGCCGTGCGCTTCCGTGAGCCCACCAACGAGATCAAC
GCTCTGCGCGCCAAGGAGCAGGGAGACTGGAAGAAGCTCA
GCACCCAGGAGATCAAGGCCCTGTACCGCGCCAGCTTCTG
CCAGACTATCGCCGAGGTCCAGGCTGGAAGCGGGGAGTGG
AAGCTCCACCTGGGCGTTTCACTCCTCTTCTGCGCCGCCGC
CATCTGGGTGGCCGTACTGATGAACATCTTCGTGTACGATG
AGCTGCCCGTTACCTTCGATGAGGAGCACCAGAAGGCGCA
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GCTGCAGCGCATCATCGACCTGGAAATCAACCCCGTCACCG
GATTGACCTCCAAGTGGGACTACGAGAACAAGAAGTGGAAG
AACCTGGAATTGCTCATGGTGGAGCTTCAGTTCCGCAAGGG
CATGAACGATCTGCTGGGTAAAACCCCGCGGGGCCTCTTCG
GGGGTCTCGCGGGGTTTTTTGCTCCCTATAGTGAGTCGTAT
TA 
 
Details Sequence 
Dome 11 
Length: 401 bp 
GATATCGGACATCTTGCGGTATTTCTTGTACACGAGGTAGAA
GATGACGCCCAGCACGAGAATCGCCACGGTCACCTCAATGG
TCTGGTACATGGCCTTCACGCTGTGCGTGTCCGGTGTACAG
ATGAATCCGTAGATGCCCCAATCGGATCTGTAGAGCCGGTA
GGCGGTCATGTTGGCAGCGTAGGCCTCGAACTGCAGCCGC
TCCTCTTCGCCGAGCGCATCGGTGCGTGCCTCGCATCCCTT
GCCGTTGGTCGACATAAGCAAAACGGCACCTTCCGCTGCAT
CCGCTCCGTTCAACTGCGGATGCTGCTCCACGTTGATGGCA
CGCACCGCTAGCTGGAAGGGATTGTGGCTGGTGCAGCGCG
GCGTGGCCATCACATAGGATAGGTTCCTGCCCG 
 
2.2 Buffer compositions 
 RNA extraction buffers 
RNAsnap Solution  
EDTA 18 mM 
SDS 0.025 % 
2-mercaptoethanol 1 % 
Formamide 95 % 
 
20% SDS  100 mL 
SDS 20 g 
HPLC grade water 80 mL  
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RNAswift Lysis Buffer  
SDS 4% 
NaCl 5M 
Tris Ethanol Wash Buffer  
Tris (pH 7.5) 10 mM 
Ethanol 80 % 
 
IPD Buffer  
Isopropanol  33 % 
DMSO 33 % 
HPLC grade water  33 % 
 
 Gel electrophoresis buffer   
Tri-Acetate-EDTA (TAE) buffer 1L of 50X 
Tris base 242 g 
Glacial acetic acid 57.1 mL 
0.5 M EDTA (pH 8.0) 100 mL 
 
The working buffer (1X of TAE) was made by diluting the stock solution with 50X 
deionised water.  
 
2.3 Amplification of DNA template using polymerase chain reaction (PCR) 
Drosophila S2R+ cells were extracted using the PurelinkTM Genomic DNA mini Kit 
(following the protocol for animal culture cells) to obtain the genomic DNA used for 
PCR amplification. The PCR process was carried out using specific primers. The PCR 
mixture consisted of 13 µL of PCR master mix (10 × reaction buffer, MgCl2, dNTP mix 
and Taq DNA polymerase) (Thermo Fisher), 1 µL of genomic DNA, 1 µL each of the 
forward and reverse primers (see Section 2.1.5), and 34 µL of PCR grade water 
(Sigma Aldrich). For the second round of PCR, 1µL of the genomic DNA from the first 
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round of product was used (1:20 dilution) and added to the same PCR mixture 
components stated above. 
 
PCR parameters for the first round were as follows: 94°C for 3 min, 35 cycles at 94°C 
for 30 s, a gradient from 54 to 58°C over 30 s, a cycle at 72°C for 30 s; and a final step 
at 72°C held for 5 min. PCR parameters for the second round were: 94°C for 3 min, 
35 cycles at 94°C for 30 s, a gradient from 49 to 60°C over 30 s, and 72°C for 30 s, 
and a final step at 72°C held 5 min. The DNA template containing 401 bp sequence 
flanked the T7 promoter sequence on both ends. 
 
The final PCR products were purified using a QIAquick PCR Purification Kit (QIAGEN, 
Germany) and were analysed using electrophoresis on 1% agarose gel in 1× TAE 
buffer (contained ethidium bromide).    
 
2.4 Bacterial transformation, induction, and culture growth   
 List of bacterial strains used 
In this study, the E. coli strand HT115 (DE3) was engineered with two different 
plasmids to generate a specific length of dsRNA.  
Bacterial strand Plasmid Antibiotic 
resistance 
Source 
HT115 (DE3) 
(Tetracycline) 
COIV PMA Ampicillin Cold spring harbor 
laboratory, NY, 
USA 
 DOME 11  Kanamycin  
 
 Culture media and antibiotics  
The optimal E. coli growth conditions were produced using Luria-Bertani (LB) and 
Enpresso media (consisting 14N and 15N ammonium sulfate) to generate 14N and 15N 
labelled materials. The LB medium was sterilised by autoclaving it at 121°C for 20 min 
prior to use. The culture media were contained with the appropriate antibiotics at the 
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required working concentrations. The stock antibiotics used were prepared with water 
and sterilised by filtration using a 0.2 µM syringe filter.  
LB medium (pH 7.5) 1L 
Bacto-tryptone 10 g 
Yeast extract   5 g 
NaCl 10g 
 
Enpresso B Defined Nitrogen Free media (15N growth media)  
Sterile water  45 mL 
Enpresso B Defined Nitrogen Free tablets 2 tablets 
15NH4Cl (40g/L, final concentration 2.5 g/L) 3 mL 
 
Antibiotic Stock concentration Working concentration 
Ampicillin 100 mg mL-1 100 µg mL-1 
Tetracycline 10 mg mL-1 10 µg mL-1 
Kanamycin 50 mg mL-1 50 µg mL-1 
 
 Plasmid transformation 
The HT115 (DE3) bacterial strain (described in Section 2.4.1) was used for the 
transformation of COIV PMA and DOME 11 plasmids. The transformations were 
performed according to the manufacturer’s (Zymo research) instructions to obtain 
competent HT115 (DE3) cells. 1 µL of plasmid DNA was added to HT115 competent 
cells and they were gently suspended for few seconds. 100 µL of the cell suspension 
was spread onto a pre-warmed agar plate (containing appropriate antibiotic) for each 
plasmid. The plate was incubated at 37°C overnight. 
 
 Double-strand RNA culture growth in LB media 
Pre-culture for the HT115 cells engineered with 765 bp dsRNA was prepared by 
inoculating a single colony of the transformed cells from a fresh plate (described in 
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2.4.3) into 5 mL of LB medium, which contained tetracycline (10 µg/mL) and ampicillin 
(100 µg/mL). The procedure for the preparation of HT115 cells engineered with 401 
bp dsRNA was identical to that of the 765 bp cells except that the medium contained 
tetracycline (10 µg/mL) and kanamycin (50 µg/mL). Both cultures were incubated with 
vigorous shaking at 37°C until the OD600 nm reached 0.6.  
In a separate experiment (Chapter IV, dsRNA extraction study), the culture for HT115 
cells expressed with 765 bp dsRNA was prepared with the procedure described above, 
dsRNA expression was performed by adding IPTG (1 mM final concentration), and the 
culture was further incubated for 2 hours.   
 
 Metabolic isotope labelling of HT115 dsRNA 
A single colony from the HT115 (DE3) cells expressing the 765 bp dsRNA in the LB 
culture (see Section 2.4.4) (without IPTG induction) was inoculated into both 14N and 
15N media (see Section 0). The culture was supplemented with 10 µg/mL of 
tetracycline and 100 µg/mL Ampicillin. Reagent A (final concentration 1.5 U/L) was 
added to the culture before it was incubated at 37°C under continuous shaking 
conditions until an OD600 of 0.6 was achieved. Then, IPTG (1 mM final concentration) 
was added to the cultures to express the dsRNA, followed by a further 2 hours of 
incubation. The same procedure as described above was used to prepare the 14N 
HT115 expressing 401 bp dsRNA culture supplemented with tetracycline (10 µg/mL) 
and kanamycin (50 µg/mL). 
 
 In vitro transcription of 13C10, 15N5 guanosine containing dsRNA 
The amplified DNA (described in section 2.3) was used as the template for subsequent 
in vitro transcription in conjunction with HiScribeTM T7 High Yield RNA Synthesis Kit 
(New England Biolabs). To perform in vitro labelling, 2.0 µL of each the NTPs (10 mM) 
except for the GTP were replaced with GTP-13C10, 15N 5 5’-triphosphate (Sigma-
Aldrich). Next, 2µL of 10 x reaction buffer, 1µg DNA template and 2µL HiScribeTM T7 
polymerase were added into in 20µL RNase-free water; the mixture was incubated at 
37 °C for 4 hours. 
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The IVT reaction product was further subjected to solid phase spin column purification 
(see Section 2.5.1.8). 
 
2.5 RNA preparation 
 Double-stranded RNA extraction 
For the comparison of dsRNA extraction methods, 1x109 HT115 E. coli. cells 
expressed with COIV PMA 765 bp dsRNA were used and each method was performed 
in three independent biological replicates as well as three technical replicates. Five 
different bacterial RNA extraction methods were evaluated: TRIzol Max, Ribopure kit, 
DNAzol, RNAzol, and RNAsnap. TRIzol max and Ribopure kit extractions were 
performed using the manufacturer’s protocol with slight modifications in the 
procedures to improve the extraction yield.  
 
2.5.1.1 Ribopure kitTM extraction  
The sample was extracted according to the Ribopure KitTM manufacturer’s protocol to 
extract total RNA from the aqueous phase. The interphase was retained and re-
extracted with the TRIzol maxTM method. The new aqueous phase resulting from 
TRIzol maxTM re-extraction was subjected to a one-time sample volume of isopropanol 
precipitation as well as an additional QIAGEN column purification method. To induce 
precipitation, the new organic phase (in which no interphase could be clearly identified) 
was subjected to a one-time sample volume of isopropanol. 
 
2.5.1.2 RNAsnap extraction 
The original protocol for RNA extraction proposed by Stead et al (2012) was followed 
except for some modifications: instead of using just one 100 µL of RNAsnap solution 
(see section 2.2.1) as suggested, three separate amounts of RNAsnap extraction 
solutions (100 µL 200 µL, and 300 µL respectively) were used. For each amount, the 
cell pellets were resuspended by adding the extraction solution and the mixture was 
vortexed vigorously. The samples were placed into a heating block set at 95°C and 
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incubated for 7 min to lyse the cells; the samples were then centrifuged at 16,000 rpm 
for 5 min at room temperature. The supernatant containing the RNA was carefully 
transferred to a fresh tube without disturbing the clean gelatinous pellet.  
 
2.5.1.3 RNAsnap ethanol precipitation and solid phase extraction 
The RNAsnap method was followed by both ethanol precipitation and QIAGEN solid 
phase extraction clean-up procedures to compare extraction yields. For the ethanol 
precipitation step, 1 mL of ethanol was added to the RNAsnap extracted sample and 
the mixture was incubated for 10 min, followed centrifugation at 20,238 rpm for 7 min. 
The supernatant was discarded, and the RNA pellet was washed with 1ml of 75% 
ethanol. Next, the sample was centrifuged for 5 min at 7,500 rpm. The supernatant 
was carefully removed without disturbing the RNA pellet. Lastly, the RNA pellet was 
air dried and resuspended in 100 µL of nuclease-free water.  
For the QIAGEN solid phase extraction (clean-up) method, 500 µL of PB, 25 µL of 
isopropanol, and 50 µL of 5M NaCl was added to the sample, and the contents were 
mixed well by pipetting up-and-down. The mixture was applied to a QIAGEN silica 
membrane column with 2 mL collection tube and centrifuged at 13,000 rpm for 1 min 
before discarding the flow from the collection tube. Next, 750 µL of PE was applied to 
the column and the mixture was centrifuged at 13,000 rpm for 1 min with the flow being 
discarded. This was followed by centrifugation at 13,000 rpm again for 1 min. The 
silica column was transferred to a new tube and added with 100 µL of nuclease-free 
water. Subsequently, the sample was left at room temperature for 1 min before being 
centrifuged at 13,000 rpm for 1 min.  
 
2.5.1.4 TRIzol MaxTM extraction with different pH values 
The TRIzol maxTM reagent was neutralised by adding Tris-HCl to reach a pH of 7.5; 
this was compared with the original TRIzol solution (pH 4.5) according to the 
manufacturer's instructions for dsRNA extraction. 
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2.5.1.5 DNAzol® isolation method 
Initially, 200 µL of TRIzol max bacterial enhancement reagent were preheated at 95°C, 
and the E. coli. pellet was resuspended in the reagent. The tube was then incubated 
at 95°C using a heating block for 4 min. Next, 1 mL of DNAzol® reagent was added to 
the lysate and the contents mixed well by repeated pipetting. After 4 min of incubating 
the homogenised samples, the RNA present in the aqueous phase were precipitated 
with 500 µL of pure ethanol. The mixture was incubated for 10 min and centrifuged at 
20,308 rpm for 7 min at room temperature. After the RNA precipitate formed as a white 
pellet along the side and bottom of the tube, the supernatant was discarded carefully 
in order to not disrupt the RNA pellet. Then, the RNA pellet was washed with 1 mL of 
75% ethanol, before being centrifuged at 7,500 rpm for 5 min at room temperature. 
The flow was discarded and the sample centrifuged at 7,500 rpm again. A micropipette 
was used to remove any remaining ethanol in the tube. The RNA pellet was left out in 
the air to dry for 1 min, before being resuspended in 100 µL of RNase-free water. 
 
2.5.1.6 RNAzol® isolation method  
Firstly, the sample was resuspended in 162.5 µL of RNase free water before adding 
25 µL of 10 X phosphate buffered saline (PBS) and 6.25 µL of 20% SDS for 
homogenisation. The sample was mixed by, several times of tube inversion. The 
mixture was then incubated at 100°C for 5 min while flicking the tube several times to 
mix the contents. Next, 6.25 µL of proteinase K (Ambion) solution at 20 mg/mL was 
added and the mixture was incubated at 58°C for 30 min while mixing the contents as 
described above. Then, 625 µL of RNAzol® RT extraction solution was added and the 
contents were mixed with a pipette before being incubated for 10 min at room 
temperature. The mixture was centrifuged at 12,000 rpm for 15 min at room 
temperature. The supernatant (at least 805 µL) was transferred to a new tube leaving 
a layer of the supernatant above the DNA/protein pellet. An equal volume (805 µL) of 
isopropanol was added and the contents mixed by tube inversion to precipitate the 
RNA. The mixture was left to stand for 10 min before being centrifuged at 12,000 rpm 
for 10 min at room temperature. The RNA pellet was observed to be along the side 
and bottom of the tube. The RNA pellet was washed with 1.0 mL of 75% ethanol three 
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times, mixed well, and centrifuged at 8,000 rpm for 3 min at room temperature. After 
discarding the flow through and centrifuging again, the residual ethanol were carefully 
removed with a micropipette. The pellet was air-dried for a minute before it was 
resuspended in 100 µL of RNase free water.  
  
2.5.1.7 RNAswift total RNA isolation method 
The RNAswift protocol (A. O Nwokeoji et al., 2016) was used to extract total RNA from 
1x109 14N and 15N HT115 cells expressing 765 bp dsRNA and 14N HT115 cells 
expressing 401 bp dsRNA. To lyse the cells, 200 µL of lysis buffer (described in 
Section 2.2.1) was preheated at 95°C and used to resuspend the cells. The suspended 
cells were incubated at 90°C for 4 min. After cell lysis, 100 µL of 5M NaCl was added 
to the lysate and the mixture was homogenised by inverting the tube up to 6 times 
before incubating it for 3 min. The lysate was then centrifuged for 10 min at 13,000 
rpm. The supernatant was collected and transferred to a fresh Eppendorf tube. RNA 
precipitation was performed by adding 500 µL of isopropanol and incubating for 5 min. 
The mixture was centrifuged for 5 min at 13,000 rpm and the flow-through was 
discarded. To wash the RNA pellet, 1 mL of 75% ethanol was used to resuspend the 
pellet prior to 5 min centrifugation. The ethanol was discarded and the RNA pellet 
allowed to air dry for 1 min. Finally, the pellet was resuspended in 100 µL of nuclease-
free water.  
 
2.5.1.8  15N in vivo and 13C 15N in vitro transcribed dsRNA purification 
For the purification of 15N HT115 cells expressed with 765 bp dsRNA, the same 
RNAswift method described in section 2.5.1.7 was followed, up to the supernatant 
collection step. Approximately 400 µL of supernatant was taken, and 0.1 µg of RNase 
A was added, followed by incubation at 37°C for 10 min. Prior to silica membrane 
column (Invitrogen) purification, 300 µL of IPD buffer (see Section 2.2.1) was added 
to the mixture. After loading the column, centrifugation was performed at 13,000 rpm 
for 1 min. The flow-through was discarded and 700 µL of wash buffer was added (see 
Section 2.2.1). Centrifugation was performed for 1 min and repeated once. The 
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purified dsRNA were eluted by adding 80 µL of nuclease-free water (QIAGEN, 
Germany). Membrane solid phase purification was also applied to clean up any 
possible impurities from the 13C15N GTP labelled in vitro transcript 401 bp dsRNA.  
 
 Enzymatic digestion of dsRNA 
Purified, heavy isotopic-labelled dsRNA were mixed with light-labelled total RNA 
(expressed dsRNA) in a range of different amounts prior to RNase A enzymatic 
digestion. For digestion, 0.1µg RNase A was added to 1 µg of RNA sample. Digestion 
was performed for an hour at 37°C.  
 
 Determination of nucleic acid concentration  
A NanoDrop 2000 UV visible spectrophotometer (Thermo Scientific) was used to 
determine the concentration of nucleic acids. The concentration of DNA/RNA was 
measured by using 10 µL of sample, diluting it with 490 µL of distilled water, and 
recording absorbance at 260 nm. The molar extinction coefficients (Table II-1) were 
used for the calculation of DNA/RNA concentrations. 
 
Table II-1: Extinction Coefficient and Concentration by Nucleic Acid Type 
Nucleic Acid Type  Extinction Coefficient (µg/mL)-1 cm-1 Concentration 
(µg/mL) 
If A260 value = 1  
ssDNA 0.027 37 
dsDNA 0.020 50 
ssRNA 0.025 40 
 
Using the conversion of molar extinction coefficients, the equations used to determine 
the concentrations of nucleic acid were as follows: 
ssDNA (µg/mL)=Dilution factor × Absorption × 37 
dsDNA (µg/mL)=Dilution factor × Absorption × 50 
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ssRNA (µg/mL)=Dilution factor × Absorption × 40 
 
2.6 Liquid chromatography  
 Ion-pair reversed-phase chromatography 
All procedures involving IP RP HPLC were performed on an Ultimate 3000 HPLC, a 
Transgenomic HPLC, or an Agilent 1100 HPLC using the columns listed in section 
2.6.3 and the mobile phases listed in section 0, throughout the experiments, column 
temperature was maintained at 50°C (except for Section 5.3.3 was performed at both 
50°C and 75°C) and the data were recorded at a UV wavelength of 260 nm.  
All oligonucleotide quantification analyses (see Section 2.6.2) were performed using 
an Ultimate 3000 HPLC with an Accucore-150-C18 (50 mm x 2.1 mm) column. 
 
 Verification of oligonucleotide concentration using IP RP HPLC 
To verify the quantification of the oligonucleotides based on NanoDrop measurements, 
individual oligonucleotides (see Section 2.1.3) at concentrations of 20 and 50 pmol 
were used. The samples were analysed in partial loop injection mode with an injection 
volume of 10 μl using standard IP RP HPLC buffers (listed in the 0). 
 
2.6.2.1 Quantification of oligonucleotides using IP RP HPLC 
To achieve accurate quantification of oligonucleotides, each sample was analysed at 
concentrations of 10, 20, and 50 pmol in full-loop injection mode with an injection 
volume of 84 μl. All analyses were performed using TBAA buffer systems.  
 
2.6.2.2 Determination of oligonucleotide hydrophobicity  
The three oligonucleotides listed in 2.1.3 were analysed at a concentration of 20 pmol 
using the standard IP RP HPLC buffers listed in 2.6.4.  
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 Stationary phases  
Columns Company 
ProSwift Monolith RP-1S (4.6 mm i.d. × 50 mm)  Thermo Fisher 
ProSwift Monolith RP-2H (4.6 mm i.d. × 50 mm) Thermo Fisher 
ProSwift Monolith RP-3U (4.6 mm i.d. × 50 mm) Thermo Fisher 
Accucore C18 column (150 mm i.d × 2.1 mm)  Thermo Fisher 
Accucore C18 column (50 mm i.d × 2.1 mm) Thermo Fisher 
 
 Mobile phase compositions  
Standard IP RP HPLC buffer A  
Triethylammonium acetate (TEAA) 100 mM 
Acetonitrile   0.01% 
 
Standard IP RP HPLC buffer B  
Triethylammonium acetate (TEAA) 100 mM 
Acetonitrile   25% 
 
TEAA+Urea IP RP HPLC buffer A  
Triethylammonium acetate (TEAA) 100 mM 
Urea 10% 
Acetonitrile 0.01% 
 
TEAA+Urea IP RP HPLC buffer B  
Triethylammonium acetate (TEAA) 100 mM 
Urea 10% 
Acetonitrile 25% 
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TBAA IP RP HPLC buffer A  
Tetrabutylammonium acetate 5 mM 
EDTA 1 mM 
Acetonitrile 10% 
 
TBAA IP RP HPLC buffer B  
Tetrabutylammonium acetate 5 mM 
EDTA 1 mM 
Acetonitrile 80% 
 
Non-retentive  HPLC Buffer A  
HPLC water   100% 
 
Non-retentive  HPLC Buffer B  
Acetonitrile 100% 
 
 Gradient conditions 
2.6.5.1 IP RP HPLC gradient conditions 
Gradient condition (1): Starting at 20% buffer B  followed by a linear extension to 
57.5% buffer B in 8 min at a flow rate of 0.4 mL min-1, performed on Ultimate 3000 
HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC buffer systems A 
and B). 
Gradient condition (2): Starting at 40% buffer B followed by a linear extension to 70% 
buffer B in 10 min at a flow rate of 0.4 mL min-1, performed on Ultimate 3000 HPLC 
(see Section 2.6.4 for the compositions of TBAA IP RP HPLC buffer systems A and 
B). 
Gradient condition (3): Starting at 20% buffer B followed by a linear extension to 
57.5% buffer B in 15 min at a flow rate of 0.4 mL min-1, performed on Ultimate 3000 
HPLC (see Section 2.6.4 for the compositions of TBAA IP RP HPLC buffer systems A 
and B).. 
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Gradient condition (4): Starting at 25% buffer B followed by an increase to 40% buffer 
B in 3 min, followed by a linear extension to 50% buffer B over 10 min at a flow rate of 
0.75 mL min-1, performed on Agilent 1100 HPLC (see Section 2.6.4 for compositions 
of standard IP RP HPLC buffer systems A and B).  
Gradient condition (5): Starting at 30% buffer B followed by an increase to 45% buffer 
B in 3 min, followed by a linear extension to 55% buffer B over 10 min at a flow rate of 
0.75 mL min-1, performed on Agilent 1100 HPLC (see Section 2.6.4 for compositions 
of standard IP RP HPLC buffer systems A and B). 
Gradient condition (6): Starting at 22% buffer B followed by a linear extension to 62% 
buffer B over 17 min, then further extended to73% buffer B in 19.5 min at a flow rate 
of 1 mL min-1, performed on Agilent 1100 HPLC (see Section 2.6.4 for compositions 
of standard IP RP HPLC buffer systems A and B for 5.3.1 experiment; TEAA+Urea IP 
RP HPLC buffer systems A and B for 5.3.3 experiment).  
Gradient condition (7): Starting at 5% buffer B followed by an increase to 10% buffer 
B in 2 min, followed by a linear extension to 45% buffer B over 17 min, further extended 
to 60% buffer B in 19.5 min at a flow rate of 1 mL min-1, performed on Transgenomic 
HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC buffer systems A 
and B).  
Gradient condition (8): Starting at 10% buffer B  followed by an increase to 20% 
buffer B in 10 min, followed by a linear extension to 52% buffer B over 17 min, further 
extended to 63% buffer B in 19.5 min at a flow rate of 1 mL min-1, performed on Agilent 
1100 HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC buffer 
systems A and B for 5.3.1 experiment; TEAA+Urea IP RP HPLC buffer systems A and 
B for 5.3.3 experiment).  
Gradient condition (9): Starting at 25% buffer B followed by an increase to 50% buffer 
B in 3 min, followed by a linear extension to 60% buffer B over 10 min, applied at flow 
rates from 0.4 to 1.2 mL min-1 in 0.2 mL min-1 increments, performed on Transgenomic 
HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC buffer systems A 
and B).  
Gradient condition (10): Starting at 30% buffer B followed by an increase to 55% 
buffer B in 3 min, followed by a linear extension to 65% buffer B over 10 min, applied 
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at flow rates from 0.4 to 1.2 mL min-1 in 0.2 mL min-1 increments, performed on 
Transgenomic HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC 
buffer systems A and B).  
Gradient condition (11): Starting at 25% buffer B followed by an increase to 30% 
buffer B in 2 min, followed by a linear extension to 65% buffer B over 17 min, and then 
further extended to 80% buffer B in 19.5 min at a flow rate of 1 mL min-1, performed 
on Transgenomic HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC 
buffer systems A and B).  
Gradient condition (12): Starting at 32% buffer B followed by an increase to 37% 
buffer B in 2 min, followed by a linear extension to 72% buffer B over 17 min, then 
further extended to 83% buffer B in 19.5 min at a flow rate of 1 mL min-1, performed 
on Transgenomic HPLC (see Section 2.6.4 for compositions of standard IP RP HPLC 
buffer systems A and B).  
 
 Non-retentive HPLC 
Non-retentive conditions refer the absence of the absorption at the surface media of 
the column. All non-retentive analyses were performed on the Ultimate 3000 HPLC 
using the columns listed in section 2.6.3 and the mobile phases listed in Section 2.6.4. 
 
2.6.6.1 Non-retentive HPLC gradient condition 
Gradient condition (13): 20% buffer B held for 2 min, applied at flow rates from 0.75 
to 1.25 mL min-1 with 0.25 mL increments (see Section 2.6.4 for compositions of non-
retentive buffer systems A and B). 
Gradient condition (14): 50% buffer B held for 2 min, applied at flow rates from 0.75 
to 1.25 mL min-1 with 0.25 mL increments (see Section 2.6.4 for compositions of non-
retentive buffer systems A and B). 
Gradient condition (15): 80% buffer B held for 2 min, applied at flow rates from 0.75 
to 1.25 mL min-1 with 0.25 mL increments (see Section 2.6.4 for compositions of non-
retentive buffer systems A and B).  
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2.7 Mass spectrometry analysis  
 Ion trap mass spectrometry  
The development of a high-throughput analytical platform for the analysis of 
therapeutic oligonucleotides was performed using an ion trap mass spectrometer 
(HCT Ultra PTM Discovery System, Bruker Daltonics). All analyses were performed 
with different buffer systems (listed in section 2.7.2) and in full scan negative ion mode 
to data acquisition.  
The ESI ionization voltage was set to -2000 V, the high-flow nebuliser was operated 
in a standard manner with nitrogen as the nebulising gas (1.51 L/min) and the injected 
drying gas flow rate was 6.0 L/min at 300° C. Mass range was selected from 300-1800 
m/z, and the average of 3 spectra, as well as highest accumulated time, were 
maintained at 200,000 µs. 
 
 Mass spectrometry mobile phase components  
A variety of ion-pair (IP) reagents in conjunction with different types of organic 
modifiers were tested at various concentrations. The pH values of the IP reagents 
were also adjusted to improve ESI-MS sensitivity and suppress cation adduct 
formations, so that enhanced signal intensities could be achieved. 
The combinations of mobile phase systems are listed in the table below. All buffers 
were prepared with 50% acetonitrile and 50% HPLC grade water. For every 
experiment, each run was performed in technical triplicate on the same day to ensure 
consistent results (except for experiment 1). Experiments were then compared to 
determine which buffer had the greatest enhancement effect. 
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Description of 
experiment  
                            Experimental Conditions 
Mobile Phase System(s) Used pH 
BC2 
oligonucleotide vs 
IP reagents 
20 mM TEA with 0, 20, 50, & 80 mM HFIP 
15 mM HA with 0, 20, 50, & 80 mM HFIP 
5 mM TBA with 0, 20, 50, & 80 mM HFIP 
20 mM DIPA with 0, 20, 50, & 80 mM HFIP 
N/A 
BC2 
oligonucleotide vs 
Organic Modifiers 
HFIP, TFE, DMSO 
5 mM TBAA with 0, 20, 50, & 80 mM HFIP 
5 mM TBAA with 0, 20, 50, & 80 mM TFE 
15 mM HAA with 0, 20, 50, & 80 mM HFIP 
15 mM HAA with 0, 20, 50, & 80 mM TFE 
pH = 7.4 
15 mM HA with 0,1, 5,10 & 20 % DMSO 
5 mM TBA with 0,1, 5,10 & 20 % DMSO 
N/A 
BC2 
oligonucleotide vs 
pH 
5 mM TBA with 50 mM HFIP 
15 mM HA with 50 mM HFIP 
 pH = 8.0 
 pH = 9.0 
  pH =10.0 
  pH =11.0 
BC2, BC2b C6, 
and BC2b C12 
oligonucleotide vs 
IP reagents 
20 mM TEA with 0, 20, 50, & 80 mM HFIP 
15 mM HA with 0, 20, 50, & 80 mM HFIP 
5 mM TBA with 0, 20, 50, & 80 mM HFIP 
20 mM DIPA with 0, 20, 50, & 80 mM HFIP 
N/A 
 
2.7.2.1 Mass spectrometry mobile phase pH value 
The pH values of mobile phases with the IP reagents TBA and HA were dynamically 
adjusted by adding acetic acid as a counter ion. Acetic acid was used to bring the pH 
values in the mobile phase to neutral. The pH of both TBA and HA reagents started at 
8.0 and were increased to their respective maximum pH points: 10.0 and 11.0.  
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 Liquid chromatography and electrospray mass spectrometry 
The RNase digestion products from stable isotopic labelled RNA were analysed on 
ESI-MS with maXis ultra-high-resolution time-of-flight (UHR-TOF) (Bruker, Daltonics) 
interfaced with a capillary liquid chromatography system (U3000, Dionex) and an 
Accucore C18 column (150 mm × 2.1 mm ID, Thermo Fisher). The buffer systems and 
gradient conditions for oligoribonucleotide separation are listed in the table below.  
 
LC ESI MS Buffer A  
Triethylammonium acetate (TEAA) 20 mM 
1,1,1,3,3,3,-Hexafluoro-2-propanol (HFIP) 80 mM 
 
LC ESI MS Buffer B  
Triethylammonium acetate (TEAA) 20 mM 
1,1,1,3,3,3,-Hexafluoro-2-propanol (HFIP) 80 mM 
Acetonitrile 50% 
 
Gradient condition (14): 10% buffer B held for 2 min, followed by a linear increase to 
20% B in 20 min, followed by a linear extension to 25% B over 10 min, and finally a 
linear extension to 80% B in 2 min. 
 
 Ultra high-resolution time-of-flight mass spectrometry 
Ultra high-resolution time-of-flight (UHR-TOF) mass spectrometry (Bruker, Daltonics) 
was performed in negative ion mode with a mass range selected from 300-2500 m/z 
for data acquisition. ESI Ionization voltage was set to -2000 V, capillary temperature 
was maintained at 300°C, N2 nebuliser gas pressure was set at 0.4 bar and a flow rate 
of 6.0 L/h was used.  
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 Data processing 
The molecular weight and electrospray charge series of the oligonucleotides and 
oligoribonucleotide fragments obtained from an in silico RNase A digestion were 
calculated using the Mongo Oligo Mass Calculator (available at 
http://Library.med.utah.edu/masspec/mongo.htm). 
A list of theoretical monoisotopic masses of the light version of RNase A digested 
oligoribonucleotides fragments was obtained by compiling all possible chemical 
terminals selected during data processing, including 5'-OH, 5'-phosphate, 5'-cyclic 
phosphate and 3'-OH 3'-phosphate, 3'-cyclic phosphate. The resulting theoretical 
monoisotopic masses were utilised to calculate the mass of heavy isotope 
oligoribonucleotide based on the number of nitrogen atoms contained in base 
compositions or the number of heavy labelled G present in the oligoribonucleotide 
sequences. The Isopro 3.1 software was used to calculate the theoretical 
monoisotopic mass spectrum peak distribution as well as the relative abundance peak 
in an isotopic series. 
Data acquired by the ion trap mass spectrometer (HCT Ultra PTM Discovery System, 
Bruker Daltonics) from varying MS buffer systems were processed using total ion 
chromatograms (TIC) and deconvolution procedures from the software package 
Bruker Compass DataAnalysis (version 4.1, Build 317) as follows: 1) The desired 
dataset and spectra were opened. 2) Spectrum view to the Compound Spectra was 
copied using the command, “Copy to Compound Spectra and Deconvolute”. 3) The 
“Charge State Ruler” was activated. 4) The ruler for the Adduct Ion was set to –H 1 
(which corresponds to negative mode ESI). 5) The ruler was moved until the Charge 
Series aligned with the corresponding oligonucleotide component mass (the correct 
peak was determined using Mongo). 6) Deconvoluted results were viewed using 
“Spectrum Data”, which included the mass and abundance of the component. 
The TIC procedure was the same with the deconvolution procedure except at the end, 
where the electrospray series mass peak values were manually chosen to match 
exactly with the charge series. The sum of the values was obtained resulting in the 
total ion count for the sample. 
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 Characterisation and quantification of oligoribonucleotides using stable 
isotope labelling in conjunction with LC ESI MS 
To quantify oligoribonucleotide fragments using metabolic and in vitro stable isotope 
labelling, stable isotope labelled dsRNA were synthesised under both in vivo (15N) and 
in vitro (13C515N10 Guanosine containing dsRNA) conditions. Different amounts of 
heavy isotope-labelled dsRNA standards (with known concentrations) were 
subsequently spiked into light isotope- labelled total RNA (expressed dsRNA). 
Prior to the experiment, all samples were quantified using UV spectrophotometry (see 
Section 2.5.3) followed by LC ESI MS analysis. Values of the ion abundance for the 
digested oligoribonucleotides were obtained from extracted ion chromatograms (XIC). 
Mass mapping approaches were subsequently used for the characterisation and 
absolute quantification of the dsRNA by identifying the same oligoribonucleotide in 
both light and heavy versions and measuring the ratio and peak areas for both light 
and heavy samples. This was done using Data Analysis (Bruker Daltonics) for ten 
identified oligoribonucleotides (from both the sense and antisense strands) in the ToF-
MS scans to obtain sufficient statistical evidence.  
 
2.8 Agarose gel electrophoresis analysis of nucleic acids 
Gel electrophoresis analysis was performed on a horizontal gel apparatus (Bio-rad). 
1% agarose powder was mixed with 100 mL of 1× Tris-Acetate-EDTA buffer (TAE) 
(described in Section 2.2.2). The mixture was dissolved using a microwave and swirled 
in a flask to ensure thorough mixing before allowing it to cool down. Ethidium bromide 
(0.5 µg mL-1) was added to the agarose solution for staining. The agarose was poured 
into a gel tray, and a gel comb was inserted. After the gel was constructed, the gel 
comb was removed. The gel electrophoresis was set in the tank which was then filled 
up with TAE to cover the gel. Prior to the analysis, samples were prepared with 
appropriate volumes of loading Dye and loaded into the wells. Following sample 
loading, the gels were run at 100V for 45 min. Gel images were captured using a UV 
illuminator. The size and intensity of each sample were classified via comparison with 
the HyperLadderTM 1kb. 
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Chapter III : Optimisation of electrospray-ionisation mass 
spectrometry for the analysis of oligonucleotides 
 
3.1 Abstract 
The development of therapeutic oligonucleotides has led to an associated rise in 
demand for analytical tools to efficiently characterise these drug agents. Liquid 
chromatography electrospray ionisation mass spectrometry (LC-ESI-MS) is the most 
widely used analytical technique for the analysis of therapeutic oligonucleotides 
(Huber and Krajete, 1999). A key parameter in LC-ESI-MS performance is the 
physiochemical composition of the mobile phase, which has a critical impact on the 
efficiency of oligonucleotide ionisation (McGinnis et al., 2013; Chen et al., 2013; Gong 
and McCullagh, 2014).   
The overall aim of the chapter is to focus on the development and optimisation of ESI-
MS-methods for the analysis of oligonucleotides. Initial work focused on the 
optimisation of ESI-MS buffers and the relationship between oligonucleotide 
hydrophobicity and ESI-MS sensitivity. A range of ion-pair reagents and organic 
modifiers were evaluated in an attempt to optimise of oligonucleotide analysis. The 
results showed that a composition containing 5 mM tributylamine (TBA) with 80 mM 
hexafluoro-2-propanol (HFIP) produced the highest signal intensity with minimal cation 
adduct formation. Furthermore, the effects of various alkylamines on oligonucleotide 
charge state distributions were studied. In particular, HA and TBA produced lower 
higher charge state distributions respectively. Together, the results show that both the 
desorption efficiency of oligonucleotides and the resulting charge state distribution are 
correlated with the Henry’s law constant of volatile alkylamines. Finally, the effects of 
oligonucleotide hydrophobicity and ESI-MS sensitivity was studied using 
oligonucleotides with C6 and C12 alkyl linkers. It was found that altering the 
oligonucleotides hydrophobicity did not significantly affect ESI-MS sensitivity under the 
experimental conditions. 
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3.2 Introduction 
The application of analytical techniques is an important part of the development of 
antisense drugs, which includes the identification and quantification of 
oligonucleotides as well as their related impurities. Impure antisense drugs may cause 
detrimental effects such as off-target silencing of unwanted genes (Ivleva et al., 2008). 
Electrospray-Ionisation Mass-Spectrometry (ESI-MS) is a powerful technique for the 
study of oligonucleotides as it is compatible with online separation while preserving 
the solution phase for the conversion of macromolecules to gaseous ion form, which 
provides further specificity and structural characterisation ability (Huber and Krajete, 
1999; Apffel et al., 1997).  
Despite these advantages, the use of LC-ESI-MS for oligonucleotide analysis is 
hindered by the conflict between LC resolution and MS sensitivity, the formation of 
RNA-metal ion adducts which impede accurate analysis, and performance issues with 
larger oligonucleotides (Huber and Krajete, 1999).  
Tremendous efforts have been made to develop an analytical platform capable of 
analysing therapeutic oligonucleotides in the presence of alkylamine ion-pairing 
reagents due to the fact that solution composition has a considerable effect on the 
magnitude of both signal enhancement and suppression (McGinnis et al., 2013; Chen 
et al., 2013; Gong and McCullagh, 2014).  
 
3.2.1 ESI-MS mobile phases containing HFIP 
Apffel et al. (1997a) first introduced a mobile phase for ESI-MS oligonucleotide 
analysis containing hexafluoro-2-propanol (HFIP) with triethylamine (TEA) (pH of 7.0), 
in which the TEA acts as an ion-pairing reagent while the HFIP acts a counter ion. 
Although the mechanism is not fully understood, it is proposed that HFIP rapidly 
evaporates from the electrospray droplet due to its high volatility and low boiling point 
(57°C), raising the droplet’s pH value to 10.0. Then, oligonucleotide-TEA ion-pairs 
dissociate and enter the gas phase for desorption, resulting in enhanced ionisation of 
the oligonucleotides. The mechanism behind this mobile phase system was described 
by dynamically adjusted droplet pH values during the electrospray process, is a key 
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process in the selective removal of the anionic counter ion from the droplet via 
evaporation.  
Moreover, Apffel et al. (Apffel et al., 1997) stated that the pH value of 10 promoted 
optimal oligonucleotide negative ion formation since it is critical for analytes to exist 
present as ions in a solution. Finally, the presence of a strong organic base such as 
TEA can successfully inhibit adduct formation. More recent work presented in this 
thesis demonstrates that a small amount of additional HFIP in the IP reagent greatly 
enhances oligonucleotide ionisation due to the availability of free protons for 
electrochemical reduction (Chen et al., 2013). Meanwhile, the competition for 
ionisation at the droplet surface occurs between the additional amounts of 
deprotonated HFIP ions from the mobile phase and oligonucleotide molecules.  
 
3.2.2 Different mobile phase compositions 
For the past 20 years, the TEA/HFIP combination has been the standard mobile phase 
for LC-ESI-MS analysis of oligonucleotides, while other IP reagents (shown in Table 
III-1) have been proposed as alternatives to TEA/TEAA. These alternative reagents 
were tested at different concentrations and pH values to reach the optimal conditions 
stated for both LC and MS.  
 
Table III-1: IP reagents used in different studies 
IP Reagent Study 
Tripropylamine (TPA) (Huang et al., 2013) 
N,N-dimethylbutylamine (DMBA) (Oberacher, Parson, et al., 2001) 
Hexylamine (HA) (McCarthy et al., 2009) 
N,N-diisopropylethylamine(DIEA) (Chen and Bartlett, 2013) 
Dibutylamine (DBA) (Levin et al., 2011) 
Tributylamine (TBA) (McGinnis et al., 2013) 
 
Recently, Basiri et al., (2017) systemically tested 15 different physiochemical IP 
reagents alongside 11 oligonucleotide sequences to determine which parameters 
influence the ESI ionisation of the oligonucleotide. They observed that TEA was not 
the ideal IP reagent compared to other IP reagents for all of the oligonucleotide 
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sequences tested as it considerably decreased the ESI-MS process sensitivity. This 
result suggests that alternative alkylamine IP reagents are necessary to improve the 
ESI-MS sensitivity of oligonucleotides. Another implication is that the choice of IP 
reagent should be considered on a case by case basis as its effectiveness would be 
strongly influenced by the oligonucleotide sequence being analysed. Unfortunately, 
this means that the optimal IP reagent for a given oligonucleotide has to be determined 
each time prior to the ESI-MS analysis, an additional step which encumbers method 
development.  
Recently, McGinnis et al. (2013) systematically examined 13 IP reagents at different 
concentrations to compare the ionisation of oligonucleotides. The IP reagents with 
better signal intensity were selected for further testing with HFIP at a range of 
concentrations from 0-100 mM. It was found that the optimised mobile phase systems 
were 10 mM DIPA and 25 mM HFIP with methanol and 15 mM TPA and 50 mM HFIP 
for hydrophilic samples and modestly hydrophobic samples respectively.  
The combination of HAA with HFIP has been previously reported as an effective 
mobile phase system for LC separation of both single- and double-stranded 
oligonucleotides (Gilar et al. 2003; McCarthy et al. 2009). However, Noll et al. (2011) 
highlighted that an HAA system was significantly less mass-sensitive than buffer 
systems containing HFIP. Even so, the use of a low mass-sensitive system like HAA 
has been suggested because of the role that acetate can play as a buffering acid 
(Apffel et al. 1997a: Bleicher, and Bayer 1994). On the other hand, combining HA as 
the IP reagent with HFIP has been proposed, as HFIP performs better compared to 
acetate due to its higher volatility and constant evaporation through the electrospray 
(Huber and Oberacher 2001). This is supported by work showing that 15 mM HA and 
50 mM HFIP outperformed other IP reagents including TEA for oligonucleotide 
analysis (Gong and McCullagh, 2014).    
 
3.2.3 Alternative to hexafluoro-2-propanol: Trifluoroethanol 
Trifluoroethanol (TFE) has been proposed as an alternate organic modifier to HFIP 
(Cech and Enke, 2001), since it can produce deprotonated anions with stability, thus 
improving ESI response. Additionally, TFE is a solvent with weak acidity that does not 
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affect the pH regardless of concentration (Wu et al., 2004). This facilitates the 
electrochemical reaction by producing trifluoroethoxide and hydrogen (Cech and Enke, 
2001), which is the dominant reaction in negative-ion ESI (Chen et al., 2013). 
Moreover, Wu et al. (2014) pointed out that TFE is more responsive to hydrophobic 
samples compared to hydrophilic ones. 
Similar to HFIP, the boiling point (74.0°C) of TFE is also lower than that of TEA 
(88.0°C). Chen et al. (Chen et al., 2013) tested the impact of TFE on oligonucleotides 
and showed that TFE did not alter the charge state regardless of concentration and 
could not evaporate fast enough to avoid the suppression and deprotonation of 
oligonucleotides. In summary, although TFE may substitute HFIP, the lack of studies 
supporting it and the combined benefits of medium acidity and volatility of HFIP makes 
HFIP a better acidic modifier over TFE.  
 
3.2.4 Influence of mobile phase pH values on ESI-MS Ionisation 
Due to the importance of pH, Gong and McCullagh (2014) proposed that increasing 
IP reagent concentration elevates the pH value of the mobile phase. When near its 
pKa value, an IP reagent, becomes less dissociated, directly affecting protonation and 
IP efficiency. 
Bleicher and Bayer (1994) reported that raising the solution pH and the percentage of 
organic solvent significantly increased droplet charge during ionisation. However, it 
should be noted that even mild variations in pH concentration can have a significant 
effect on ionisation, selectivity, capacity factor, and resolution. Therefore, pH values 
should be carefully controlled to ensure sufficient experimental reproducibility. Optimal 
pH values have been suggested for a mobile phase containing a mixture of buffer and 
acid to resist change when the sample and ionisable analytes enter the column 
(Mannur et al., 2011). 
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3.2.5 Effect of analyte hydrophobicity on ESI-MS performance  
Studies show that the hydrophobicity of oligonucleotides has a strong correlation with 
electrospray ionisation efficiency (Null et al., 2003; McGinnis et al., 2013). The 
contribution of hydrophobicity and the correlated free energy with solvation on the ESI-
MS spectrum of nucleic acids was evaluated (Null et al. 2003). An improved correlation 
between higher signal intensity and increasing hydrophobicity was observed, by 
adding an alkyl chain to the 5' terminus on a 20-mer oligonucleotide.  
In summary, the available literature suggests that the choice of alkylamine ion-pairing 
reagents in ESI-MS has the most significant effect on oligonucleotide signal intensity. 
The main parameters to be considered for an IP reagent are its boiling point, proton 
affinity, water solubility, Henry's law constant, as well as the hydrophobicity content of 
the oligonucleotides. However, a range of contrasting data and theories are evident in 
the literature. (Apffel et al., 1997; Null et al., 2003; Huber and Oberacher, 2002; Chen 
et al., 2013; McGinnis et al., 2013; Gong and McCullagh, 2014; Basiri and Bartlett, 
2014; Basiri et al., 2017).   
This chapter describes approaches to the development and optimisation of ESI-MS 
for oligonucleotides analysis. In addition, the aim was to study the effect of different 
hydrophobic tags on oligonucleotides on ESI-MS sensitivity. Initial work focused on 
the optimisation of an ESI-MS mobile phase. Six ion-pairing reagents of interest (TBA, 
TBAA, TEA, HA, HAA and DIPA) were systematically examined in combination with 
various types of organic modifiers and pH values.   
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3.3 Results and discussion  
Part A 
3.3.1 Effect of different IP reagents on ESI-MS analysis of oligonucleotides 
The experimental objective was to determine how different IP reagents in combination 
with varying concentrations of HFIP affect the ESI-MS analysis (ESI signal) of 
oligonucleotides, which were 2 µM infusions of a 15 mer oligonucleotide (BC2 see 
materials and methods). The IP reagents tested were TEA, HA, TBA, and DIPA while 
HFIP concentrations ranged from 0 mM to 80 mM. A typical MS spectrum of the 
oligonucleotide obtained in negative ion mode is shown in Figure III-1 with its different 
charge states highlighted. Following data acquisition, the signal intensity of all 
corresponding charge states for the oligonucleotide (i.e. total ion chromatogram) was 
recorded for each of the different buffer compositions (see Figure III-2). 
 
Figure III-1: A typical MS spectrum of the 15 mer oligonucleotides obtained in 
negative ion mode. The range of different charge states from -3 to -6 are highlighted. 
 
Table III-2: Physiochemical properties of the ion-pair reagents in this study 
IP agent  
Boiling  
point (°C) 
Proton 
affinity 
(kcal/mol) 
Water 
Solubility 
(g/L) 
kH,cc 
(aq/gas) 
pKa 
HA 130.00 221.70 20.57 1.57 10.56 
DIPA 83.90 232.30 75.31 0.42 11.05 
TEA 89.70 234.70 68.30 0.35 10.78 
TBA 216.50 238.60 0.08 0.08 10.90 
*HA=Hexylamine, DIPA= Diisopropylamine, TEA= Triethylamine, TBA= Tributylamine 
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Figure III-2: ESI-MS signal intensity of unmodified 15 mer (5̍-
CAAAAGTCCGTGAGA-3̍) oligonucleotide, with concentration at 2 µM. Samples 
were infused with 4 sets of buffers; Set 1 (a,b,c,d) 20 mM TEA with 0, 20, 50, 80 mM 
HFIP respectively; Set 2 (a,b,c,d) 15 mM HA with 0, 20, 50, 80 mM HFIP respectively; 
Set 3 (a,b,c,d) 5 mM TBA with 0, 20, 50, 80 mM HFIP respectively; Set 4 (a,b,c,d) 20 
mM DIPA with 0, 20, 50, 80 mM HFIP respectively, were studied on ESI-MS in 
negative ion mode. The signal intensity (total ion chromatogram) for each buffer 
composition was recorded for three minutes and performed in triplicates. The means 
and standard deviations for each triplicate were calculated. 
 
Firstly, TEA (Figure III-2, 1a-1d,) displayed a general increase in signal intensity with 
increasing amounts of HFIP. The highest signal (~4 x 106) was obtained with 80 mM 
HFIP, which is twice as high compared to TEA without HFIP. Secondly, with HA 
(Figure III-2, 2a-2d), a U-shaped trend can be observed, with signal intensities 
dropping after initial addition of HFIP before increasing again when 80 mM HFIP was 
added. In this case, only a small increase in intensity was observed through the 
addition of HFIP.  
Thirdly, TBA (Figure III-2, 3a-3d) produced the greatest effect of signal enhancement, 
with a maximum value at 80 mM of HFIP (3d), an almost 100% improvement over 0 
mM HFIP (3a). Furthermore, this value was the highest recorded among all buffer 
combinations, suggesting that it is the optimum combination for the oligonucleotide 
studied. Finally, for DIPA (Figure III-2, 4a-4d), a downward trend was observed when 
the HFIP concentration was increased. DIPA with 80 mM HFIP (4d) produced the 
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lowest signal intensity among all buffer combinations, implying that DIPA performs 
better without any HFIP added. 
Overall, it appears that for the analysis of the 15 mer oligonucleotide (BC2), a 
combination of 5 mM TBA with 80 mM HFIP provides the highest signal intensity 
across all buffers, followed by 20 mM TEA, 20 mM DIPA and 15 mM HA. These results 
may be related to the Henry’s Law constant as the IP reagent with the lowest kH,cc 
(aq/gas) produced the highest ESI-MS signal. This conclusion is supported by Chen 
et al. (2013) who proposed that IP reagents with lower kH,cc (aq/gas) result in an 
increase of the oligonucleotide concentration at the droplet surface, thus leading to 
more effective ionisation. However, the positive effect of the Henry’s Law constant 
may be dependent on the sequence of the oligonucleotide used, as a recent study has  
shown conflicting results (Basiri et al., 2017) 
Unfortunately, the results of this experiment could not confirm a link between 
increasing concentration of HFIP and enhancement of oligonucleotides signal intensity. 
It is possible that certain IP reagents respond adversely to HFIP which explains the 
negative correlation in the case of HA and DIPA. It has been suggested that the 
complex interaction between the physiochemical properties of the buffer components 
and the solubility of IP reagents in HFIP may have an effect (Gong et al. 2014). 
 
3.3.2 Effect of varying alkylamines on cation formation and charge state distribution  
In addition to signal intensity, the effect of different IP reagents with varying HFIP 
concentrations on cation adduct formation and charge state distribution were 
investigated. The ESI-MS spectra of the oligonucleotide in the presence of TEA is 
shown in Figure III-3, where the charge state distribution and the sodium adducts 
observed in the 3- charge state are highlighted. Analysis of the charge state 
distribution revealed a range of values from 7- to 3- under these conditions, with the 
3- charge state as the most abundant especially in the presence of 80 mM HFIP.  
The ESI-MS spectra of the oligonucleotide analysed in the presence of HA displayed 
low levels of cation adduction as shown in Figure III-4. However, when HFIP was 
added to the system, a few observations were noted: (1) the charge state distribution 
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was reduced and the 7- charge state was no longer observable; (2) the extent of 
sodium adduction was reduced; (3) the spectral pattern shifted, with the most intense 
signal moving from the higher charge states 5- and 6- to the lower charge state 3- (i.e., 
the charge state was reduced). Hence, the addition of HFIP (a weak acidic modifier), 
is predicted to lower the solution’s pH value and provide additional protons to the 
oligonucleotides, leading to a shift in the observed charge state distribution, consistent 
with previous observations (McGinnis et al., 2013). 
The ESI-MS spectra of the oligonucleotide analysed in the presence of TBA is shown 
in Figure III-5. The combination of TBA and HFIP led to improved spectral quality, 
while a small amount of cation adduction was observed. For TBA, the most abundant 
charge state was 6- across all HFIP concentrations (20-80 mM) while the absence of 
HFIP showed a similar effect as with HA without HFIP. The highest intensity switched 
the charge state from 5- to 6- after HFIP was added. Interestingly, the results show 
significant differences compared to the addition of HFIP to HA. The ESI-MS spectra 
of the oligonucleotide analysed in the presence of DIPA is shown in Figure III-6 Charge 
state distribution analysis revealed that for DIPA without HFIP, the most intense 
charge states were 5- and 6-. In general, increased abundance of the 3- charge state 
was observed with the addition of HFIP in a similar manner to that observed for TEA 
and HA. The mobile phase systems consisting of DIPA and HFIP showed a small 
reduction in cation adduction with increasing HFIP, suggesting a positive correlation 
between higher HFIP concentration and reduced cation adduction. 
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Figure III-3: Spectrum of 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at 
a concentration of 2 µM infused with 20 mM of TEA and 0 - 80 mM HFIP: studied 
using ESI-MS negative mode. The spectrum shows cation adduction and charge 
state distribution. Data were recorded for three minutes. 
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Figure III-4: Spectrum of 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at 
a concentration of 2 µM infused with 15 mM of HA and 0 - 80 mM HFIP: studied 
using ESI-MS negative mode.  The spectrum shows cation adduction and charge 
state distribution. Data were recorded for three minutes. 
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Figure III-5: Spectrum of 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at 
a concentration of 2 µM infused with 5 mM of TBA and 0 - 80 mM HFIP: studied 
using ESI-MS negative mode.  The spectrum shows cation adduction and charge 
state distribution. Data were recorded for three minutes. 
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Figure III-6: Spectrum 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at a 
concentration of 2 µM infused with 20 mM of DIPA and 0 - 80 mM HFIP: studied 
using ESI-MS negative mode. The spectrum showed cation adduction and charge 
state distribution. Data were recorded for three minutes.  
20 mM DIPA+ 80mM HFIP+ 50% 
651.
7 
760.
5 
912.
8 
1141.
5 
1522.
1 
0 
1 
2 
3 
4 
5 
5 x1
0 
Inten
s. 
40
0 
60
0 
80
0 
100
0 
120
0 
140
0 
160
0 
m/
z 
4d 3- 
4- 
5- 6- 
7- 
4c 
4- 5- 
6- 
3- 
7- 
651.
7 
760.
5 
912.
8 
1141.
3 
1522.
3 
0 
1 
2 
3 
4 
5 
5 x1
0 
Inten
s. 
40
0 
60
0 
80
0 
100
0 
120
0 
140
0 
160
0 
m/
z 
20 mM DIPA+ 50mM HFIP+ 50% 
651.
7 
760.
5 912.
8 1141.3 
1522.
3 
0 
2 
4 
6 
5 x1
0 
Inten
s. 
40
0 
60
0 
80
0 
100
0 
120
0 
140
0 
160
0 
m/
z 
4b 
4- 5- 
6- 
3- 
7- 
20 mM DIPA+ 20mM HFIP+ 50% 
4a 
3- 
4- 
5- 6- 
7- 
651.
8 
760.
5 
912.
8 
1141.
4 
1522.
3 
0 
2 
4 
6 
5 x1
0 
Inten
s. 
40
0 
60
0 
80
0 
100
0 
120
0 
140
0 
160
0 
m/
z 
20 mM DIPA+ 20mM HFIP+ 50% 
75 | P a g e  
3.3.3 Charge state distribution of different alkylamine ion-pair reagents  
A comparison of the charge state distribution of the 15-mer oligonucleotide across 4 
different IP reagents with 20 mM HFIP is shown in Figure III-7. Significant charge 
reduction was observed on the 15 mM HA buffer system, which could be explained 
using either Henry’s law or the effect of the pKa value. 
 
Figure III-7: MS spectrum of the oligonucleotides in negative mode showing the 
observed charge state distribution of the 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) 
oligonucleotide at a concentration of 2 µM was infused within TEA, HA, TBA and 
20 mM HFIP+50% ACN/Water. Data were recorded for three minutes.  
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Figure III-7 show that HA which has the highest kH,cc(aq/gas) also has the lowest 
charge state distribution (predominantly 3-) while TBA which has the lowest 
kH,cc(aq/gas) has the highest charge state distribution (predominantly 6-). Constants 
for other IP reagents used in the experiment are given in Table III-2. These results are 
consistent with the conclusions drawn by Chen et al. (2013) the kH,cc(aq/gas) has the 
effect of reducing the charge state distribution as the higher the reagent’s kH,cc(aq/gas) 
(such as HA), the more likely it is to remain in solution with the analyte to form a 
complex before separating from the analyte during the subsequent droplet evaporation 
process. The pKa value is another factor which may have influenced the results. It was 
observed that HA having the lowest pKa (10.56) out of all the IP reagents and, in the 
presence of 20 mM of acidic modifier HFIP resulted in the lowest charge state 
reduction across all the IP reagents evaluated. 
 
3.3.4 Effect of pH on the ESI-MS mobile phase for the analysis of oligonucleotides 
The present work evaluated the influence of the pH values of the IP reagents: 
hexylamine (HA) and tributylamine (TBA) on ESI-MS response in negative ion mode. 
Acetic acid was added to the alkylamines to generate buffers with the desired pH. The 
evaluation was done by comparing the signal intensities at pH values of 8, 9, 10, and 
11 with a 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at a concentration of 2 
µM. Each buffer composition was analysed to obtain the oligonucleotide signal 
intensity (total ion chromatogram) for three minutes. From Figure III-8, it can be seen 
that for HA, signal intensity increased with pH up to a maximum of 11.0 (Figure III-8). 
In the case of mobile phases with higher pH values, acetic acid was added to convert 
the solution to neutral. It follows that the solution containing more acetic acid has 
lowered ionisation efficiency due to competition between acetate ions and the 
oligonucleotides, an inference that is supported by results in literature (Apffel et al. 
(1997a). For TBA, the greatest signal intensity was observed at pH 9 rather than the 
expected pH of 10. However, as with HA, the lowest signal intensity was observed 
with the most acetic acid present (pH 8.0). 
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Figure III-8: The effect of pH values on signal intensity using 5 mM TBA and 15 
mM HAA. 
 
3.3.5 Effect of pH on the charge state distribution of IP reagents TBA and HA 
The effect of varying pH values on the charge state distribution of buffers with TBA 
and HA was also investigated. The pH of the buffer systems was adjusted by lowering 
the pH using acetic acid to form the IP-acetate ions. TBA buffer was tested in the pH 
range of 10.0 to 8.0 (Figure III-9). As the pH was lowered from 10.0 to 8.0, the most 
intense signal shifted from the higher charge states of -6 and -5 to the lower charge 
state of -3. In addition, the signal intensity at the higher charge states (-7) weakened 
considerably. The pattern of the charge state distribution at pH 9.0 was similar to that 
at pH 10.0 but with stronger intensities at most charge states except -3. These 
observations suggest a relationship between the amount of acetic acid added and the 
degree of charge state reduction. 
Previous experiments showed that HA might have an effect on charge state reduction 
when compared with other IP reagents. In this experiment using HA, it was observed 
that the -4 charge state was more intense at pH 8.0 than at pH 9.0 (Figure III-10). In 
addition, from Figure III-12. The total ion count signal intensities were higher at pH 
10.0/11.0, further demonstrating that increasingly adding acetic acid as a counter ion 
results in signal suppression. A similar pattern of charge state distribution was 
observed between pH 9.0 and pH 10.0. 
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Interestingly, at pH 11.0 (i.e. without any acetic acid added), additional charge states 
of -7 and -8 appeared (Figure III-10). This finding is supported by Muddiman et al., 
(1996) who reported that the addition of acetic acid to the solution resulted in charge 
state reduction. As can be seen from pH 8.0 to11.0, higher amounts of acetic acid 
weakened the signal intensities at the higher charge states. In other words, depending 
on whether the IP reagent is contained in a more acidic or basic solution, the charge 
states will decrease or increase respectively.  
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Figure III-9: MS spectrum showing the effect of pH values on the charge 
distribution of the 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at a 
concentration of 2 µM with 5 mM TBA. Data were recorded for three minutes. 
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Figure III-10: MS spectrum showing the effect of pH values on the charge 
distribution of the 15 mer (5̍-CAAAAGTCCGTGAGA-3̍) oligonucleotide at a 
concentration of 2 µM with 15 mM HA. The data were recorded for three minutes. 
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3.3.6 Effect of organic modifiers HFIP, TFE and DMSO in the mobile phase 
In this experiment, HAA and TBAA were used as buffers instead of HA and TBA to 
study how the addition of ammonium acetate affects oligonucleotide ESI-MS 
ionisation. HAA and TBAA were chosen in particular due to their large relative 
differences in kH,cc (aq/gas). In addition, the effect of different organic modifiers was 
studied using HFIP, TFE and, DMSO with 5 mM TBAA and 15 mM HAA for the 
analysis of oligonucleotides using ESI-MS. It was hypothesised that each of these 
organic modifiers would have a specific magnitude of enhancement effect on ESI-MS 
performance.   
The experiment was performed with 15-mer (CAAAAGTCCGTGAGA) 
oligonucleotides at a concentration of 2 µM. The oligonucleotides were infused with 
either 5 mM TBAA or 15 mM HAA in combination with HFIP or TFE in the range of 0-
80 mM. The samples were studied on ESI-MS using negative-ion mode. The signal 
intensity (i.e. total ion chromatogram) was recorded for three minutes for each buffer 
composition, and the results are summarised in Figure III-11. 
The data show that for 5 mM TBAA, the optimal concentration of HFIP was 10 mM, 
which produced the highest signal intensity (total ion count, TIC) (see Figure III-11). It 
is notable that further increasing the concentration of HFIP to 80 mM significantly 
reduced signal intensity to approximately 5,000,000 counts, but high concentrations 
of TFE did not critically suppress the signal intensity. At 10 mM and 20 mM of HFIP 
and TFE, similar effects were observed, resulting in approximately equal values for 
signal intensity. Finally, whereas 80 mM of HFIP induced ion suppression, 80 mM of 
TFE appeared to boost signal intensity, though the signal intensity was still almost 
equal to that at 0 mM TFE.  
Based on Figure III-11 B and Figure III-12 B, the standard deviations for each dataset 
are relatively low, except for the 20 mM TFE and 0 mM HFIP and 20 mM TFE datasets, 
which were likely due to instrument instability. The experiment was run in instrument 
triplicate on the same day. When HAA was used as the IP reagent (Figure III-12 A), a 
similar trend to TBAA was observed. No significant changes in ESI intensity were 
observed between 0-20 mM HFIP/TFE. At 80 mM of HFIP, more suppression occurred, 
with the signal intensity below the original value without HFIP. The results for TFE 
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were unexpectedly similar to HFIP at concentrations of 10 mM and 20 mM. At 80 mM 
the results diverged with TFE and showed a slightly increased signal intensity. The 
findings of this experiment are consistent with the conclusions of Wu et al. (2004) who 
found that high concentrations of TFE (>100 mM) improved signal intensity. In addition, 
McGinnis et al. (2013) noted that lower HFIP concentrations (25 - 50 mM) are more 
effective than higher HFIP concentrations (100 mM). 
Overall, at the same concentration of organic modifier, 15 mM HAA performed better 
than 5 mM TBAA at enhancing signal intensities. On the other hand, the HAA and TFE 
combination did not show significant improvement in signal intensity with increasing 
TFE concentration. Thus far, published details on the use of the combination of HAA 
and TFE and its effects on signal intensity have been scarce, thus motivating this study. 
Based on the results, this combination may have potential as a signal-enhancing 
mobile phase system. 
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Figure III-11: The effect of organic modifier in a TBAA containing mobile phase.  
(A) Signal intensity of the 15 mer oligonucleotide in 5 mM of TBAA with 0 - 80 mM 
HFIP vs. with 0 - 80 mM TFE. The signal intensity (total ion chromatogram) for each 
buffer composition was recorded for three minutes and performed in triplicates. (B) 5 
mM TBAA with various concentrations of HFIP and TFE, the means and standard 
deviations for each triplicate were calculated. 
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Figure III-12: The effect of organic modifier in an HAA containing mobile phase.  
(A) Signal intensity ratio of the 15-mer oligonucleotide in 15 mM of HAA with 0 - 80 
mM HFIP with 0 - 80 mM TFE. The signal intensity (total ion chromatogram) for each 
buffer composition was recorded for three minutes and performed in triplicates. (B) 15 
mM HAA with various concentrations of HFIP and TFE, the means and standard 
deviations for each triplicate were calculated. 
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Part B 
3.3.7 Effect of analyte hydrophobicity on ESI-MS 
Increased oligonucleotide hydrophobicity has been suggested to result in enhanced 
ESI-MS signal intensity (Null et al. 2003). To test this hypothesis, the following 
synthetic oligonucleotides were used: unmodified BC2b, modified hydrophobic BC2b 
with a C6 amino linkage (used to couple the amine-reactive to the oligonucleotide), 
and BC2b with C12 spacer linkage (which is a 12-carbon spacer used to insert a long 
spacer arm into the oligonucleotide) (See Figure III-13). The aim of this experiment 
was to compare the ESI MS signal intensity of the unmodified sample (BC2) with that 
of the modified samples (BC6 and BC12) using four different IP reagents (TEA, TBA, 
HA, and DIPA) in combination with different concentrations of HFIP.  
 
 
Figure III-13: Structure of oligonucleotide modifications. (A) Amino-link C6, (B) 
Spacer C12 modification. 
 
The various alkylamine IP reagents used in this experiment paired with the 
hydrophobic oligonucleotide sample backbone may make it more hydrophobic (Null et 
al. 2003). As a result, the signal intensity may increase by promoting oligonucleotide 
desorption while the alkylamines evaporate and dissociate from the oligonucleotide in 
the gas phase. 
Following quantification of the different oligonucleotides using the NanoDrop 
spectrophotometer, a solution of 2 µM oligonucleotide was infused for ESI-MS 
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analysis. The typical ESI-MS spectrum for each oligonucleotide with their associated 
molecular weights confirming the applied modifications is shown in Figure III-14. The 
results show no significant change in the charge state distribution to the hydrophobic 
tag. 
 
 
Figure III-14: Mass spectrum of BC2, BC6, BC12 oligonucleotides at a 
concentration of 2 µM (infused in a buffer system containing 5 mM TBA and 0 
mM HFIP on ESI-MS). Data were recorded in negative mode for three minutes. 
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3.3.8 Verification of NanoDrop measurement of oligonucleotides using HPLC  
For a comparative analysis of each oligonucleotide, accurate quantification is 
important to ensure that equal amounts are analysed each time in the MS. To verify 
the quantification of the oligonucleotides from the NanoDrop spectrophotometer, 
HPLC analysis of the individual oligonucleotides with concentrations of 20, and 50 
pmol were analysed using UV absorbance measurements (260 nm). Each sample was 
injected in triplicate under partial loop mode (Figure III-15). A comparison using the 
same gradient demonstrates a significant increase in the retention time of the C12 
modified oligonucleotide, which was not observed for the C6 modified oligonucleotide. 
The results also show an increase in hydrophobicity of the C12 oligonucleotide when 
analysed using the weak ion-pair reagent.  
Additionally, unmodified BC2b was found to have the highest intensities while modified 
BC2b C6 and BC2b C12 showed much lower intensities across the two different 
concentrations. Due to the possibility of inaccurate concentration measurements from 
the NanoDrop, normalisation was performed based on the peak areas obtained from 
the HPLC (Table III-3). 
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Figure III-15: IP RP HPLC quantitative analysis of BC2b, BC2b C6 and BC2b C12.  
Concentrations of 20 pmol and 50 pmol were analysed using a weak ion-paring 
reagent (TEAA) in conjunction with an Accucore C18 column (150 mm i.d × 2.1 mm) 
under gradient condition 1 (see chapter 2.6.5.1).  
 
3.3.9 Quantification of oligonucleotides based on synthesis yields  
In addition to quantification using the NanoDrop spectrophotometer, synthesis reports 
from the oligonucleotide supplier were also used for the calculation of sample 
concentrations. Further verification was subsequently performed through HPLC 
analysis (UV absorbance 260 nm) of individual oligonucleotides at concentrations of 
10, 20, and 50 pmol. Each sample was injected in triplicate using full loop injection to 
ensure high reproducibility for the quantification. The resulting chromatogram (shown 
in Figure III-16) indicates that very similar peak areas were obtained, demonstrating 
improved accuracy of the initial quantification compared to the NanoDrop 
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spectrophotometer. However, the BC2 oligonucleotide had an increased intensity 
compared to the other oligonucleotides for the same amount of oligonucleotide 
analysed. Similar retention times were observed for all the oligonucleotides (Figure 
III-16), which was a consequence of using a strong ion-pairing reagent (TBAA), 
causing the dynamic anion-exchange process to dominate in size-dependent 
separation (Dickman, 2011). 
The results summarised in Table III-4 show that the NanoDrop concentrations differed 
from that obtained from the synthesis reports. Nevertheless, in each case 
normalisation based on the accurate HPLC analysis can be used to ensure equal 
concentrations of the oligonucleotide are analysed using ESI-MS. 
 
Table III-3: Calculation steps for the normalisation of oligonucleotide 
concentrations measured by NanoDrop UV spectrophotometer. 
Concentration Calculation 
20 pmol 
52.0
79.6
53.3
2
6BC 
BC
 
45.0
79.6
06.3
2
12BC 
BC
 
50 pmol 
65.0
28.11
35.7
2
6BC 
BC
 
71.0
28.11
03.8
2
12BC 
BC
 
Overall 
59.0
2
65.052.0
2
6BC 


overallBC
 
58.0
2
71.045.0
2
12BC 


overallBC
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Figure III-16: Results from IP RP HPLC analysis of BC2b, BC2b C6 and BC2b C12 
at concentrations of 10 pmol, 20 pmol, and 50 pmol. Analysis was based on 
synthesis reports (from the oligonucleotide supplier) using a strong ion-pairing reagent 
(TBAA) in conjunction with an Accucore C18 column (150 mm i.d × 50 mm) under 
gradient condition 2 (see chapter 2.6.5.1).  
91 | P a g e  
Table III-4: Results from different methods of measuring oligonucleotide sample 
concentration. 
Sample Nanodrop Synthesis Report 
BC2b 1260 µM 1320 µM 
C6 479 µM 846 µM 
C12 914 µM 486 µM 
 
Table III-5: Calculation steps for the normalisation of oligonucleotide 
concentrations, calculated from the synthesis report. 
Concentration Calculation 
10 pmol 
14.1
22.4
8.4
2
6BC 
BC
 
98.0
22.4
13.4
2
12BC 
BC
 
20 pmol 
72.0
4.11
22.8
2
6BC 
BC
 
76.0
4.11
69.8
2
12BC 
BC
 
50 pmol 
68.0
03.27
25.18
2
6BC 
BC
 
71.0
03.27
27.19
2
12BC 
BC
 
Overall 
85.0
3
68.072.014.1
2
6BC 


overallBC
 
82.0
3
71.076.098.0
2
12BC 


overallBC
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3.3.10 ESI-MS analysis of oligonucleotides with varying hydrophobicities using 
different alkylamines 
To study the effect of oligonucleotide hydrophobicity on ESI-MS sensitivity, 2 µM of 
direct infusions of oligonucleotides were used in the presence of different ion-pair 
reagents. The overall ESI-MS signal intensities were measured and normalised based 
on the data in Table III-3. Experimental results show that for TEA, HA, and TBA the 
oligonucleotide with the C6 tag had the highest ESI-MS signal compared to that with 
a C12 tag and the oligonucleotides without any tags. However, the most hydrophobic 
oligonucleotide with the C12 tag did not result in the highest ESI-MS signal as should 
be expected. Replicate analysis was also performed normalising the quantification of 
the three oligonucleotides based on the HPLC Absorbance 260 nm prior to direct 
infusion as previously described. This approach ensured that equal amounts of 
oligonucleotides were analysed before ESI-MS analysis (Figure III-16). 
The results show that similar ESI-MS intensities were obtained for each 
oligonucleotide modification (Figure III-17 B) in contrast to data obtained from literature 
(Null et al. 2003). Despite performing two normalisations (one based on initial 
NanoDrop measurements and one based on the synthesis report), the unmodified 
oligonucleotides still showed higher signal intensities compared to the oligonucleotide 
with the C12 tag. Hence, it may be surmised that the overall hydrophobicity of the 
oligonucleotides does not enhance ESI-MS intensity based on results in this study. 
These results appear to contradict previous observations by Null et al. (2003) where 
the use of a 20 mer oligonucleotide with an additional amino-C12 modification (which 
resulted in a four-fold increase in hydrophobicity relative to its unmodified state) 
resulted in improved signal intensities. However, it should be noted that no direct 
evidence for the accurate quantification of the oligonucleotide prior to LC-ESI-MS 
analysis was provided in their study. 
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Figure III-17: The effect of oligonucleotide hydrophobicity on ESI-MS mass 
signal intensity with various buffer systems.  (A) Samples used were unmodified 
15 mer (5̍-CAAAAGTCCGTGAGA-3)̍ oligonucleotide, modified C6 15 mer 
oligonucleotide, and modified C12 15 mer oligonucleotide at a concentration of 2 µM. 
Samples were infused with 4 sets of buffers; Set 1 20 mM TEA; Set 2 15 mM HA; Set 
3 5 mM TBA; Set 4 20 mM DIPA, HFIP was used in conjunction with all the buffer sets, 
the analyses were studied on ESI-MS in negative ion mode. Signal intensities (the 
results of total ion chromatogram were further normalised based on NanoDrop LC UV 
analysis). Data for each buffer composition were recorded for three minutes. The 
means and standard deviations for each triplicate were calculated. (B) Signal intensity 
of the 15 mer unmodified BC2 oligonucleotide, modified BC2b C6, and BC2b C12 
oligonucleotide. The injected concentration 2 µM was based on the synthesis report, 
which was post-normalised prior to the ESI-MS analysis in 20 mM of TEA with 20 mM 
HFIP. 
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3.4 Conclusions 
Analysis of a wide range of IP reagents and organic modifiers were performed to 
optimise ESI-MS conditions for the analysis of 15 mer oligonucleotides 
(CAAAAGTCCGTGAGA). It was shown that 5 mM TBA produced the highest signal 
intensity while also responding positively to increasing HFIP concentration. This result 
is consistent with recent studies where TBA was shown to be one of the best 
performing IP reagents in terms of signal intensity over various concentrations 5 mM 
-15 mM (McGinnis et al. 2013). It was further demonstrated that utilising an IP reagent 
with a high Henry’s law constant resulted in a low charge state distribution of the 
oligonucleotide, while low Henry’s law constants resulted in higher charge states 
distributions. 
The investigation into the effects of HFIP from 0-80 mM for varying IP reagents was 
inconclusive as no consistent trend of either improvement or reduction of ESI-MS 
signal intensity could be observed. Nevertheless, the highest ESI-MS signal intensities 
were observed using 5 mM TBA in combination with 80mM HFIP in this study. 
A comparison between HAA and TBAA showed that HAA benefitted more from 
increasing amounts of either HFIP or TFE with increased signal intensities. Comparing 
the organic modifiers TFE and HFIP, TFE was generally better at enhancing ESI-MS 
signals, especially at higher concentrations; demonstrating potential benefits as an 
alternative in comparison to the expensive and hazardous HFIP.  
The optimal pH conditions were found to depend on the IP reagents used: pH 9.0 and 
pH 11.0 for TBA and HA respectively. The charge state distribution did not seem to be 
affected by pH in the case of TBA but was altered when using HA within a pH of 8.0 
to11.0. 
The effects of oligonucleotide hydrophobicity were studied using a range of modified 
oligonucleotides with either a C6 tag or C12 tag at the 5’-end of the oligonucleotide. 
Following accurate quantification of the modified oligonucleotides using HPLC UV 
analysis, no significant increase in ESI-MS signal intensity was observed from higher 
hydrophobicity. These results are in contrast to observations in literature where the 
utilisation of a 20 mer oligonucleotide with an additional amino-C12 modification 
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(resulting in a four-fold increase in hydrophobicity relative to the unmodified state) 
demonstrated improved signal intensities (Null et al., 2003).  
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Chapter IV : Purification and quantification of dsRNA 
extracted from microbial cells 
4.1 Abstract  
RNA interference (RNAi) is a powerful technique used to down-regulate specific target 
gene expression. It is widely employed in the study of gene functions in eukaryotic 
organisms and holds potential for many promising applications in both medicine and 
insect management strategies. The application of RNAi requires high quantities of 
quality dsRNA, which is currently challenging to produce. The production of large-
scale dsRNA has led to a need for analytical techniques capable of rapidly isolating, 
purifying, and analysing dsRNA.   
Extraction of dsRNA is critical for downstream applications of RNAi; this chapter aims 
to study five different RNA extraction methods currently available on the market 
(including a number of variations using the guanidine isothiocyanate-
phenol/chloroform procedure) for the high-throughput extractions of dsRNA from 
microbial cells. Experimental results based on extraction from 109 E. coli cells show 
that the DNAzol method yielded the highest amount of dsRNA extracted, despite the 
presence of genomic DNA in the extracted samples. 
In addition, the successful utilisation and development of stable isotopic labelling to 
characterise and quantify dsRNA in complex RNA mixtures, specifically using 
metabolic labelling and in vitro labelling of dsRNA in conjunction with mass 
spectrometry has been reported (Kung et al., 2018). Reference dsRNA was 
synthesised (15N and 13C15N dsRNA), both in vivo and in vitro prior to purification and 
quantification. The reference dsRNA was subsequently mixed into RNA extracted from 
E. coli that were engineered to express dsRNA. Following isolation of the total RNA 
(including dsRNA), known amounts of isotope-labelled dsRNA standard were added, 
and the mixture digested with a ribonuclease prior to MS analysis and quantification 
of dsRNA. It was demonstrated that isotope labelling of reference dsRNA simplifies 
the characterisation and mass mapping of dsRNA fragments based on the significant 
mass shift between light and heavy oligonucleotides.  
97 | P a g e  
4.2 Introduction 
 RNAi and dsRNA extraction 
Exploitation of the RNAi pathway to block the expression of specific genes holds 
considerable promise for the development of novel RNAi-based insect management 
strategies (Gordon and Waterhouse, 2007). Many potential applications of RNAi exist 
such as the control agricultural-insect pests and the engineering of pathogen-resistant 
plants (Mao et al., 2007; Baum et al., 2007; Duan et al., 2012). Recent developments 
in RNA interference (RNAi) have created a need for cost-effective, large-scale 
synthesis of dsRNA, which in turn requires effective analytical techniques to purify, 
characterise and accurately quantify dsRNA prior to RNAi application. A wide range 
of dsRNA products can be generated either via bacterial expression systems or in vitro 
transcription for RNAi application. The development of suitable analytical methods to 
characterise the dsRNA products produced from both in vitro and in microbial systems 
remains a significant challenge. 
Double-stranded RNA (dsRNA) is the key initiator in the RNAi mechanism. Large 
quantities of dsRNA can be synthesised for the use of RNAi applications either in 
bacterial systems or through in-vitro transcription (Li et al., 2011; Palli, 2014). 
Nevertheless, the synthesis process is hampered by difficulties in isolating and 
enriching RNA (Phongsisay et al., 2007). These difficulties arise due to the highly labile 
structure of RNA, making it susceptible to endonuclease and exonuclease degradation 
while requiring a complicated procedure to isolate RNA (Nwokeoji et al., 2016). 
A number of methods have been developed and evaluated for the extraction of RNA 
from E. coli cells. The total RNA extracted from these methods, however, suffered from 
low yield and poor quality (Phongsisay et al., 2007). For example, during the 
developmental stage of RNA extraction technology, guanidium isothiocyanate was the 
primary detergent used to lyse cells and denature proteins. It was used with a caesium 
chloride cushion to isolate RNA; this method involved long hours of centrifugation 
(Glisin et al., 1974). Even though undegraded RNA could be effectively separated from 
DNA, this method was still relatively time-consuming (Chirgwin et al, 1979).  
Difficulties with its use eventually led to the substitution of the caesium chloride 
cushion gradients with phenol isolation (Lin-Chao and Bremer 1986). However, 
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significant issues have been reported when phenol was used for RNA extractions. 
Firstly, phenol is highly toxic; secondly, it is difficult to be removed from the extracted 
RNA completely: finally, despite high quality and high integrity RNA produced from 
phenol, it is often irreproducible (Donovan and Kushner, 1986). Subsequently, 
guanidium isothiocyanate was used in combination with phenol-chloroform to improve 
extraction quality. This improved protocol included an additional phenol-chloroform 
phase separation step before centrifugation, which allowed the total RNAs to be 
soluble in the top acidic aqueous phase, without any contamination from DNA and 
proteins, resulting in extracted RNA of consistently high quality (Chomczynski and 
Sacchi, 1987). The method above was eventually commercialised by Life 
Technologies as “TRIzol®”. A schematic illustration of the extraction/phase separation 
employed for RNA extractions is shown in Figure IV-1. 
 
Figure IV-1: Phase separation during guanidium thiocyanate-phenol/chloroform 
extraction. Acidic phenol retains RNA in the upper aqueous phase (bases and 
phosphate groups remain charged under acidic conditions, positively and negatively 
respectively, therefore retaining water solubility), while DNA is moved into either the 
interphase or lower organic phase due to differences in the overall polarity of ssRNA 
compared to dsDNA at acidic pH values.  
 
More recently, several RNA extraction kits have been developed to make it simpler for 
most laboratories to isolate RNAs of interest with high yield and purity levels (Stead et 
al., 2012; Nwokeoji et al., 2016). The principles behind these RNA extraction kits are 
similar to each other and are all based on either chemical or mechanical mechanisms 
to lyse cells while removing protein to extract RNA.   
Effective implementation of RNAi requires high-quality dsRNA at sufficiently high 
yields. While there are currently a number of methods used for the purification of total 
RNA (i.e. single-stranded RNA), their application in dsRNA purification has not been 
reported. Therefore, the experiments in this chapter analysed five RNA isolation 
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methods: Ribopure, RNAsnap, TRIzol Max, DNAzol, and RNAzol by utilising their 
corresponding reagents to extract dsRNA and performing a quantitative and qualitative 
comparison on the results. 
 
4.3 Results and discussion  
Part A 
 Comparative analysis of different extraction methods for the isolation of 
dsRNA 
The current experiment aimed to compare a range of RNA extraction methods (listed 
in Table IV-1) for the extraction and purification of dsRNA from microbial cells. 
Following RNA extraction, gel electrophoresis and ion-pair reversed-phase liquid 
chromatography were utilised to analyse the integrity of the extracted RNA. 
Quantification of dsRNA was performed by combining the quantification from 
NanoDropTM spectrophotometer A260, with measured peak areas to calculate the 
amount of dsRNA present in the total RNA from IP RP HPLC. Final quantities of 
dsRNA were calculated by multiplying total RNA concentration with the dsRNA 
percentage for each sample.  
Table IV-1: Specification of RNA extraction reagents 
Reagent Main component SPE Precipitation 
TRIzol MaxTM Phenol, guanidine 
isothiocyanate, ammonium 
thiocyanate 
N/A Isopropanol 
RibopureTM 
(RNAwiz) 
Phenol/guanidine thiocyanate Glass-fiber 
filter 
purification 
Ethanol 
RNAzol® Phenol, potassium thiocyanate N/A Ethanol 
RNAsnap Formamide QIAGEN 
Spin column 
Ethanol 
DNAzol Guanidine isothiocyanate N/A Ethanol 
precipitation 
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4.3.1.1 Extraction of dsRNA using RibopureTM Kit 
Initially, RNA extractions were performed using Ribopure kits on 109 E. coli cells 
(expressing 765 bp dsRNA). High-quality total RNA were extracted as observed by 
the abundant yields of ribosomal RNAs with minimal RNA degradation (see Figure 
IV-2 A). However, no dsRNA were observed in the chromatograms or gel 
electrophoresis (see Figure IV-2 A and C). Based on the assumption that dsRNA were 
not present in the aqueous phase, further experiments were performed to re-extract 
the RNA from the remaining intermediate and organic phases using the TRIzol reagent 
(Figure IV-2A, B, and C respectively). The results showed no dsRNA in any of the 
phases. Thus, it is concluded that the Ribopure kit is only suitable for the extraction of 
rRNA, (for which it can generate high-quality total RNA with minimal degradation) but 
not for dsRNA. 
 
4.3.1.2 Extraction of dsRNA using the RNAsnap method 
Stead et al. (2012) demonstrated a new extraction method called ‘RNAsnap’ which is 
based on the use of formamide. This single-step method is able to efficiently recover 
all species of intracellular RNA compared to commercial kits (guanidinium 
isothiocyanate and phenol-chloroform based methods), yielding approximately 60 µg 
of total RNA from 108 E. coli. cells. Therefore, it was desired to test the RNAsnap 
method on its ability to extract dsRNA. 
Initial attempts at using the RNAsnap method for dsRNA extraction while following the 
original protocol resulted in a highly viscous sample. This observed change in sample 
viscosity suggested that the RNAsnap samples might not be compatible with direct, 
downstream analysis. In subsequent attempts, the extracted samples were analysed 
in conjunction with gel electrophoresis. Figure IV-3 A shows that the formamide 
extracted sample caused significant smearing on all bands of the gel. Despite that, the 
region of expected rRNA and dsRNA bands were still visible.  
To improve the RNAsnap method, the amount of RNAsnap lysis solution used for RNA 
extraction was increased from 200 µL to 300 µL. In addition, ethanol precipitation and 
solid phase extraction (silica membrane spin column) were performed on the 
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RNAsnap extracted samples (Figure IV-3 B) to reduce sample viscosity as well as to 
clean up the remaining lysis solution.  
It was found that using ethanol precipitation (Figure IV-3 B, lanes 5-7) did not 
significantly lessen the smearing issues when compared to the first attempt observed 
on the gel (Figure IV-3 B, lanes 2-4). Therefore, the RNAsnap method was further 
tested with SPE clean-up. Although the inclusion of SPE clean-up improved gel quality, 
significant amounts of RNA were lost (Figure IV-3 B, lanes 8-10). 
Following optimisation, the RNAsnap samples were further purified using both solid 
phase extraction and ethanol precipitation for dsRNA extraction (Figure IV-3 C). The 
additional SPE clean-up step effectively reduced the previously encountered smearing 
issues (Figure IV-3 C, lanes 6-7). Next, the optimised samples (Figure IV-3 C) were 
further analysed using IP RP HPLC (D-G). The results are shown in the 
chromatograms from the IP RP HPLC analysis of RNAsnap total RNA extraction. 
Comparing the extraction materials on the gel and HPLC (Figure IV-3 C and D-G), the 
amount of dsRNA observed from the HPLC was unexpectedly lower.  
In a separate issue, RNAsnap samples appear to have affected the performance of 
the stationary phase on the HPLC after the analysis; a loss of resolution was observed 
on a control pUC 18 DNA Hae III digested ladder analysis (data not shown). Overall, 
the yield of rRNA was higher than that of dsRNA, as shown on the chromatograms 
(Figure IV-3 E).  
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                    C 
                      
 
 
 
 
Figure IV-2: Results from IP RP HPLC analysis of total RNA extracted from E. 
coli. (expressing 765 bp dsRNA) using RibopureTM. (A) Ribosomal RNA extracted 
from the Ribopure aqueous phase (B) The resulting Ribopure interphase re-extracted 
by TRIzol max using gradient condition 11 (see Chapter 2.6.5) (C) The gel 
electrophoresis analysis of all the different phases of Ribopure extraction.    
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Figure IV-3: Quality assessment of RNAsnap samples analysed on agarose gel 
electrophoresis and IP RP HPLC analysis. (A) using the unmodified RNAsnap 
method (B) extracted with 100-300 µL of extraction solution and ethanol precipitation 
using the Qiagen SPE method (C) extracted with 100 µL of extraction solution and 
ethanol precipitation using the Qiagen SPE method. IP RP HPLC analysis of RNAsnap 
extractions (D) RNAsnap (E) RNAsnap with EtOH precipitation (F) RNAsnap and SPE 
(G) EtOH precipitation with SPE. All samples were analysed using IP RP HPLC 
gradient condition 11 (see Chapter 2.6.5).  
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 Comparative analysis of guanidine isothiocyanate-phenol/chloroform based 
methods for the isolation of dsRNA 
The TRIzol MaxTM, RNAzol®, and DNAzolTM methods (see Table IV-1) were selected 
for a comparative analysis of dsRNA extraction. Samples containing 1x109 of E coli. 
cells expressing 765 bp dsRNA were used for all RNA extractions. Analyses were 
performed using both gel electrophoresis and IP RP HPLC (Figure IV-4 A-D) and runs 
were performed with three independent biological replicates for each method (see 
appendix A1-A3).   
In each case, successful extraction of the dsRNA was observed, although it should be 
noted that degradation of the rRNA occurred in each of these samples on IP RP HPLC 
analysis (Figure IV-4 A-C). Results from gel electrophoresis showed similar yields for 
dsRNA from the three extraction methods Figure IV-4 D. The results also show that 
additional purification of the genomic DNA occurred only from DNAzol samples. In 
order to further verify the quality and quantities of extracted dsRNA, further analysis 
of the IP RP HPLC chromatogram was performed.   
The amount of dsRNA present in the total RNA was quantified by combining the peak 
areas from IP RP HPLC analysis, with the quantification results from NanoDropTM 
spectrophotometer A260. Then, multiplication of total RNA concentration with the 
percentage of dsRNA provided the final quantities of dsRNA in each sample (see 
Table 4.3.2-1). The results show that out of all the methods tested the DNAzol method 
was the optimal dsRNA extraction method in terms of dsRNA isolation yield. 
With respect to absolute values, the TRIzol Max method produced the least amount 
of both total RNA and dsRNA. Although, although, the RNAzol/proteinase K method 
produced the highest yield of total RNA (nearly three times as much compared to the 
TRIzol Max), the ratio of dsRNA extracted by TRIzol Max was still higher in contrast 
to RNAzol. The DNAzol method managed to produce a higher amount of dsRNA 
(almost twice as much compared to the TRIzol method and one and a half times more 
compared to RNAzol). It was found that these three methods were similar in the degree 
of degradation observed for ssRNA (16S and 23S rRNA) (Figure IV-4 A-C), although 
this did not affect the quality of the dsRNA of interest.  
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The results revealed some unexpected properties of the DNAzol method. Despite 
being designed specifically for DNA purification and not RNA, it was able to quickly 
and efficiently extract dsRNA compared to the other methods tested. It is also 
important to note that the aqueous phase pH values were 7.5 for DNAzol and 4.5 for 
TRIzol and RNAzol.  
It is hypothesised that the results may be a consequence of dsRNA having a duplex 
form, allowing it to behave similarly to dsDNA rather than to ssRNA. For instance, in 
the presence of acids (aqueous phase: pH 4.5), the duplex is considered neutralised  
and preferentially partitions in the organic phase (although DNA surface is surrounded 
by negative charges, the isoelectric point of phosphate backbones is greater than 4.5 
and thereby these charges are wiped out due to full protonation) (Avison, 2008). 
However, under acidic pH conditions, ssRNA remains charged due to the presence of 
both the positively charged of exposed bases and the negatively charged phosphate 
backbone, which when mediated through hydrogen bonding via the exposed 
nitrogenous bases, makes ssRNA water soluble. Thus, ssRNA is partitioned into the 
aqueous phase, a process which is not possible for dsDNA. Hence, using phenol at a 
neutral pH ensures that duplex nucleic acids are fully partitioned in the aqueous phase. 
The hypothesis above may help explain why a high yield of dsRNA was extracted 
under pH conditions higher than acidic (i.e. neutral conditions). Further evidence to 
support this hypothesis was found by using Tris-HCl to adjust the pH of the TRIzol 
aqueous phase from 4.5 to 7.5 (Figure IV-5 A and B). This produced an improved 
dsRNA yield of 45 µg, versus 19 µg when the pH was at 4.5. It can be inferred from 
the combined results that higher pH conditions result in significantly higher dsRNA 
yields compared to acidic conditions.  
It should be noted that the existence of genomic DNA was revealed from the total RNA 
profiles during IP RP HPLC analysis of the samples extracted using both the DNAzol 
and TRIzol max methods at pH 7.5 (Figure IV-4 B and Figure IV-5 B respectively). The 
presence of genomic DNA further suggests that the pH value influenced the type of 
nucleic acid isolated. In other words, neutral pH conditions (pH of 7-8), caused the 
partitioning of both genomic DNA and dsRNA into the aqueous phase. Meanwhile, 
under acidic pH conditions, only RNA could be partitioned into an aqueous phase. This 
postulate is supported by previously obtained results and recent data observed with 
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the TRIzol max method at pH 4.5 (Figure IV-4 A and Figure IV-5 A), where only total 
RNA was successfully extracted.  
In summary, both the DNAzol and TRIzol max methods (Figure IV-4 B and Figure IV-5 
B) had increased yields of dsRNA under pH 7.5 compared to under pH 4.5 (see Table 
4.3.2-2). Despite the presence of genomic DNA (a problem easily solved by removal 
via SPE-column clean-up, (Figure IV-5 C)), the amount of dsRNA extracted by the 
DNAzol and TRIzol max (pH 7.5) methods were still the highest out of all the methods 
compared.  
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Figure IV-4: The extraction analysis of E. coli expressed with 765 bp dsRNA. 
Extracted using (A) TRIzol Max (B) DNAzol and (C) RNAzol and proteinase K using 
IP RP HPLC under gradient condition 12 (see Chapter 2.6.5), peak areas were 
measured as highlighted (D) Agarose gel electrophoresis analysis of total RNA 
samples from the three extraction methods. 
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Table IV-2: Quantitative results (yields) from the analysis using different RNA 
isolation methods. Extractions were performed in triplicate and shown with the mean 
and standard deviations. 
Metric RNA extraction method 
 RNAzol DNAzol TRIzol (pH 
4.5) 
TRIzol 
(pH 7.5) 
Ribopure RNAsnap 
Yield (µg) per 109 cells 180 ±7.07 135 ±7.07 65  ± 7.07 120± 8.02 19±1.08 232±14.1 
dsRNA (µg) in total 
RNA 
29.5±4.95 49.5±12.02 18.8±4.52 45.3±10.1 0 N/A 
*Ribopure kit was unable to extract any dsRNA. 
*RNAsnap was not directly compatible with downstream analysis, and its dsRNA extraction 
yield was relatively low. Therefore, it was not included in this comparison.  
 
 
Figure IV-5: Results from the IP RP HPLC analysis of total RNA extracted using 
TRIzol Max under different pH conditions.  (A) The total RNA extraction using 
TRIzol at pH 4.5 and (B) pH 7.5 (C) TRIzol pH 7.5 total RNA extraction in conjunction 
with SPE column to remove genomic DNA contamination under gradient condition 12 
(see Chapter 2.6.5).  
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 Conclusions 
The choice of extraction method directly affects the species and quality of the RNA 
extracted. Thus, these factors need to be carefully considered before selecting a 
suitable RNA extraction method. This study demonstrated a rapid dsRNA extraction 
method which uses the DNAzol solution in conjunction with an optimised procedure. 
Experimental times were less than 30 minutes, and no additional phenol-chloroform is 
needed for further phase separation. Based on extraction from 109 E. coli. cells, the 
DNAzol method and the TRIzol method at pH 7.5 had similar yields (49.5 µg dsRNA), 
which were higher compared to all the other methods considered. Despite both 
methods resulting in the presence of contaminating genomic DNA, they were easily 
removed using either solid phase extraction or DNase treatment.   
The other methods studied had a number of major drawbacks: Ribopure kits can only 
extract rRNA and was not suitable for the purification of dsRNA. The TRIzol Max 
method suffered from long experimental times despite high amounts of dsRNA 
extracted (at pH 7.5); the RNAzoL/proteinase K method only managed to extract a low 
amount of dsRNA despite a high amount of total RNA extracted; finally, the RNAzol 
method appears to be effective only for the extraction of small RNA such as rRNAs. 
These drawbacks further support the use of the modified DNAzol method as the 
method of choice for dsRNA extraction. 
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Part B  
 Characterisation and quantification of dsRNA using stable isotope labelling in 
conjunction with LC-MS analysis  
Mass spectrometry is a powerful tool for the direct identification and characterisation 
of nucleic acids (Kowalak et al., 1993). Prior to mass spectrometry analysis, 
purification of the RNA of interest using HPLC is an essential step. For further LC-MS 
analysis, specific RNA enzymatic digestion (RNase) is required in the case of large 
RNA molecules in order to produce smaller oligoribonucleotide fragments, which are 
then amenable for direct on-line LC separation and MS measurement. RNase 
mapping is the main approach used with MS for the characterisation and location of 
individual RNA from sequences (Kowalak et al., 1993; Hossain and Limbach, 2007).  
Although a wide number of MS-based technologies have been employed for RNA 
studies, the analysis remains challenging due to limited sensitivity and resolution in 
contrast to proteomics MS analysis. In fact, when oligoribonucleotides are cleaved via 
RNase digestion a heterogeneous mixture is produced which makes MS analysis 
more complex because of the presence of the 2’3’- cyclic phosphate intermediate and 
3-phosphate from digestion products (Waghmare and Dickman, 2011).  
More recently, research has focused on developing more quantitative methods in 
conjunction with RNase mass mapping methods. Initial studies focused on the 
development of incorporating a quantitative approach by using isotopic labelling in 
conjunction with RNase mapping. Waghmare and Dickman (2011) first introduced the 
use of metabolic labelling in E. coli culture growths to generate both light and heavy 
labelled RNA, combining them for the purpose of rRNA isolation, and using LC-MS for 
the identification and quantification of oligoribonucleotides and RNA modification. 
Their approach facilitates RNA application in both qualitative and quantitative analysis 
while allowing the rapid determination of potential oligoribonucleotides and 
compositional isomers. Popova and Williamson (2014) adapted Waghmare and 
Dickman’s method using a reference mature 15N labelled rRNA from E. coli in their 
study to understand the roles that rRNA modifications play inside the living cells 
(Popova and Williamson, 2014).  
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In addition to isotope labelling (metabolic labelling), in vitro transcribed RNAs with 
chemical isotopic labelling, such as 13C10-guanosine triphosphate (GTP), have been 
used as an internal reference to quantitatively characterise rRNA post-transcriptional 
modification from Schizosaccharomyces pombe and Saccharomyces cerevisiae 
(Taoka et al., 2015; Taoka et al., 2016). Incorporating isotopic quantification 
technology by either in vivo or in vitro transcribed strategies increases the utility of an 
MS-based approach to absolute quantification.  
A similar approach to isotopic labelling termed ‘‘comparative analysis of RNA digests 
(CARD)’’ extends isotopic labelling to tRNA sequencing by labelling the known 
sequence with H216O, and the unknown sequence with H218O in order to distinguish 
an unknown sequence by a mass increase of 2 Da (Li and Limbach, 2013). The use 
of this method to achieve tRNA quantification has been challenged (Castleberry and 
Limbach, 2010). Issues were reported by the authors due to difficulties in determining 
only 2 Da mass shift from complex change states; these were addressed only through 
use of a high mass accuracy MS. Attempts have been made to modify the method 
published by Taoka et al (2015) using stable isotopic labelling in vitro transcribed as 
an internal standard in order to improve the CARD approach for characterising tRNA; 
this new method is called SIL-CARD (Paulines and Limbach, 2017). 
New advancements in RNA interference (RNAi) have led to a need for economical 
and large-scale production of dsRNA, which in turn necessitates effective analytical 
techniques for full characterisation and accurate quantification of dsRNA before RNAi 
application. In this study, two stable isotopic labelling techniques: metabolic labelling 
and in vitro labelling were used on reference dsRNA in conjunction with mass 
spectrometry. The techniques were shown to successfully characterise and quantify 
dsRNA in complex total RNA mixtures produced from E. coli. 
 
 Synthesis of stable isotope labelled dsRNA 
In this study, metabolic labelling in E. coli HT115 (DE3) cells (transformed with 
plasmids to express either 765bp or 401 bp dsRNA) was performed in conjunction with 
light (14N) and heavy (15N) isotope media. Following cell growth, the 15N dsRNA was 
extracted and purified in conjunction with RNase A to remove the background 
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rRNA/tRNA (Nwokeoji et al., 2017). The results of the purification from the 15N HT115 
expressing a 765 bp dsRNA are shown in Figure IV-6 A. In addition to the purification 
of a dsRNA generated in vivo using metabolic labelling in vitro transcribed 13C1015N5 
(GTP) dsRNA (401 bp) were also synthesised and purified using solid phase extraction 
prior to IP RP HPLC Figure IV-6 B. The results the successful synthesis and 
purification of the stable isotope labelled dsRNA standards generated both in vivo and 
in vitro. Following purification and analysis using IP RP HPLC, quantification of each 
sample was performed using UV spectrophotometry.  
These results highlight the importance of analysing purified dsRNA samples prior to 
downstream dsRNA application. Using IP RP HPLC for total RNA analysis: (1) enables 
the determination of the purity of the product; (2) provides information on the 
proportion of dsRNA present; (3) provides a level of confidence regarding the 
NanoDrop measurements as well as the approximate amount of dsRNA labelled 
sample required when spiking into an unknown amount of 14N total RNA.  
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Figure IV-6: Results from IP RP HPLC analysis of in vivo and in vitro purified 
heavy stable isotope labelled dsRNA reported in terms of absorbance and 
retention time.  (A) Purified metabolic isotopically labelled 15N 765 bp dsRNA from E. 
coli HT115 (DE3), approximately 1.9 µg of dsRNA was injected (B) Purified in vitro 
transcribed 401 bp dsRNA isotopically labelled with enriched 13C15N guanosine 
triphosphate, 2 µg of dsRNA was injected. The analysis was performed using gradient 
condition 6 (see chapter 2, 2.6.5.1). 
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Figure IV-7: IP RP HPLC analysis of 14N metabolic labelling total RNA extracted 
from E. coli (DE3) cells expressing dsRNA, reported in terms of absorbance and 
retention time.  (A) 14 N Total RNA extracted from E. coli expressing 765 bp dsRNA, 
with approximately 7 µg of total RNA injected. (B) 14N Total RNA extracted from E. coli 
expressing 401 bp dsRNA, with approximately 11 µg of total RNA injected and 
analysed using gradient condition 6 (see chapter 2, 2.6.5.1). 
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 Characterisation of dsRNA using stable isotopic labelling in conjunction with 
RNase mass mapping for LC-MS analysis 
To characterise and quantify the dsRNA expressed in E. coli total RNA two different 
strategies were employed: illustrated workflows are shown in Figure IV-8. 15N dsRNA 
generated in vivo was used as the reference standard (Figure IV-8 A). In addition, 
13C15N guanosine labelled dsRNA were prepared via in vitro transcription also used 
as a reference standard, prior to RNase mass mapping in conjunction with mass 
spectrometry analysis (Figure IV-8 B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV-8: Schematic of the stable isotope labelling process in conjunction 
with LC-ESI-MS analysis. (A) The metabolic labelled 15N dsRNA produced from E. 
coli cells is the reference RNA and is combined with 14N total RNA containing 765 bp 
dsRNA for RNase A digestion. The mass spectrum will reveal a number of pairs 14N 
and 15N oligoribonucleotides; the differences in mass correspond to the number of 
nitrogen atoms. (B) In vitro transcribed dsRNA synthesised with 13C15N guanosine 
triphosphates were used as the reference RNA, and combined with 14N total RNA 
containing 401 bp dsRNA for RNase A digestion. The mass spectrum reveals a 
number of pairs of 14N and 13C15N oligoribonucleotides, the differences in mass 
correspond to the number of C and N atoms per guanosine on the oligoribonucleotides. 
 
A B 
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To characterise and quantify the dsRNA expressed in E. coli, total RNA were extracted 
from HT115 cells expressing 765 bp dsRNA and 401 bp dsRNA and analysed using 
IP RP HPLC (Figure IV-7 A-B.). The results show the expected chromatogram 
highlighting the presence of the abundant tRNA/rRNA in conjunction with dsRNA. 
Direct analysis using UV spectrophotometry cannot accurately determine the amount 
of dsRNA present in these complex mixtures. Therefore, following validation of the 
expression and extraction of the dsRNA in complex RNA mixtures extracted from E. 
coli, the 15N dsRNA standard previously generated were spiked into these samples. 
Approximately equal amounts of reference dsRNA (15N 765 bp dsRNA generated via 
metabolic isotopic labelling) were mixed with unlabelled dsRNA present in the complex 
RNA mixture followed by RNase A enzymatic digestion, in order to generate a series 
of oligoribonucleotides. The digested oligoribonucleotides were analysed using online 
ion-pair LC interfaced with ESI-MS (LC-ESI-MS). The ESI-MS was performed using 
an ultrahigh resolution time-of-flight (UHR-TOF) mass analyser instrument. Following 
LC-ESI-MS analysis, fragments of five different dsRNA oligoribonucleotides were 
chosen exclusively in the sense and antisense strands from total RNA and identified 
and characterised using the metabolic isotope labelling approach (Table IV-3 and 
Table IV-4). Due to the complexity of the sample, oligoribonucleotides which were less 
than 3 mers long were not considered.  
The application of stable isotope labelling enables rapid identification of 
oligoribonucleotides generated from the dsRNA as they appear as light and heavy 
pairs in contrast to the oligonucleotides generated from the background rRNA and 
tRNA in the total RNA extraction. The theoretical monoisotopic masses of the light 
version of oligoribonucleotides were obtained using an in silico RNase A digest of the 
dsRNA, which were then utilised for comparison with the experimental monoisotopic 
masses. Based on the theoretical monoisotopic of light oligoribonucleotides, the 
amount of heavy isotope oligoribonucleotide can be calculated from the number of 
nitrogen atoms in the base compositions. A representative mass spectrum of the 
isotope labelled pair identified from the dsRNA is shown in Figure IV-9. The 
oligoribonucleotide AAGAUp light (827.013 m/z -2 charge) and heavy (837.985 m/z, -
2 charge) is shown in (Figure IV-9 A). As there are 22 nitrogen atoms on the 
oligoribonucleotide, this resulted in a 21.94 Da mass shift on the heavy isotope 
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labelled oligoribonucleotide. A single unique oligoribonucleotide GGAGGUp from the 
antisense strand was distinguished in both light (1015.508 m/z) and heavy (1028.969, 
m/z) versions of isotopic labelling (Figure IV-9 B). As there are 27 nitrogen atoms in 
the oligoribonucleotide, this resulted in a 26.92 Da mass shift. 
Furthermore, using the predicted monoisotopic masses for mass mapping will typically 
result in a number of potential base compositions in the sense or antisense strands. 
An example of the theoretical light (2032.292 m/z) and heavy (2060.292 m/z) 
oligoribonucleotides detected with two possible base compositions which could be 
related to the experimental masses are shown (Table IV-5). This is commonly found 
in RNA digestion products which generate a range of isobaric isomers and is difficult 
to distinguish because of the small mass difference (1 Da) between cytidine (243.2166 
g/mol) and uridine (244.2014 g/mol). However, according to the base composition 
assignment along with the heavy isotope experimental mass, only the base 
composition (G4A1U1) corresponded to 27 nitrogen atoms with the experimental 
masses (light, 2033.032 Da) and (heavy, 2059.955 Da), thus an oligoribonucleotide 
GGAGGUp in the antisense strand could be assigned (Table IV-5). Similar base 
compositions from either the sense or antisense strands were able to be identified 
using base composition assignment in conjunction with RNase predicted masses. 
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Figure IV-9: Mass spectrum of the identification of E. coli expressed dsRNA (765 
bp) using metabolic isotopic labelling in conjunction with an RNase A digestion.  
The same digested oligoribonucleotides from the heavy isotope labelled will appear 
with increased mass compared to the light isotope labelled, depending on the number 
of nitrogen atoms present in the oligoribonucleotide. (A) Two pairs of isotopically 
labelled oligoribonucleotides were identified in the dsRNA sense strand. 
Oligoribonucleotides: AAGAUp (light, 827.013 m/z, -2 charged) (heavy, 837.985 m/z, 
-2 charged) (B) A pair of light versus heavy oligoribonucleotides, GGAAGCp (light, 
1007.511 m/z) and (heavy, 1020.971 m/z) were identified from the digested dsRNA 
anti-sense strand, with the expected mass differences. 
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Table IV-3: Comparison of the light and heavy monoisotopic masses of the 
sense strand oligoribonucleotides. 
 
Sequence 
14N 
Theoretical 
mass 
14N 
Experimental 
mass 
15N 
Theoretical 
mass 
15N 
Experimental 
mass 
14N 
Δ Da 
15N 
Δ Da 
AAGAUp 1656.239 1656.018 1678.239 1677.991 -0.221 -0.248 
GAGAUp 1672.234 1672.041 1694.234 1693.985 -0.193 -0.249 
GGAAGAAG
Cp 
3019.449 3019.077 3062.148 3061.946 -0.372 -0.202 
AGGAGAUp 2346.333 2346.058 2378.333 2378.502 -0.275 +0.169 
AAGGCp 1671.249 1671.048 1694.249 1693.983 -0.201 -0.266 
 
Table IV-4: Comparison of the light and heavy monoisotopic masses of the 
antisense strand oligoribonucleotides. 
 
Sequence 
14N 
Theoretical 
mass 
14N 
Experimental 
mass 
15N 
Theoretical 
mass 
15N 
Experimental 
mass 
14N 
Δ Da 
15N 
Δ Da 
GGAGGUp 2033.276 2033.272 2060.276 2060.209 -0.004 -0.067 
GAAGGUp 2017.281 2017.299 2044.281 2044.229 -0.018 -0.051 
AGAAGAGG 
AGUp 
3694.532 3694.286 3746.523 3746.443 -0.246 -0.079 
AGAGGGUp 2362.328 2362.049 2394.328 2393.953 -0.279 -0.375 
GAGAGGCp 2361.344 2361.007 2394.344 2393.950 -0.337 -0.394 
 
Comparison of the theoretical and experimental masses of the dsRNA (765 bp) 
digested oligoribonucleotides shown in heavy and light monoisotopic masses.  
The oligoribonucleotides were generated from RNase A digestion. Grey highlight 
represents a single predicted unique oligoribonucleotide sequence which is only in 
either the sense or anti-sense strand. Bold represents a number of unique theoretical 
monoisotopic isomers in either the sense or antisense strand.  The prediction of 
oligoribonucleotide base composition corresponds to the theoretical monoisotopic 
masses of light 2033.276 Da and heavy 2060.276 Da, and the number of nitrogen 
atoms present.  
 
Table IV-5: Two potential base compositions were found, the G4A1U1p consisted 
of 27 nitrogen atoms which match the experimental masses (light, 2033.032 Da, 
and heavy, 2059.955 Da). This confirms that the sequence of oligoribonucleotide 
GGAGGUp is from the antisense strand. 
C G A U p 14Nmonoisotpic 
mass Da 
15N 
monoisotopic 
mass Da 
Δ 
14N 
Δ 
15N 
Nitrogen 
atoms 
1 4 1 0 1 2033.0328 2059.9552 -0.7409 0.3367 28 
0 4 1 1 1 2033.0324 2059.9550 0.2436 0.3210 27 
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In addition to providing further evidence and assisting in the identification of 
oligoribonucleotides generated from the dsRNA product by identifying light and heavy 
isotope pairs, the analysis also enables distinguishing between those 
oligoribonucleotides generated from rRNA. An example is shown in Figure IV-10 here 
a single 14N labelled mass (no isotope pair) was identified, confirming that a different 
species of RNA was identified instead of dsRNA. Based on the theoretical digestion 
list of the total RNA, the isolated mass fragment was matched to the 16S ribosomal 
RNA oligoribonucleotide, AAAGAGAAGCp and shows up in 1109.690 m/z, -3 charge 
state. 
 
Figure IV-10: Identification of the 16S ribosomal RNA oligoribonucleotide MS 
spectra, AAAGAGAAGCp in total RNA (expressed 765 bp dsRNA). Observed by 
identifying the 14N isotopic labelling (light, 1109.690 m/z, -3 charged) without a 
corresponding 15N isotope pair (heavy, 1125.827 m/z, -3 charged).   
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 Characterisation of dsRNA using in vitro transcribed dsRNA as an internal 
reference 
Following analysis of dsRNA using the metabolic isotopic labelling approach in 
conjunction with LC-MS, the use of in vitro labelled dsRNA (13C15N guanosine dsRNA) 
was further demonstrated as the internal standard to characterise and quantify dsRNA 
expressed in E. coli. The use of stable isotope labelled in vitro transcripts as internal 
standards was initially demonstrated by Taoka et al (2015). Total RNA were extracted 
from E. coli HT115 cells expressing 401 bp dsRNA and analysed using IP RP HPLC 
(Figure IV-7 B). A range of amounts of 13C15N guanidine dsRNA (401 bp) were added 
prior to RNase A enzymatic digestion and analysis of the oligoribonucleotide using LC-
ESI-MS as previously described.  
Theoretical monoisotopic masses were obtained from the RNase A digest of the 
dsRNA sequence prediction and were compared with the experimental monoisotopic 
masses. Five digested dsRNA oligoribonucleotides from both sense and anti-sense 
strands were assigned from the complex mixture of 14N labelled total RNA using the 
isotopic labelled guanosine dsRNA approach (Table IV-6 and Table IV-7). A range of 
monoisotopic masses corresponding to unique dsRNA oligoribonucleotides were 
identified from the sense and antisense strands, including GGACp, AGAAGAUp, and 
GAGAAUp (Table IV-6). Meanwhile, the unique oligoribonucleotides; GGGCp, 
GGAAGGUp, AAGGGAUp, GAGGCp, and AAGAUp were also assigned to the anti-
sense strand (Table IV-7).   
Figure IV-11 shows a representative mass spectrum of E. coli. dsRNA characterisation 
in total RNA (14N) using the in vitro transcript dsRNA (13C15N) method. The expected 
oligoribonucleotide in the sense strand AGAAGAUp was identified with the 
corresponding masses, light (1164.0187 m/z, -2 charge) and heavy (1179.0351 m/z, -
2 charge) with a mass tolerance of ± 0.5 Da. The 30.03 Da mass difference between 
the light and heavy oligoribonucleotide fragments was expected due to the two 13C15N 
labelled guanosines present in the reference RNA (Figure IV-11 A). Another example 
which highlights the benefit of using dsRNA in vitro transcripts as the internal reference 
during the identification of dsRNA oligoribonucleotide fragments. GGAAGGUp 
oligoribonucleotide was identified (light, 1180.0116 m/z -2 charged) from the reference 
(heavy, 1210.0421 m/z -2 charged) in the antisense strand (Figure IV-11 B):  The 
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results show the expected mass shift of 60 Da from the oligoribonucleotide fragment 
which contains 4 guanosines residues. 
 
Table IV-6: Comparison of the light and heavy monoisotopic masses of the 
sense strand oligoribonucleotides. 
 
Sequence 
14N 
Theoretical 
mass 
13C15N 
Theoretical 
mass 
14N 
Experimental 
mass 
13C15N 
Experimental 
mass 
14N 
Δ Da 
13C15N 
Δ Da 
GGACp 1342.197 1372.197 1342.030 1372.061 -0.166 -0.135 
GAGGUp 1688.228 1733.228 1688.031 1372.081 -0.196 -1.147 
AGAAGAUp 2330.338 2360.338 2330.051 2360.087 -0.286 -0.250 
GAGAAUp 2001.286 2031.286 2001.046 2031.075 -0.240 -0.210 
AGAUp 1327.186 1342.186 1327.035 1342.355 -0.150 +0.169 
 
Table IV-7: Comparison of the light and heavy monoisotopic masses of the anti-
sense strand oligoribonucleotides. 
 
Sequence 
14N 
Theoretical 
mass 
13C15N 
Theoretical 
mass 
14N 
Experimental 
mass 
13C15N 
Experimental 
mass 
14N 
Δ Da 
13C15N 
Δ Da 
GGGCp 1358.192 1403.192 1358.031 1403.069 -0.160 -0.122 
GGAAGGUp 2362.328 2422.328 2362.039 2422.100 -0.288 -0.227 
AAGGGAUp 2346.333 2391.333 2346.042 2391.086 -0.290 -0.246 
GAGGCp 1687.244 1732.244 1687.038 1732.084 -0.205 -0.159 
AAGAUp 1656.239 1671.239 1656.039 1671.054 -0.199 -0.184 
 
Comparison of the theoretical and experimental masses of the dsRNA (401 bp) 
RNase A digested oligoribonucleotides shown in light and heavy monoisotopic 
masses. The oligoribonucleotides were generated from RNase A digestion. Grey 
highlighting represents a unique oligoribonucleotide sequence which is only in the 
sense or anti-sense strand. Underlined bold represents the number of theoretical 
isomers in either the sense or antisense strand. 
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Figure IV-11: Mass spectrum showing the identification of E. coli expressing 
dsRNA (401 bp) using in vitro transcribed dsRNA synthesised with 13C1015N5 
enriched Guanosine triphosphate (GTP) in conjunction with an RNase A 
digestion. The digested oligoribonucleotides from the in vitro transcript will have the 
characteristic15 Da mass increase compared to the same oligoribonucleotides from 
the in vivo dsRNA. (A) Light (1164.0187 m/z) and heavy (1179.0351m/z) isotopic 
labelled AGAAGAUp oligoribonucleotide fragments from the digested dsRNA sense 
strand. The 30.03 Da mass difference between the light and heavy monoisotopic 
corresponds to the number of guanosine on the oligoribonucleotide (B) Light 
(1180.0116 m/z) and heavy (1210.0421) isotopic labelled GGAAGGUp 
oligoribonucleotide from the digested dsRNA anti-sense strand; A mass difference of 
30.03 Da obtained on the mass spectra signifies that 4 guanosine nucleobases (60 
Da) were present, since the masses were -2 charged, the 30.03 Da mass increase 
was detected on the heavy monoisotope.  
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 Quantitative analysis of dsRNA oligoribonucleotides using stable isotope 
labelling  
The benefits of using stable isotopic labelled reference dsRNA for characterising 
dsRNA in conjunction with RNase mass mapping have been demonstrated in the 
previous section. In the current study, these approaches were further applied to a 
quantitative application in order to rapidly and accurately quantify dsRNA in complex 
RNA mixtures.  
A range of amounts of the E. coli 15N purified dsRNA (765 bp) were combined with 14N 
total RNA (containing 765 bp dsRNA). Following RNase A enzymatic digestion, the 
digested oligoribonucleotide fragments were analysed using LC-ESI-MS. Relative 
quantification was then achieved by measuring the ratio and peak areas of both light 
and heavy samples for five different identified oligoribonucleotides from both the sense 
and antisense strands.  
The mass spectra (Figure IV-12 A) shows the identification of 14N and 15N sense strand 
oligoribonucleotide (765 bp expressed dsRNA), AAGAU detected in varying amounts 
of spiked 15N dsRNA. A further example of the mass spectra of the antisense 14N and 
15N oligoribonucleotide, GAAGGUp is shown in Figure IV-12 A. Relative quantification 
was then achieved by measuring the ratio and peak areas of both light and heavy 
samples for 10 different identified oligoribonucleotides (Figure IV-12 B and C).  
The experimental ratios for both sense and antisense strands are shown in Figure 
IV-12 C, where the standard deviations refer to experimental errors. Average 
experimental errors were ±0.09 (SD) and 6.1% (CV) for all of the oligoribonucleotides, 
which were analysed via different dynamic ranges. Spiking in different amounts of the 
15N standards enabled the absolute quantification of the dsRNA (see Table IV-8), 
which was 466.48 ng. 
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Table IV-8: Quantification of 765 bp dsRNA oligoribonucleotides using stable 
isotope labelling. Mean and standard deviation information as well the coefficient of 
variation are included. 
 
Average 14N/15N ratio Quantification of  
14N dsRNA (ng/ µL) 
0.289±0.04 485.30  
0.907±0.11 
3.209±0.12 
Average SD ±0.09 
Average CV 6.1% 
447.96 
466.15 
466.47±18.67 
 
Table IV-9: Quantification of 401 bp dsRNA oligoribonucleotides using in vitro 
transcript stable isotope labelling. Mean and standard deviation information as well 
the coefficient of variation are included. 
 
Average 14N/15N ratio Quantification of  
14N dsRNA (ng/ µL) 
0.277±0.05 640.86  
1.069±0.12 
3.453±0.32 
Average SD ±0.16 
Average CV 10.2% 
618.31 
614.50 
624.56±14.24 
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Figure IV-12: Absolute quantification using stable isotope labelling in 
conjunction with mass spectrometry for the analysis of E. coli expressed with 
765bp dsRNA. (A) MS spectra of digested oligoribonucleotide AAGAUp (sense 
strand), (B) GAAGGUp (antisense strand) in a different light and heavy ratios 
respectively. (C) Light to heavy ratios of ten different oligoribonucleotides. (D) Absolute 
quantification of experimental masses shown for ten different oligoribonucleotides with 
the error bars representing standard deviation.  
D 
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 Quantitative analysis of dsRNA oligoribonucleotide using 13C15N labelled in 
vitro transcript reference dsRNA  
Following quantitative analysis of 765 bp dsRNA using the metabolic isotopic labelling 
approach in conjunction with LC-MS, we further demonstrated the use of in vitro 13C15N 
guanosine containing dsRNA (401 bp) as the internal reference to quantify the same 
sequence of dsRNA expressed in E. coli. 
The representative mass spectrum of the doubly charged unique sense and antisense 
sense strands oligoribonucleotide, AGAAGAUp and GGAAGGUp are shown with 
varying amounts of spiked isotope labelled standard (Figure IV-13 A). As seen from 
the examples, the mass separated by 15 Da can be easily distinguished between the 
sample and reference. A comparison of the five, experimentally observed light and 
heavy oligoribonucleotides obtained for both sense and antisense strands is shown in 
Figure IV-13 B/C. 
Figure IV-13 C shows the overall quantitative analysis of the experimental ratios for 
14N versus 15N oligoribonucleotides, includes information on standard deviations which 
represent experimental error. It can be observed that the experimental standard 
deviations indicate an average error of about ± 0.16 (SD) and 10.2% (CV) for different 
mixed ratios. In summary, the absolute quantification of the amount of dsRNA in the 
total RNA can be achieved by spiking 13C15N guanosine containing IVT dsRNA 
standards into total RNA mixture (expressing dsRNA). Absolute quantification amount 
of 14N dsRNA present in total RNA corresponding to 624.56±14.24 ng/µL (Table IV-9). 
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Figure IV-13: Absolute quantification of in vivo dsRNA (401 bp) using in vitro 
transcribed dsRNA synthesised with 13C1015N5 enriched guanosine triphosphate 
(GTP). (A) Mass spectra of the light and heavy, AGAAGAUp and (B) GGAAGGUp 
oligoribonucleotides of both sense and antisense strands shown in different light and 
heavy labelled mixed ratios. (C) Light to heavy ratios of ten different 
oligoribonucleotides from both sense and antisense strands. (D) Absolute 
quantification of the experimental masses shown for ten different oligoribonucleotides 
with the error bars representing standard deviation.  
D 
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 Conclusions 
Stable isotopic labelling of dsRNA using both in vivo (15N) and in vitro (13C15N 
guanosine) to generate internal standards was used in conjunction with mass 
spectrometry for the characterisation and quantification of dsRNA in complex RNA 
mixtures. 
From the experiments, several key capabilities of stable isotopic labelling were 
identified: (1) the method could readily characterise dsRNA fragments based on 
comparative analysis of light and heavy labelled oligoribonucleotides monoisotopic 
masses. (2) Possible compositional isomers in either sense or antisense strands of 
dsRNA could be identified through the determination of the number of heavy atoms on 
the oligonucleotide; (3) Absolute quantification of dsRNA in a total RNA mixture could 
be achieved knowing the amount of heavy-labelled dsRNA spiked into light-labelled 
total RNA (expressing dsRNA), without prior purification of contaminating small RNAs.  
These features provide the stable isotope labelling method with a discernible 
advantage over conventional methods used for rapid nucleic acid quantification such 
as UV spectrophotometry, which cannot provide quantitative information on individual 
components in a complex mixture without prior purification. HPLC, another often used 
method, suffers from limited quantification accuracy due to the presence of abundant 
tRNA and rRNA or other multiple heterogeneous RNA originating from dsRNA 
synthesis, which may co-elute with the dsRNA and therefore prevent accurate 
quantification.  
Stable isotope labelled dsRNA standards were synthesised (15N and 13C15N guanosine 
containing) in vivo and in vitro prior to purification and quantification. The stable 
isotope dsRNA standards were subsequently mixed into RNA extracted from E. coli 
that were engineered to express dsRNA prior to RNase digestion and LC-ESI-MS 
analysis. Absolute quantification was performed based on the resulting light and heavy 
oligonucleotides identified using mass spectrometry. Using this approach, it was 
determined that 624.6 ng/µL and 466.5 ng/µL of dsRNA was present in 80 µL of total 
RNA extracted from 108 E. coli cells expressing 765 bp and 401 bp dsRNA respectively. 
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Chapter V : Effects of monolith porosity on the analysis of 
nucleic acids using ion-pair reversed-phase HPLC 
5.1 Abstract 
Monolithic porous columns are a new generation of powerful stationary phases utilised 
for the separation of biomolecules. However, the behaviour of monolithic columns is 
not well understood. This chapter aims to study the performance of monolithic columns 
with different porosity size distributions (PSD); ProSwift RP-1S (standard PSD), RP-
2H (high PSD), and RP-3U (ultra-high PSD) for the analysis of nucleic acids under 
retentive and non-retentive elution modes using HPLC.  
Nucleic acids of different sizes and classes were analysed including dsDNA, 
oligonucleotides, rRNA, dsRNA, and MS2 ssRNA. Under IP RP HPLC conditions the 
RP-1S and RP-2H columns demonstrated higher separation efficiencies over the RP-
3U column for the analysis of large MW nucleic acids. The RP-3U column was optimal 
for the analysis of oligonucleotides while the RP-2H column showed the lowest 
resolution when it was used to analyse small oligonucleotides. The effect of varying 
flow rates (0.4 mL/min to 1.4 mL/min) was also studied using dsDNA and 
oligonucleotides on all columns showing that in general higher flow rates significantly 
improved resolutions regardless of column porosity.  
To further study the effects of column porosity, elution times for nucleic acids of 
different sizes were tested under non-retentive conditions. A general trend where 
elution time decreased with increasing analyte size was observed on the RP-1S and 
RP-2H columns. In contrast, this effect was not observed on the RP-3U column. Using 
the RP-1S and RP-2H columns under varying acetonitrile concentrations did not alter 
the elution time of smaller oligonucleotides. However, the elution times of larger 18 
mer oligonucleotides and ssRNA were affected at high concentrations of acetonitrile 
(80%). Interestingly on the RP-3U column, variations in ACN concentration did not 
affect elution times. These results have provided further insight into the behaviour of 
monolithic columns and the effects of column porosity on the analysis of nucleic acids. 
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5.2 Introduction  
The growing application of nucleic acids in bioscience has driven the demand for 
improved approaches for their synthesis, purification, and characterisation. Prior to the 
use of synthetic materials in biological systems, effective techniques for separation, 
characterisation and quantification of these materials are required. Polyacrylamide gel 
electrophoresis (PAGE) and liquid chromatography are principal analytical techniques 
for these purposes. Unfortunately, PAGE involves long analysis times, is labour 
intensive and leads to poor quantitative accuracy as well as irreproducible results, 
making the method impractical for analytical purposes. In contrast, high-performance 
liquid chromatography (HPLC) demonstrates inherent advantages compared to the 
conventional analytical methods including better efficiency, significant improvements 
in characterisation and quantitative ability, as well as highly reproducible results.  
Ion-pair reversed-phase high-performance liquid chromatography (IP RP HPLC) is a 
well-established standard analytical platform for nucleic acid separation (Huber et al., 
1992). A wide range of reversed-phase columns such as conventional silica-based 
C18 resins and polymeric resins have been used in IP RP HPLC (Huber et al., 1993). 
Monolithic columns are a new generation of polymer-based columns which have 
recently been used for the separation of biomolecules in particular proteins (Xie et al., 
1997). However, relevant studies on the application of monolithic columns to analyse 
nucleic acids have been much less prominent. 
Monolithic columns have been successfully applied for efficient and high-resolution 
separations of nucleic acids using IP RP HPLC. (Premstaller et al., 2000 and  Walcher 
et al., 2002). A wide range of monolithic reversed-phase columns designed with 
different chemical and physical properties are available. Major factors to be considered 
when choosing a column include column dimension, pore size distribution, pore 
structure, and mass transfer properties of the packing material. The different 
properties of columns show significant impact on the performance of nucleic acids 
chromatography, by affecting parameters such as cycle time, peak resolution, peak 
shape, separation efficiency, retention time, and column operational pressure. In 
addition, since macromolecules such as nucleic acids have low diffusivity rates, 
choosing a column configuration with favourable mass transfer rates is crucial for their 
successful separation. The objective of this study was to compare the 
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chromatographic efficiency of different pore size distributions (PSD) for nucleic acids 
analysis using ProSwift monolithic columns in 4.6 mm x 50 mm ID (Table V-1).  
 
Table V-1: Specifications of the ProSwift reversed-phase columns used  
Parameter ProSwift  
RP-1S 
ProSwift  
RP-2H 
ProSwift  
RP-3U 
Base matrix PS-DVB PS-DVB PS-DVB 
Surface Chemistry Phenyl Phenyl Phenyl 
Pore size 
distribution 
1.1 µm  
Standard 
permeability  
2.2 µm  
High permeability  
5.2 µm 
Ultra permeability 
Bed height  45 mm 43 mm 40 mm 
Column volume 0.76 mL 0.73 mL  0.65 mL 
Flow rate 0.5-4 mL/min 1-10 mL/min 1-16 mL/min 
 
 Morphology of ProSwift reversed-phase monolithic columns 
Porous polymeric monolithic media are engineered using in situ polymerisation, which 
is based on a cross-linked material interconnected network in a single cylindrical 
polymer rod. The morphologies of the ProSwift RP-1S, Rp-2H, and RP-3U monolithic 
columns can be seen in a scanning electron micrograph (SEM).  
Figure V-1 shows fine, moderate, and large pores for the RP-1S, RP-2H, and RP-3U 
columns respectively. The RP-3U column is further distinguished with interconnected 
and non-uniform pore sizes.    
Small and large aggregates of globules comprise the media in a typical monolith 
structure and produce structures similar to a cauliflower. The abundant space between 
the large aggregate globules offers high flow operational capabilities and low back 
pressure. Between the smaller globules are open or through pores. As a result, the 
analyte has rapid access to the functionalised surface media.  In a conventional bead-
based column, mass transfer is controlled by molecular diffusion, in contrast to a 
monolithic column, where mass convection takes place through the open pores. The 
presence of mass convection minimises slow mass transfer rates in monolithic 
columns. Monolithic columns have approximately 60% pore volume which is much 
higher than porous beads.  The pore sizes of monolithic columns are characterised 
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into two types: large pores, approximately a micron or greater, and small pores, which 
are specifically engineered to be less than ten to hundreds of nanometres.  
Although interstitial volume is absent in monolithic materials, the internal porosity 
contains micro, meso, and macropores (Hiroyoshi et al., 1996), and as a consequence, 
all of the eluents must travel through these pores, following the shortest flow path. 
Polymerisation of the monolith creates mesopores, and the resultant microfollicular 
configuration lacks diffusive micropores. In principle, the absence of micropores allows 
an increase in resolution due to the intraparticle convection (Rodrigues et al., 1993).  
Convective flow is more efficient with species of large molecular weights at high flow 
rates (Hiroyoshi et al., 1996).  
With respect to chromatographic resolution, conventional beads frequently result in 
poor peak resolutions due to slow analyte mass transfer. In contrast, the unique 
features of monolithic column morphology lead to rapid mass transfer which minimises 
widening peak shapes with high resolutions under a wide range of flow rates. This 
advantage in mass transfer is crucial for high efficiency separation of large 
biomolecules whose diffusion rates are lower than small molecules. This chapter will 
explore the influence of pore sizes of ProSwift RP-monolithic columns on nucleic acid 
analysis using IP RP HPLC, and under isocratic non-retentive HPLC conditions.  
 
 
Figure V-1: SEM images of the ProSwift reversed-phase monolithic columns: 
RP-1S, RP-2H, and RP-3U with pore size distributions: 1.1 µm, 2.2 µm, and 5.2 
µm respectively.  Morphology of the ProSwift is composed of aggregates of globules, 
the spaces around the aggregates are through pores which enable fast analyte access 
(Image reproduced from the Dionex product manual). 
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5.3 Results and discussion  
Part A 
 Effects of different porosities of monolith RP columns on the analysis of nucleic 
acids under IP RP HPLC conditions  
RP-1S, 2H, and 3U columns were used to analyse dsDNA (fragment size range 80-
587 bp) under the same IP RP HPLC gradient condition to compare their 
performances. The comparative analysis of dsDNA separation is shown in Figure V-2 
A-C. The results show that smaller dsDNA fragments (80 and 102 bp) were retained 
longer on the RP-1S column (Figure V-2 A), while larger fragments (179 bp to 587 bp) 
were more retentive on the RP-3U column (Figure V-2 C). General trends on the effect 
of differently sized dsDNA on retention time demonstrate that higher porosities 
correlate with increased retention times for larger dsDNA fragments (257-587 bp) (RP-
3U> RP-2H> RP-1S). The opposite was observed (decreased porosities led to an 
increase in retention time for smaller sized dsDNA (80-102 bp) (RP-1S> RP-2H> RP-
3U). These results may be the consequence of an increase in the functional surface 
hydrophobicity of the RP-3U column, as the larger dsDNA fragments were shown to 
be more interactive with the higher porosity monolithic column. This was despite much 
lower column volume compared to the other columns (see Table V-8), a feature which 
usually entails lower analyte elution times. However, as the same PS-DVB material is 
used in all 3 columns, the increase in surface hydrophobicity is unlikely to explain the 
large differences in retention time seen for the larger dsDNA. Furthermore, the 
increased hydrophobicity should also increase the retention time of the smaller dsDNA 
fragments. Therefore, it is proposed that the different porosity of the RP-3U column 
has a significant impact on the retention of larger dsDNA fragments using IP RP HPLC.  
Full width half maximum (FWHM) values were utilised to evaluate the overall peak 
resolutions of the DNA fragments: 80 bp, 102 bp, 179 bp, and 295 bp across the three 
columns. The FWHM values obtained for the columns corresponding to the fragments 
were: 0.10, 0.10, 0.14, 0.14 minutes, 0.12, 0.11, 0.16, 0.18 minutes, and 0.16, 0.14, 
0.24, 0.25 minutes for the RP-1S, RP-2H, and RP-3U columns respectively under the 
same gradient conditions. This result shows that higher resolutions were achieved in 
the order RP-1S >RP-2H >RP-3U (Figure V-2) i.e. decreasing column porosity is 
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correlated with increasing dsDNA resolution. The RP-3U column showed a noticeable 
broadening of the peaks compared to the RP-1S and RP-2H columns. Further analysis 
to improve the separation efficiency of dsDNA using the RP-3U column was carried 
out using a steeper gradient. A significant improvement in the resolution of large 
dsDNA fragments (434-587 bp) was observed. 
In summary, the results show that dsDNA separations are sensitive to differences in 
porosity. Monolithic columns with wide pore-sizes have also been applied to high-
efficiency protein separation and were less influenced by changes in porosity (Trojer 
et al., 2006). It is possible that hydrodynamic properties play a role in separation, and 
that these disparities in hydrodynamic volume are responsible for the apparent 
difference in behaviour between protein and DNA separation on the different monoliths. 
Most proteins fold into globular ellipsoid molecules, while duplex DNA tend to be 
worm-like filament molecules. Which contain greater hydrodynamic volume than 
ellipsoid molecules, possibly contributing to their sensitivity to porosity effects 
(Fernandes et al., 2002). 
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Figure V-2: pUC18 HaeIII digest dsDNA ladder IP RP HPLC analysis performed 
on ProSwift monolith columns of different porosities.  (A) RP-1S, (B) RP-2H, and 
(C) RP-3U using gradient condition 4 (see Chapter 2.6.5) (D) RP-3U at 50°C with flow 
rate 0.75 mL/min using gradient condition 5 respectively. The dsDNA fragment sizes 
are highlighted in base pair. 
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Following the analysis of dsDNA, a comparative study on RNA separation was 
performed by analysing total RNA and ribosomal RNA using the polymeric monolith 
columns (see Figure V-3 ). Interestingly, using the same gradients on all three columns 
did not significantly affect the retention time of rRNA in contrast to previous data from 
the analysis of large dsDNA (see Figure V-2). The results show that the order of elution 
was RP-3U<RP-2H<RP-1S and this is reflective of the small differences in column 
volumes of each column (see Table V-1). 
The RP-2H column produced optimum resolutions and separation, as seen from both 
the highest baseline resolution (Rs) of 4.17 minutes and the narrowest peak shape 
(FWHM 0.12 and 0.11 minutes for 16S and 23S rRNA respectively) (Figure V-3 B). 
The RP- 3U column generated relatively good resolutions (Rs = 3.45 minutes; FWHM 
of 0.16 and 0.17 minutes for 16S and 23S rRNA respectively, and demonstrated better 
baseline resolving power (Figure V-3 C) compared to the RP- 1S column. For the RP-
1S column, despite good peak shapes (FWHM 0.13 and 0.14 minutes) (Figure V-3 A), 
its baseline resolution of 2.23 minutes was not as good as the RP-2H and RP-3U 
columns. In developing HPLC elution method, the anticipation is usually to attain a 
separation of the peak of interest from other peaks with Rs ≥ 2 (Snyder and Dolan, 
2007). In this study, all three monolithic columns produced high-resolution separation 
of the 16S and 23S rRNA, with no significant effect on the chromatographic 
performance when analysing large ribosomal RNA using monolithic columns of 
different ranges of pore size distribution. 
Monoliths of different pore sizes were further compared by analysing a large ssRNA 
(MS2 RNA, consisting 3569 nucleotides), (Figure V-4 A-C). Using identical gradients 
for each column, the order of elution time was found to be consistent with data from 
the analysis of rRNA, in contrast with observations on large dsDNA. The results again 
showed only small differences in the performance of the RP-1S and RP-2H columns, 
as well comparable resolutions observed on the RP-3U column (FWHM= 0.11, 0.12, 
and 0.15 minutes respectively; (Figure V-4 A-C). However, the results show that 
differences in peak shape were observed, where fronting peaks appeared for the RP-
2H and RP-3U columns (Figure V-4 B and C). The fronting peaks may have been 
caused by an impurity from the MS2 RNA which started co-eluting. This was in contrast 
to the wide peak shape generated on the RP-1S column, which demonstrated lower 
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separation efficiency on the smaller porosity monolithic column. Overall, the 
chromatograms obtained on both the ribosomal RNA and the MS2 RNA clearly 
demonstrate similar performances for all three columns.  
In addition to analysing large MW nucleic acids, 20 mer oligonucleotides were 
analysed on the different monoliths (Figure V-5 A-D). The results show an optimum 
resolution on the RP-3U column, as seen from the Gaussian peak with an FWHM of 
0.14 minutes (Figure V-5 C). Unexpectedly, a much lower resolution was obtained on 
the RP-2H column, as the FWHM was not measurable due to poor peak shape. Higher 
resolution was observed on the RP-1S column (FWHM was 0.17 minutes) (Figure V-5 
A) compared to the RP-3U column. Low resolutions were observed on two identical 
RP-2H columns (Figure V-5 B and C). It is proposed that this may have been due to 
restrictions on diffusive rates resulting from significant gel porosity of the RP-2H 
columns, thus reflecting stagnant mass transfer zones and limiting its efficacy for the 
separation of small molecules such as oligonucleotides under strong retention mode 
(Nischang and Brüggemann, 2010). In addition, smaller biomolecules such as 
peptides and oligonucleotides are much more sensitive to changes in porosity 
compared to larger molecules (Trojer et al., 2006), which might explain the significant 
differences when observing separation performance oligonucleotide using different 
monoliths. However, considering the similarity between the pore sizes of the RP 1S 
and RP 2H columns (1.1 µm and 2.2 µm respectively) and the previous data, it was 
unexpected that such differences were observed for the analysis of oligonucleotides. 
Noticeably, lower retention times for the 20 mer oligonucleotide were observed on the 
monolithic RP-3U column compared to the RP-1S column under the same 
chromatographic conditions (Figure V-2 A and C). These results agree with previous 
data on the analysis of small dsDNA, and rRNA where shorter elution times on the 
larger pores of the RP-3U column were observed primarily due to the lower dead 
volumes (0.65 mL and 0.76 mL) of the RP-3U and RP-1S columns respectively. In 
addition, it is proposed that the smaller molecules will elute faster in larger pores than 
in smaller pores due to different mass transfer properties.   
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Figure V-3: A comparison of RP-1S, RP-2H, and RP-3U monoliths for the 
analysis of ribosomal RNAs extracted from E. coli, using IP RP HPLC at 50°C. 
(A) RP-1S (B) RP-2H, and (C) RP-3U monolith columns respectively. The two peaks 
shown on the chromatogram refer to 16s rRNA and 23s rRNA using gradient 6 (see 
Chapter 2.6.5).   
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Figure V-4: A comparison of chromatographic performance on the analysis of 
bacteriophage MS2 RNA using ProSwift monolith columns of different 
porosities with IP RP HPLC at 50°C.  (A) RP-1S (pore size distribution 1.1µm), (B) 
RP-2H (pore size distribution 2.2 µm), and (C) RP-3U monolith columns (pore size 
distribution 5.2 µm) respectively, using gradient 6 (See Chapter 2.6.5). 
141 | P a g e  
 
Figure V-5: A comparative analysis of 20 mer oligonucleotides under IP RP 
HPLC using ProSwift monolithic columns. (A) RP-1S (B) RP-2H column No. 1 (C) 
RP-2H column No. 2 and (D) RP-3U at 50°C by gradient condition 7, figure C was 
performed under a steeper gradient condition 8  (see Chapter 2.6.5).   
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 Performance of different monolith columns at various flow rates 
The objective of the HPLC method development is to perform analysis in shorter times 
and to avoid compromising performance in resolution, efficiency, as well as sensitivity. 
In this respect, the effects of flow rates on monolithic columns (ProSwift RP-1S, RP-
2H, and RP-3U) were studied across the range 0.4 mL min-1 to 1.4 mL min-1 in 
conjunction with IP RP HPLC for the analysis of 20 mer oligonucleotides and pUC18 
Hae III DNA ladder.  
The results show that for the analysis of 20 mer oligonucleotides using the RP-1S 
column, an increase in flow rate corresponded with an expected decrease in RT (18.77 
to 10.36 minutes) as shown in (Figure V-6 A-F) due to the internal void volume of the 
column, while FWHM improved from 0.25 to 0.18 minutes (Table V-2). In particular, 
the fronting peak which was apparent at low flow rates appears to be reduced at higher 
flow rates. Lower flow rates at 0.4 mL min-1 and 0.6 mL min-1 also demonstrated peak 
broadening and peak tailing (Figure V-6 A and B).  
The results are consistent with previous data (data not shown) where a broad peak 
was observed in the analysis of the 20 mer oligonucleotide on the RP-2H column over 
flow rates ranging from 1.0 mL min-1 to 1.4ml min-1. In contrast, using the RP-3U 
column, a narrow peak was obtained across elevated flow rates (Figure V-7 A-F). In 
addition, retention time differed only slightly at 1.0, 1.2, and 1.4 mL/min-1 (6.92 to 6.66 
minutes). Optimum performance was achieved at higher flow rates of 0.8 and 1.0 
mL/min-1 (FWHM 0.14 minutes) (Figure V-7 C and D; Table V-4). Thus, the RP-3U 
column clearly demonstrates the highest resolution for the separation of 
oligonucleotides across a wide range of flow rates (within the range 0.4-1.4 mL/min-1).    
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Figure V-6: The effect of increased flow rates on ProSwift RP-1S (1.1 µm pore 
size) monolith column for the analysis of 20 mer oligonucleotide at 50°C by IP 
RP HPLC. (A) 0.4 mL min-1 (B) 0.6ml min-1 (C) 0.8 mL min -1 (D) 1.0 mL min-1 (E) 1.2ml 
min-1 (F) 1.4 mL min-1 using gradient condition 7 (see Chapter 2.6.5). 
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Figure V-7: The effect of different flow rates on ProSwift RP-3U (5.2 µm pore size) 
monolith column for the analysis of 20 mer oligonucleotide at 50°C by IP RP 
HPLC. (A) 0.4 mL min-1 (B) 0.6ml min-1 (C) 0.8 mL min -1 (D) 1.0 mL min-1 (E) 1.2ml 
min-1 (F) 1.4 mL min-1 using gradient condition 7 (see Chapter 2.6.5). 
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The relationship between retention times and peak resolutions using ProSwift 
RP-1S, RP-2H, and RP-3U columns for the analysis of 20 mer oligonucleotides 
at different flow rates.  Resolution was not available on the RP-2H column due to 
lack performance. Comparing these three columns, the RP-3U column at flow rates of 
0.8 and 1.0 mL/min provided the optimum peak resolution. The trends produced on 
the RP-1S and RP-3U columns suggest that higher flow rates may enhance 
resolutions on porous polymeric monolith columns. 
 
 
Table V-2: Effect of increasing flow rate using the ProSwift-1S column for 20 mer 
oligonucleotide analysis 
Flow rate (mL/min) Retention Time (RT) Full Width Half 
Maximum (FWHM) 
0.4 18.77 0.25 
0.6 15.95 0.19 
0.8 11.74 0.16 
1.0 11.06 0.17 
1.2 10.65 0.18 
1.4 10.36 0.18 
 
Table V-3: Effect of increasing flow rate using the ProSwift-2H column for 20 mer 
oligonucleotide analysis 
Flow rate (mL/min) Retention Time (RT) Full Width Half 
Maximum (FWHM) 
0.4 15.55 * 
0.6 13.11 * 
0.8 12.20 * 
1.0 11.54 * 
1.2 11.31 * 
1.4 10.91 * 
*No resolution excluded   
 
Table V-4: Effect of increasing flow rate using the ProSwift-3U column for 20 mer 
oligonucleotide analysis 
Flow rate (mL/min) Retention Time (RT) Full Width Half 
Maximum (FWHM) 
0.4 10.60 0.15 
0.6 8.46 0.15 
0.8 7.45 0.14 
1.0 6.92 0.14 
1.2 6.79 0.16 
1.4 6.66 0.16 
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Further analysis into the effect of flow rates using monoliths of the different pores sizes 
under IP RP HPLC was performed using dsDNA fragments (80-587bp), while the 
fragments of 102 bp and 295 bp were used to evaluate the peak resolutions (Table 
V-2-Table V-4).  
The results show that due to the combination of a delay in the gradient and the 
columns’ internal volume, it was not practical to operate the flow below 0.8 mL/min. 
Overall, adjusting flow rates (0.8-1.4 mL/min) did not significantly improve the 
resolutions obtained for the majority of dsDNA fragments in each column. Similar 
findings have been reported by Huber’s group using a DNAsep column for DNA 
fragment analysis (Huber et al., 1993). This phenomenon could be the consequence 
of mass transfer resistance between the column surface and the eluent, resulting in 
peak broadening or poorer peak shapes at high flow rates. The results are also in 
contrast with a previous study on peptides and proteins which found that increased 
flow rates benefit mass transfer rates and show improved resolution and separation 
(Cabrera et al., 2000 and Thermo product manual, 2014). 
The RP-1S column demonstrated a small improvement in resolution with FWHM from 
0.07 to 0.05 minutes for 102 bp dsDNA (Figure V-8 B-E and Table V-5). However, the 
FWHMs were unaltered for 295 bp dsDNA in the same flow rate range. The RP-2H 
column showed optimal performance at a flow rate of 0.8 mL/min-1 (Figure V-9 C and 
Table V-6). By extending the range of flow rates, good peak resolutions were achieved 
for fragment sizes ranging from 80 bp-458 bp. The RP-3U column produced a similar 
peak resolution for 102 bp dsDNA fragments (average FWHM 0.08 minutes) (Table 
V-7), and much broader peak areas for 295 bp fragments were observed (FWHM 0.30 
to 0.25 minutes corresponding to flow rates 0.6-1.4 mL/min-1) (Figure V-10 B-F) in 
comparison to the RP-1S and RP-2H columns despite the flow rates applied. 
In summary, the optimal performance for oligonucleotide analysis when using the RP-
1S and RP-3U columns can be obtained at higher flow rates, typically between 0.8 
and 1.0 mL/min. Specifically, the RP-3U column can operate at a wider range of flow 
rates to produce maximum oligonucleotide resolution. As previously observed, the 
resolution obtained on the RP-2H column was significantly lower compared to that of 
the RP-1S and RP-3U columns. In addition, the analysis of different-sized dsDNA 
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fragments using the RP-1S column demonstrated optimal separation at higher flow 
rates (0.8-1.4 mL/min-1).  
 
Figure V-8: The effect of different flow rates on the ProSwift RP-1S (1.1 µm pore 
size) monolithic column for the analysis of pUC18 DNA Hae III digest ladder at 
50°C by IP RP HPLC.  (A) 0.4 mL min-1 (B) 0.8ml min-1 (C) 1.0 mL min-1 (D) 1.2ml 
min-1 (E) 1.4 mL min-1 using gradient condition 9 (see Chapter 2.6.5). 
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Figure V-9: The effect of different flow rates on the ProSwift RP-2H (2.2 µm  pore 
size) monolithic column for the analysis of pUC18 DNA Hae III digest ladder at 
50°C by IP RP HPLC.  (A) 0.4 mL min-1 (B) 0.6ml min-1 (C) 0.8 mL min-1 (D) 1.0 mL 
min-1 (E) 1.2ml min-1 (F) 1.4 mL min-1 using gradient condition 9 (see Chapter 2.6.5). 
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Figure V-10: The effect of different flow rates on ProSwift RP-3U (5.2µm of pore 
size) monolithic column for the analysis of pUC18 DNA Hae III digest ladder  at 
50°C by IP RP HPLC.  (A) 0.4 mL min-1 (B) 0.6 mL min-1 (C) 0.8 mL min-1 (D) 1.0 mL 
min-1 (E) 1.2 mL min-1 (F) 1.4 mL min-1using gradient condition 10 (see chapter 2.6.5). 
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The relationship between retention times and peak resolutions using monolith columns, 
ProSwift RP-1S, RP2H, and RP-3U analysing pUC 18 Hae III Digest ladder at different flow 
rates. The lower flow rates caused delays on elution time. Therefore, the retention time and 
the resolutions are not available in the RP-2H and RP-3U column at flow rate 0.4 mL/min. 
dsDNA 102 and 295 bp fragments were used to evaluate the FWHM. 
Table V-5: Effect of increasing flow rate using the RP-1S column for pUC18 DNA 
Hae III Digest ladder analysis 
Flow Rate (mL/min) Retention 
Time (RT) 
Full Width 
Half 
Maximum 
(FWHM) 
Retention 
Time (RT) 
Full Width 
Half 
Maximum 
(FWHM) 
0.4 * * 13.76 0.14 
0.6 * * * * 
0.8 6.05 0.07 9.70 0.13 
1.0 5.35 0.07 8.84 0.13 
1.2 4.86 0.06 8.19 0.13 
1.4 4.42 0.05 7.64 0.15 
*No resolution excluded     
 
Table V-6: Effect of increasing flow rate using the RP-2H column for pUC18 DNA 
Hae III Digest ladder analysis 
Flow Rate (mL/min) Retention 
Time (RT) 
Full Width 
Half 
Maximum 
(FWHM) 
Retention 
Time (RT) 
Full Width 
Half 
Maximum 
(FWHM) 
0.4 * * * * 
0.6 * * * * 
0.8 5.58 0.07 10.19 0.15 
1.0 4.90 0.07 9.27 0.15 
1.2 4.48 0.06 8.68 0.16 
1.4 4.15 0.06 8.18 0.19 
*No resolution excluded     
 
Table V-7: Effect of increasing flow rate using the RP-3U column for pUC18 DNA 
Hae III Digest ladder analysis 
Flow Rate (mL/min) Retention 
Time (RT) 
Full Width 
Half 
Maximum 
(FWHM) 
Retention 
Time (RT) 
Full Width 
Half 
Maximum 
(FWHM) 
0.4 * * * * 
0.6 * * 11.31 0.30 
0.8 5.14 0.08 10.10 0.25 
1.0 4.53 0.08 9.18 0.25 
1.2 4.09 0.08 8.49 0.26 
1.4 3.72 0.07 7.97 0.25 
*No resolution excluded     
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 Effect of chemical denaturants in conjunction with IP RP HPLC  
IP RP HPLC uses a hydrophilic buffer triethylammonium acetate (TEAA) and organic 
solvent acetonitrile (ACN) as a standard mobile phase for nucleic acid analysis. The 
analysis is normally performed at room temperature or 50°C using linear gradient 
elution, a condition referred to as non-denaturing chromatography. Under such 
conditions, however, long- single-stranded nucleic acids might assume secondary 
structures, resulting in wide or multiple peaks. IP RP HPLC is often performed at high 
temperatures (75°C) to overcome these effects; however, even elevated temperatures 
may not denature long double-stranded nucleic acids. 
Recently, the use of urea in conjunction with HPLC for the analysis of long single-
stranded oligonucleotides and double-stranded oligonucleotides has been reported as 
an alternative method for denaturing HPLC (Fueangfung et al., 2014). Urea is a 
denaturant reagent widely used in biomolecules through the direct binding interaction 
or by changing the solvent environment by favouring unfolding (Bennion and Daggett, 
2003).   
A series of experiments were performed to study the effect of using the standard 
TEAA-ACN mobile phase with a 10% urea solution. A ProSwift RP-1S column 
(standard pore size) was used to analyse 20 mer oligonucleotides, E. coli 16S and 
23S ribosomal RNA and bacteriophage MS2 RNA at both denaturing and non-
denaturing conditions and column temperatures of 50°C and 75°C. Analysing 20 mer 
oligonucleotide with the TEAA mobile phase at 50°C produced a sharp peak with 
FWHM 0.12 minutes, (Figure V-11 A). Potential impurities appeared to co-elute as 
shown by the multiple peaks appearing at front of the main oligonucleotide peak 
(FWHM 0.136 minute) in the mobile phase containing urea (Figure V-11 B). The 
addition of 10% urea resulted in a decrease in retention time (Figure V-11 B), similar 
to that observed in the absence of urea at 75°C. The addition of 10% urea under 
denaturing conditions further reduced the retention time (Figure V-11 D). These results 
are consistent with previous data that showed reduced fragment retention times under 
denaturing conditions (Gjerde et al., 2009). Comparing the FWHM however, did not 
show any significant improvement in the resolution of the oligonucleotides. However, 
for highly complex structures such as oligonucleotides and RNA, the additional 
denaturing conditions may have a greater effect on resolution. For example, potential 
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impurities started denaturing, as seen from a hump apart from the main peak on the 
TEAA buffer (Figure V-11 C). Additionally, the mobile phase containing urea had a 
significant effect leading to the co-elution of impurities as shown by into two small 
humps in front of the oligomer (Figure V-11 D).  
Performing the same comparative analysis for the analysis of total RNA using 16S and 
23S rRNA at 50°C produced very sharp peaks under both mobile phases, as seen 
from the FWHM of 0.106 and 0.111  minutes, with and without 10% urea respectively 
(Figure V-12 A and B). FWHM values at 75°C were similar, at 0.106 and 0.108 minutes 
with and without 10% urea respectively (Figure V-12 C and D). Although the additional 
10% urea in TEAA-ACN caused a slight increase in peak resolution, a significant 
reduction in retention time was observed at both temperatures, indicating a possible 
reduction in ion pairing with the analyte (or stationary phase) and reduction in overall 
hydrophobicity.  
Finally, analysis of the large bacteriophage MS2 RNA was performed (Figure V-13). 
Gaussian peaks obtained on the two systems and temperatures (50°C TEAA with 
FWHM = 0.13 minutes, 50° TEAA and 10% urea with FWHM = 0.10 minutes; 75°C 
TEAA with FWHM = 0.11 minutes and TEAA and 10% urea with FWHM = 0.09 
minutes). The denaturing urea-TEAA buffer system altered the retention time with 
slightly improved resolutions observed at 50°C and 75°C. 
In summary, the experiments performed with urea as an additive to the IP RP HPLC 
mobile phase showed that it was compatible with an HPLC system, in part because 
no significant loss of resolution was observed during or after the analysis. However, 
no significant improvement in the resolution of oligonucleotides or ssRNA was 
observed. 
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Figure V-11: The analysis of 20 mer oligonucleotides using standard TEAA 
buffer vs. 10% urea and TEAA under non-denaturing and denaturing 
temperature conditions by ProSwift RP-1S column. (A) 0.1M TEAA at 50°C (B) 
0.1M TEAA and 10% urea at 50°C (C) 0.1M TEAA at 75°C (D) 0.1M TEAA and 10% 
urea at 75°C under IPRP HPLC using gradient condition 8 (see chapter 2.6.5). 
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Figure V-12: The analysis of  E. coli ribosomal RNA 16s and 23s using standard 
TEAA buffer vs. 10% urea and TEAA under non-denaturing and denaturing 
temperature conditions by ProSwift RP-1S column. (A) 0.1M TEAA at 50°C (B) 
0.1M TEAA and 10% urea at 50°C (C) 0.1M TEAA at 75°C (D) 0.1M TEAA and 10% 
urea at 75°C under IP RP HPLC using gradient condition 6 (see chapter 2.6.5). 
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Figure V-13: The analysis of  large bacteriophage MS2 RNA using standard 
TEAA buffer vs. 10% urea and TEAA under non-denaturing and denaturing 
temperature conditions by ProSwift RP-1S column. (A) 0.1M TEAA at 50°C (B) 
0.1M TEAA and 10% urea at 50°C (C) 0.1M TEAA at 75°C (D) 0.1M TEAA and 10% 
urea at 75°C under IP RP HPLC using gradient condition 6 (see chapter 2.6.5).  
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Part B  
 Impact of gel porosity and the matrix of monolith columns 
The performance of porous polymer monoliths for the analysis of macromolecules 
using IP RP HPLC under gradient elution mode was previously studied (see Chapter 
V part A). However, a lack of fundamental knowledge on gel porosity structure and the 
function of polymer monolithic media for the analysis of large biomolecules 
necessitates further investigation (Nischang, 2012). Recently, porous polymeric 
monolith properties have been studied by measuring the material in a dry state, 
providing a limited understanding of micro and macro-scale dynamics as well as mass 
transfer performance for biomolecules  (Nischang and Brüggemann, 2010). During the 
cross-linking stage of the polymeric monolith material, significant gel porosity is formed 
within the large heterogeneous globular structure. The specific gel porosity is absent 
in the dry state in polymeric monolith but appears in the scaffold when in a solvated 
state. Transport phenomena of large molecules remain unknown, as gradient elution 
mode has restricted spaces which are intended for analyte mass transfer assessment 
(Nischang, 2012). Using the isocratic elution mode, polymeric monoliths have 
demonstrated poor performance, possibly due to the large flow through pore 
heterogeneity (Nischang, 2012). Using non-retained elution conditions, the pore-fluid 
gel surface area is non-adsorbing and as a consequence, pore structures can be 
rapidly detected (Trilisky et al., 2009). Characterising different pore size distribution 
(PSD) is important to understand and predict the behaviour of chromatographic 
performance.  
The primary aim of this experiment was to study the impact of different pore structures 
of the selected polymeric monolith columns, investigate the presence of micro, meso, 
and macro-pores, and determine how different sized nucleic acid analytes travel in 
convective media. Secondary objectives included relating previous IP RP HPLC 
experimental observations, and performance of the ProSwift RP-1S, RP-2H, and RP-
3U with a range of nucleic acids under non-retentive conditions.  
The analysis was initially performed to study the effect of elution for a range of different 
sized nucleic acids under non-retentive isocratic chromatographic mode, using varying 
percentages of acetonitrile compositions in the mobile phase. The nucleic acids used 
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were: oligodeoxynucleotides starting from: 3 mer (MW: 806 g/mol), 6 mer (MW: 1763 
g/mol), and 18 mer (MW: 5340 g/mol), as well as higher molecular weight MS2 RNA 
(MW: 1,090,064 g/ mol). 
 
 Impact of nucleic acid size and polymeric monolith porosity on elution time 
To further study the effect of nucleic acid analytes on the elution performance of the 
monoliths, nucleic acid analytes of a wide range of sizes were compared under non-
retentive isocratic conditions (50% acetonitrile at a flow rate of 1 mL/min) (see Figure 
V-14). In order to accurately determine the effect of different porosities on elution time 
in all the non-retentive analyses, it was necessary to compensate for deviations in 
column internal volume as a result of the column manufacturing process, despite equal 
dimensions for the RP-1S, RP-2H, and RP-3U columns. This was done through 
normalisation of the elution times based on the internal column volumes of each 
column. The normalisation factors and normalised elution times are shown in Table 
V-8. 
 
Table V-8: Normalisation of elution times of different-sized nucleic acids based 
on internal column volume. 
   Non-Normalisation elution time 
(min)  
Normalisation elution time (min) 
 
Column 
 
Column 
volume 
(mL) 
 
Normalisation 
factor 
MW 
806 
(g/mol) 
MW 
1763 
(g/mol) 
MW 
5340 
(g/mol) 
MW 
10,900,
64 
(g/mol) 
MW 
806 
(g/mol) 
MW 
1763 
(g/mol) 
MW 
5340 
(g/mol) 
MW 
10,900,6
4 
(g/mol) 
RP-1S 0.76 0.76 0.44 0.43 0.42 0.35 0.44 0.43 0.42 0.35 
RP-2H 0.73 0.76/0.73=1.04
1 
0.4 0.383 0.376 0.31 0.416 0.398 0.39 0.384 
RP-3U 0.65 0.76/0.65=1.16 0.33 0.33 0.33 0.34 0.385 0.385 0.385 0.394 
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The results demonstrate that there is a clear relationship between the MW of single-
stranded (ss) nucleic acids with elution time in the order: 3 mer>6mer>18 mer 
oligonucleotides> MS2 RNA for the RP-1S and RP-2H monoliths (Figure V-14). The 
largest MS nucleic acids had the lowest elution time under all conditions, due to their 
size, resulting in limited access to the porous structure. These results are consistent 
with previous data for the analysis of differently-sized protein biomolecules under non-
retentive conditions (Nischang, 2014).   
In contrast, elution times using the RP-3U column did not appear to show significant 
differences for all sizes of nucleic acids involved. Nischang (2014) varied protein size 
of analytes to determine the appearance of porosities on the RP-1S and RP-3U 
column but the results showed only small variation in apparent porosities exiting at the 
50% acetonitrile solvation state. Under the same conditions, however, the RP-1S 
column demonstrated wide variation in apparent porosities (Nischang, 2014). The 
current experiment is in good agreement with Nischang’s observations, where the size 
of nucleic acids influenced elution times on the RP-1S and RP-2H columns, indicating 
the presence of different porosities under non-retentive mode. However, this effect 
was not apparent on the RP-3U column. 
 
Figure V-14: Retention time against molecular weight of various sizes of nucleic 
acid analytes; analysis performed using polymeric monolith columns of 
different porosities.  RP-1S (squares), RP-2H (circles), and RP-3U (triangles) under 
a selected flow rate of 1 mL/min with mobile phase solvent. obile phase consisted of 
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50/50 acetonitrile and water (v/v) using gradient condition 12 (See chapter 2.6.6). The 
error bars correspond to the standard deviation (N=3). 
 
 Impact of acetonitrile concentration on elution volume  
Previous analysis suggested that swelling in porous polymer monolith was observed 
with increased concentration of acetonitrile. It has been proposed that when the 
amount of acetonitrile is more than 50% in the eluent, the pores start to close 
(Nischang, 2014). This phenomenon is expected since the gel porosity of a polymeric 
monolith can be enhanced through solvation and swelling as more free volume is 
generated in the polymer monolith (Nischang, 2013). In order to systematically 
evaluate the effect of a wide range of acetonitrile compositions against a series of 
nucleic acids on elution time, isocratic elution modes with 20%, 50%, and 80% of 
acetonitrile/water were tested with the monolith columns (Figure V-15). A general trend 
where a reduction in retention time is observed: as the percentage of acetonitrile is 
increased on the RP-1S and RP-2H columns, elution time decreases in the order of 
20%>50%>80% acetonitrile.  
The results show that changing to a higher percentage of acetonitrile had no significant 
effect on the elution of smaller-sized oligonucleotides (MW 806 g/mol). This 
observation appeared on both monolith RP-1S and RP-2H columns (Figure V-15 A 
and B) and is in good agreement with previous studies involving a wide range of sizes 
of peptides and proteins, where it was shown that permeation volume is less sensitive 
to smaller-sized analytes (Nischang, 2014). Interestingly, analytes of higher molecular 
weight (18 mer oligonucleotides (MW 5340 g/mol) and MS2 RNA (MW 10,900,64 
g/mol) seem to be more sensitive to the increasing percentage of acetonitrile (80%), 
which leads to noticeable variation in elution porosity on the RP-1S column.        
Moreover, the analysis on oligonucleotides using the RP-2H monolith column 
presented comparable trends, peak shapes and peak widths to the RP-1S column 
under non-retentive mode (Figure V-18 A-D). These results disagree with earlier 
studies on IP RP HPLC (Figure V-5 A and B), where a dispersion peak was observed 
on the RP-2H column for oligonucleotides analysis (Figure V-5 B). This conflict could 
be explained by the solvation state of the porous monolithic material. As swelling 
occurs during solvation, extra pore space facilitates rapid permeation and diffusion of 
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smaller molecules within the gel structure (Causon et al., 2012). In contrast to the ion 
paring elution mode where a lower percentage of acetonitrile is used (non-solvation), 
oligonucleotides adsorb to the highly permeable functional surface then proceed to 
move in and out of different pore spaces, before desorbing from the column slowly. 
The low mass transfer rates cause loss of efficiency. Thus, pore spaces have a 
considerable impact on the transport and chromatographic behaviour of polymeric 
monolith columns. It has also been hypothesised that the change in polymer monolith 
nano-scale gel porosity significantly influences the materials’ physio-chemical 
properties, which is clear when analysing small molecules. In particular, the 
performance measured in the tests under isocratic elution mode strongly depends on 
the amount of gel porosity present in the polymer monolith (Nischang et al., 2011).  
In contrast, the analysis of nucleic acid elution time on the RP-3U column did not 
significantly change with the percentage of acetonitrile (Figure V-15), suggesting that 
increasing ACN concentration does not further alter the gel porosity in the RP-3U 
column. Notably, nucleic acid analytes with different molecular weights differed 
negligibly in elution time e.g. the 3mer, 6 mer, and 18 mer oligonucleotides. In addition, 
for the analysis of large MW MS2 RNA, the elution time increased with increasing 
percentage of ACN within the range of 20 to 50%. This phenomenon is in agreement 
with data on the RP-1S column where the larger analyte is more sensitive to changes 
in ACN content on a polymeric monolith column. The RP-3U morphology shows larger 
globules and agglomerates of irregular sizes with interconnected pores compared to 
the RP-1S and RP-2H columns. The results indicate that large flow through channels 
or macropores are present in the RP-3U column in the solvated state since small-sized 
analytes experienced similar retentions times. 
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Figure V-15: The effect of molecular weight of different-sized nucleic acids 
under a binary acetonitrile and water (v/v) environment (20%, 50%, and 80%) on 
elution time using monolith ProSwift columns (A) RP-1S, (B) RP-2H, and (C) RP-
3U. Flow rates were 1 mL/min using gradient condition 13-15 (see Chapter 2.6.6). The 
error bars correspond to the standard deviation (N=3).  
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 Elution performance under non-retentive conditions at elevated flow rates  
The effect of analyte size alongside retention time at various flow rates (0.75 mL/min, 
1.0 mL/min, and 1.25 mL/min) were studied under 50% acetonitrile volume in the 
mobile phase (20% and 80% data are not shown) analysed on the RP-1S, RP-2H, and 
RP-3U columns (see Figure V-16). The elution time for nucleic acids of a range of 
MWs on the RP-1S and RP-2H columns show the expected decrease in elution time 
as MW increases across 3 different flow rates and is consistent with previous data 
(Figure V-14). In contrast, elution times for the RP-3U column were indistinguishable 
between all sizes of analytes and at the different flow rates, in agreement with previous 
data. In terms of individual elution performance under each column, it is evident that 
the range of analytes studied are more retentive in the finer pore sizes of the RP-1S 
column, followed by decreased elution times within the medium pore sizes of the RP-
2H column, and finally significantly reduced elution volume in the larger pores of the 
RP-3U column. The ratios are consistent throughout the selected flow rates used in 
the experiment. 
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Figure V-16: Retention time versus molecular weight for different nucleic acids 
analytes with the ProSwift monolithic at flow rates 0.75,1.0, and 1.25 mL. (A) RP-
1S, (B) RP- 2H and, (C) RP-3U columns. The mobile phase consisted 50:50 
acetonitrile and water and was used with gradient condition 14 (see chapter 2.6.6). 
The error bars correspond to the standard deviation (N=3). 
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 Effects of analyte concentration on retention time using porous polymeric 
monolith columns under non-retentive conditions 
To further characterise the structural properties of porous polymeric monolithic 
columns, an experiment was performed with the objective of investigating the effect of 
analyte concentration versus elution time under non-retentive conditions. 
Oligonucleotides of lengths 6 mer and 18 mer, as well as large MS2 RNA (used as a 
standard to compare elution across the columns), were used at concentrations of 500 
pmol, 50 pmol, and 5 pmol. Samples were injected with 20%, 50%, and 80% 
acetonitrile (different solvation state) at flow rates of 1 mL/min-1. As suggested by 
Trilisky et al., (2009), under solvation state the gel porosity of polymeric monoliths 
swell, allowing rapid determination of various gel porosities at low elution times. 
The results are summarised in Figure V-17 A-C and the specific chromatograms 
obtained are shown in Figure V-18 A-D. Standard deviations were calculated to 
measure experimental error, with less than 0.005 of error in the data reported. It can 
be seen that in the case of 6 mer and 18 mer oligonucleotides, a decrease in analyte 
concentration reduces elution times (Figure V-18 A-D). This phenomenon is surprising 
since under non-retentive conditions the mobile phase system is operating in a highly 
organic environment and thus, adsorption is absent at the monolithic surface. 
Therefore, any overloading on the stationary phases should not have a direct effect 
on elution time under such conditions. This finding provides potential evidence for the 
existence of different gel porosity paths, by showing that higher concentrations of 
oligonucleotides take longer to travel through pores. Compared to a higher 
concentration, a low concentration of oligonucleotides of the same size has less 
overall mass, and can more easily travel through shorter paths, resulting in shorter 
elution times. In contrast, the results for the RP-3U column show no significant 
differences in elution time with the analyte concentrations. For example, 6 mer 
oligonucleotides of 5, 50 and 500 pmol had nearly identical elution times of 0.37, 0.39, 
and 0.40 minutes respectively (Figure V-18 E).  
Altering the percentage of acetonitrile in the mobile phase (i.e. higher ACN content), 
resulted in a more significant decrease in elution time for the range of analytes 
observed in the RP-1S column (Figure V-15). This result is consistent with Nischang's 
findings (2014a) who characterised analytical polymer monoliths using different 
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percentages of ACN and proteins of a wide range of sizes to investigate apparent 
elution porosity using the RP-1S column.  
In addition, looking at the effect of acetonitrile in the mobile phase to analyse 50 pmol 
of 18 mer oligonucleotides, different elution times were observed at different 
concentrations (20-80%) of acetonitrile on the RP-1S column; When using 5 pmol 
instead at 80% of acetonitrile, a significant decrease in elution time occurred (see 
Figure V-15 and Figure V-17). Moreover, altering the percentage of ACN on the 
analysis of 18 mer oligonucleotides using the RP-2H column indicated an apparent 
variation in elution porosity which was determined by the difference in elution times 
(Figure V-15 B).  
Varying analyte size, analyte concentration, and acetonitrile concentration had 
insignificant impacts using the RP-3U column (except for the MS2 RNA). This is 
evident from the trend in Figure V-15 C, which remained flat (signifying similar elution 
times) for all sizes of analyte despite varying acetonitrile compositions.  
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Figure V-17: Normalised elution times for different-sized biomolecules analysed 
using monolith columns RP-1S, RP-2H, and RP-3U under non-retentive 
conditions (20-80% acetonitrile) (see chapter 2.6.6). The error bars correspond to 
the standard deviation (N=3). 
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Figure V-18: Comparative analysis of the impact of different sized 
oligonucleotides at various concentrations on normalised elution times using 
monolith columns.  ProSwift RP-1S, RP-2H, and RP-3U columns and 20% 
acetonitrile under non-retentive condition using gradient condition 13 (see chapter 
2.6.6). 
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5.4 Conclusions 
Three monolithic columns with different pore size distributions were used in 
conjunction with ion-pair reversed-phase high-performance chromatography (IP RP 
HPLC) to analyse nucleic acids ranging from small DNA oligonucleotides to large 
dsDNA fragments and large ssRNA. The results from using identical gradients 
demonstrated that the relative retention times of the oligonucleotides, rRNA and MS2 
RNA, were similar, reflecting the small differences in column volumes across the 
different monoliths. In contrast, the analysis on the larger dsDNA fragments revealed 
increased retention times on the RP-3U column and is possibly due to a difference in 
permeability of these large duplex DNA fragments compared to the other nucleic acids. 
The ProSwift RP-1S column with the standard pore size produced an optimal 
performance for the analysis of a wide range nucleic acids, including DNA 
oligonucleotides, dsDNA fragments, and ssRNA samples. In contrast, the RP-2H 
column displayed a much lower resolution for the analysis of oligonucleotides 
compared to the RP-1S column but showed a comparable performance for the larger 
MW nucleic acids. These results demonstrate that potentially low diffusion rates of 
small oligonucleotides may cause significantly low resolution. The porosity of the RP-
2H column is one magnitude greater compared to that of RP-1S, yet their performance 
in terms of peak shape and peak resolution was relatively similar, except when 
analysing oligonucleotides. Analysis on the RP-3U column demonstrated that it was 
optimal for the analysis of oligonucleotides, probably due to its much larger pores. In 
general, the results from the analysis of nucleic acids show that for most nucleic acids 
except for small oligonucleotides, reducing the practical porosity produces better peak 
resolutions while increasing the porosity results in peak broadening. The better 
performance of the RP-1S column could be related to its structural homogeneity, in 
contrast to the larger, more homogeneous pore structure (consisting of macropores) 
of the RP-3U column. 
Further analysis of the different monoliths was performed under non-retentive 
conditions to study the effects of polymeric monolith porosity on elution time of a range 
of different nucleic acids. The results show that under non-retentive chromatographic 
conditions, the different pore conformations present in the polymeric monolith scaffold 
on both RP-1S and RP-2H columns affect the elution time of the nucleic acids, with a 
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general trend of reduced retention time as the MW of the nucleic acid increase. In 
contrast, on the RP-3U column, no significant effect of MW on retention time was 
observed, demonstrating that the RP-3U column lacks the different types of pores 
required for accessibility by the range of nucleic acids.  
These results further suggest the existence of macropores on the RP-3U column. The 
finer porous structure on the RP-1S column clearly demonstrates better efficiency 
compared to the RP-2H and RP-3U columns, which may be associated with the 
structural homogeneity in the solvated state of the RP-1S column. Accordingly, the 
RP-2H column illustrates a structure moderately balanced between the homogeneity 
and heterogeneity, whereas the RP-3U column has the most pronounced 
heterogeneous structure.  Even though the stationary phases used in this study 
consist of the same fundamental material, their distinct morphological properties alter 
the availability of stationary phase surface area, directly affecting their capability and 
performance. In the current study, we showed the significance of sorbent pore size for 
a range of nucleic acid applications using retentive and non-retentive HPLC analysis.  
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Chapter VI : Final discussion and future work  
The overall aim of this thesis was to develop analytical methods focused on ion-pair 
reversed-phase chromatography and mass spectrometry for the analysis of nucleic 
acids. This chapter is subdivided into three sections and covers the improvements and 
limitations of the developed techniques, possible applications, as well as the scope for 
future experiments.    
 
6.1 Optimisation of electrospray-ionisation mass spectrometry for the analysis 
of oligonucleotides 
The difficulty in balancing the need for high resolution and adequate MS sensitivity is 
one of the main limitations in unleashing the full potential of LC-ESI-MS in 
oligonucleotide analysis. Other issues, such as the formation of RNA-metal ion 
adducts and performance issues with larger oligonucleotides are also significant 
(Huber and Krajete, 1999). The physiochemical properties of a mobile phase are 
understood to have a significant impact on the electrospray desorption efficacy of 
oligonucleotides. Chapter III aimed to study the roles of these properties in the 
desorption process of the oligonucleotides through experiments using various 
alkylamine ion-paring reagents.  
Several relevant factors were found to significantly influence the performance of an 
ESI-MS system including boiling point, water solubility, Henry’s law constant (kH,cc 
(aq/gas)), organic modifier use, pH value of the system, and the hydrophobicity 
content of the oligonucleotides. The optimal buffer system was found to consist of 5 
mM TBA and 80 mM HFIP, demonstrated the highest ion abundance and minimal 
cation adduction and, responded efficiently with increasing the concentration of HFIP. 
This result was inferred to be the effect of TBA’s low kH,cc (aq/gas) value, which led 
to highly efficient ionisation of oligonucleotides. The kH,cc (aq/gas) value was also 
found to have an effect on charge state distribution: higher values (e.g. in HA) led to 
lower charge state distributions while lower values (e.g. TBA) led to higher charge 
state distributions. Additionally, the IP hydrophobicity also had a significant effect on 
ESI-MS sensitivity, in agreement with McGinnis et al., (2013). The increased IP 
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hydrophobicity leads to the reduction of surface tension in ESI droplets, providing 
greater sensitivity for the ESI-MS system (Oberacher, Oefner, et al., 2001). These 
results and the knowledge of how the relevant parameters affect ESI-MS performance 
allows for a more systematic approach to future evaluations. For example, 
tripropylamine (TPA), and dimethylbutylamine are hypothetically better ion-pairing 
reagents than TEA due to their higher hydrophobicity. Further experiments could focus 
on systematically evaluating and combining the ion-pairing reagents TPA and DMBA 
with different organic modifiers such as HFIP and TFE for the comparative analysis of 
different sequence oligonucleotides. The optimal ion-pairing reagent for each 
oligonucleotide should be considered on a case-by-case basis, as the choice is 
dependent on the sequence of oligonucleotide under investigation each time, as 
suggested by Basiri et al., (2017). Finally, the optimal ESI-MS mobile phase could be 
paired with an on-line LC separation system to investigate the compatibility between 
both instruments.  
In addition, it should be noted that significant standard deviation was observed for the 
datasets in experiment section 3.3.1, which can be explained by instrument drift 
resulting from the running of replicate samples on different days. Issues with data 
variability are quite common in ESI-MS signal intensity studies, and have been 
reported by Basiri et al., (2017). There are several ways that the experiments 
performed could be improved in future studies; one would be using an oligonucleotide 
and a buffer as a reference and compare other buffer combinations with the same 
oligonucleotides to report the ratio of MS signal intensities as suggested by Basiri et 
al., (2017), who found that it resulted in much better reproducibility of results with 
minimal variability between the experiments.  
One possible application of the results of this experiment is the generation of a 
predictive model to identify a subset effective mobile phases. Basiri et al., (2017) have 
already created a model which predicts the performance of IP reagents from their 
experiments. Such a model may be expanded to include a wider class of nucleic acids 
and IP reagents while accounting for the parameters which were found to be important. 
Initially, the available IP reagents could be sorted according to their suitability to the 
sequence or type of analyte. They can then be paired with an appropriate organic 
modifier to produce effective mobile phase combination according to their specific 
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physiochemical properties. Results from future work should be stored in a database 
to improve the model. Thus, by combining the results of these experiments with a 
predictive model it is possible to benefit researchers in this field, through improved 
efficiency and reduced processing times. 
 
6.2 Purification and quantification of dsRNA extracted from microbial cells 
RNA interference has received significant interest from the biopharmaceutical 
industries for its application to study various biological systems including the ability to 
analyse specific gene functions. The specificity of RNAi is a highly attractive feature in 
drug development and a wide range biotherapeutics, including antisense 
oligonucleotides and siRNAs, are emerging to treat a variety of important diseases. 
Meanwhile, researchers in agriculture are discovering ways to use novel RNAi-based 
methods to prevent disease in beneficial insects as well as for insect management by 
acting as an alternative to chemical insecticides. The potential for RNAi applications 
has led to a huge increase in demand for RNA-related products such as dsRNA. 
However, technologies with the capacity to synthesize large quantities of dsRNA by 
in-vitro transcription or in bacterial systems are stifled by the lack of efficient and high-
throughput systems capable of rapid extraction, purification, and analysis of dsRNA. 
Chapter IV presented a study on various RNA extraction methods to extract high yields 
of dsRNA engineered from E. coli cells in conjunction with stable isotope labelling for 
the quantitative analysis of dsRNA using LC-ESI-MS.  
A variety of guanidine isothiocyanate-phenoL/chloroform based extraction methods 
were utilised to compare dsRNA extraction quantities and qualities. A high yield of 
dsRNA extraction was achieved in a rapid manner using the DNAzol method without 
performing complicated steps and the use of phenol-chloroform for phase separation. 
Although DNAzol obtained the maximum yield of dsRNA compared to the other 
methods used in this experiment, a number of major drawbacks were found in other 
extraction methods such as: complicated, labour-intensive, and time-consuming 
procedures which may lead to degradation of RNA; procedures requiring the use of 
hazardous chemicals; relatively low yields of dsRNA despite large quantities of total 
RNA extracted; and compatibility issues between extracted RNA and downstream 
analysis. The discovery of an efficient nucleic acid extraction method such as that 
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presented in this thesis is a crucial development step and could potentially benefit 
molecular biology as well as provide the required materials for downstream production 
and disease diagnostics. 
Using a modified protocol DNAzol, (a DNA extraction reagent) resulted in efficient 
dsRNA extraction. In addition, it was demonstrated that modifying the TRIzol method 
by using phenol at neutral pH also increased the extraction yield of dsRNA compared 
to traditional phenol based RNA extractions at acidic pH. 
The finding that dsRNA can be extracted using neutral pH solutions greatly expands 
the pool of possible solutions available for dsRNA extraction, removing the restriction 
to only acidic solutions, and allowing the use of neutral pH solutions. The lifting of this 
restriction increases the chance of finding dsRNA extraction methods with improved 
performance in yield, quality, and processing time. However, future extraction 
development should manage the possibility of contaminating genomic DNA is present 
in the extracted dsRNA sample at neutral pH by considering further solid phase 
extraction or DNase treatment steps, which can efficiently remove the contamination. 
In addition to RNA extraction, stable isotope labelling approaches were also employed 
in conjunction with mass spectrometry for the absolute quantification of dsRNA. Stable 
isotope labelling approach by in vivo and in vitro labelling of dsRNA in conjunction with 
mass spectrometry were successfully demonstrated for the characterisation and 
quantification of dsRNA in complex total RNA mixtures. Rapid characterisation was 
achieved via the discrimination between light and heavy isotope oligonucleotide 
fragments. The isotope labelling approach allowed the development of a procedure 
for the absolute quantification of dsRNA when a known amount of reference dsRNA 
is spiked into an unknown amount of sample followed by the analysis of various peak 
ratios of the selected oligonucleotides. 
This method overcomes the drawbacks present in conventional methods used in 
quantitative analysis such as UV spectrophotometry and HPLC, which requires prior 
purification of the dsRNA and are unable to quantify dsRNA in complex mixtures. 
Stable isotope labelling has added the benefit of not altering any biophysical or 
biochemical properties of the oligonucleotide sample.  
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6.3 Effects of monolith porosity on the analysis of nucleic acids using ion-pair 
reversed-phase HPLC 
A wide range of monolithic reversed-phase columns has been designed with various 
chemical and physical properties for different analytical purposes. Differences in 
column properties such as pore size distribution and pore structure can lead to 
significant differences in chromatographic performance. To understand these effects, 
chapter V reports on the performance of polymeric monolith columns of different pore 
size distribution (PSD), i.e. ProSwift RP-1S (standard PSD), RP-2H (high PSD), and 
RP-3U (ultra-high PSD) on the analysis of nucleic acids centred on the retentive and 
non-retentive HPLC modes. Using polymeric monolith columns with IP RP HPLC, it 
was possible to separate nucleic acids of a wide-range of sizes (from small 
oligonucleotides to large DNA fragments as well as RNA) with high resolution. For 
nucleic acids with larger molecular weights, higher resolutions were achieved in the 
descending order RP-1S>RP-2H>RP-3U, suggesting that lower porosity may be 
better suited for the analysis of nucleic acids. On the other hand, a higher porosity 
demonstrated high-resolution separations of small oligonucleotides. In terms of scale, 
although the porosity of the RP-2H column is only one magnitude greater than the RP-
1S column, a significantly lower resolution of oligonucleotides was observed.  The 
results demonstrated that using identical gradients, the relative retention time of 
oligonucleotides and ssRNA was similar, reflecting the small differences in column 
volumes across the different monoliths. Interestingly, the results revealed that larger 
dsDNA fragments showed an increased retention time on the RP-3U column 
highlighting possible different permeability of these large duplex DNA fragments 
compared to the other nucleic acids.  
Finally, under non-retentive mode the elution times on the RP-1S and RP-2H columns 
were significantly affected by the nucleic acid size and analyte concentrations, while 
the RP-3U column did not display similar characteristics. The understanding of the 
effect of column porosity developed from these experiments may be beneficial in 
further studies on column behaviour as well as column design. A potential application 
is that column manufacturers can design more suitable columns by basing it on 
parameters such as the size of the analyte being studied and choosing an appropriate 
porosity. 
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In summary, these results might be attributed to structural homogeneity, as a better 
separation performance was observed on the RP-1S column in contrast to the RP-3U 
column, which has a larger and more homogenous pore structure (mesopore). In 
addition, the results observed under non-retentive chromatographic mode reveal the 
different pore conformations (which experienced different elution times for a wide 
range of analyte sizes) present in the polymeric monolith scaffold of the three columns. 
This hypothesis is consistent with previous work on the analysis of a range of 
biomolecules using the RP-1S and RP-3U columns (Nischang, 2014). In summary, 
these results have provided further insight into the characteristics and behaviour of 
monolithic reversed-phase columns for the analysis of nucleic acids. The results 
demonstrate the impacts of nucleic acid size, retention, and mobile phase composition 
on the performance of porous polymer monoliths while highlighting their unique 
inherent column characteristics.  
Further experiments may provide further insight into the different monoliths by further 
studying flow velocity and plate height as additional variables in a similar approach as 
Nischang (2014) who previously characterised polymeric monolith columns by using 
different sizes of proteins to determine their plate height curves under non-retentive 
conditions. These results suggest that flow velocity and molecular weight of the 
analyte have a significant impact on column performance. It is proposed that further 
analysis evaluating column performance should be carried out by measuring the 
height equivalent to a theoretical plate value against various combinations of nucleic 
acids and flow rates under a non-retentive mode. 
 
6.4 Final remarks 
This thesis presented several analytical methods centred on ion-pair reversed-phase 
chromatography and mass spectrometry, which have been developed to facilitate 
high-throughput analysis of nucleic acids demanded by the bio-therapeutic and 
agritech markets. Impurities from the oligonucleotide synthesis process can often be 
present together with the target oligonucleotides and may lead to negative effects. A 
mobile phase optimised for oligonucleotide characterisation was determined based on 
several key parameters such as hydrophobicity and the Henry’s Law constant of the 
alkylamine reagents. The results provide key insight into how such parameters affect 
176 | P a g e  
analytical performance and may help oligonucleotide producers choose mobile 
phases optimised to their needs at product characterisation stage. The modification of 
an existing DNA extraction method to enable the extraction of dsRNA through the use 
of neutral pH solutions at high yields was successfully demonstrated. Stable isotope 
labelling was also developed and utilised for the accurate quantification of dsRNA. 
Together these tools can further provide siRNA oligonucleotide therapeutic 
manufacturers and the agritech industry with improved methods for the purification 
and characterisation of nucleic acid products to be part of highly efficient (bio) 
manufacturing processes. High-resolution nucleic acid separations were achieved 
using a range of different monoliths. Moreover, a comparative analysis of monolith 
column porosities delivered a better understanding of the interplay between porosity 
and analyte size and their relation to HPLC performance. Both column manufacturers 
and their customers stand to benefit by applying this knowledge to choose better-
suited columns based on the analyte type. There may also be potential new 
opportunities using alternative monolith column porosities apart from those studied 
here. Overall, the main industries that utilise RNA-pharmaceutical companies 
performing drug development for antisense and other therapeutic oligonucleotides, 
agricultural companies researching next-generation RNAi insecticides, and other 
biotechnology sectors can use the insights and methods from this research to 
significantly improve multiple aspects of their analytical operations. 
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Appendix  
 
 
Appendix A1 The IP RP HPLC analysis of E. coli expressed with 765 bp dsRNA 
extracted using TRIzol Max performed in biological triplicate under gradient condition 
12 (see chapter 2, 2.6.5.1).     
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Appendix A2 The IP RP HPLC analysis of E. coli expressed with 765 bp dsRNA 
extracted using DNAzol performed in biological triplicate under gradient condition 12 
(see chapter 2, 2.6.5.1).    
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Appendix A3 The IP RP HPLC analysis of E. coli expressed with 765 bp dsRNA 
extracted using RNAzol performed in biological triplicate under gradient condition 12 
(see chapter 2, 2.6.5.1).   
